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    Enamelin (Enam) is essential for proper dental enamel formation. In Enam null mice 
the mineralization front associated with the secretory surface of the ameloblast membrane 
fails to initiate and elongate enamel mineral ribbons, so no true enamel forms. The 
mineralization front is a complex of enamel proteins that cannot be reconstituted in vitro.  
The main purpose of this dissertation was to develop an in vivo assay to study the 
structural and functional characteristics of enamelin in enamel formation by establishing 
a range of enamelin transgene expression that recovers the enamel phenotype of Enam 
knockout mice. A mouse expression vector was constructed using 4.6 kb of 5’ 
amelogenin gene up to the translation initiation codon, the 3.8 kb Enam cDNA, and 1.1 
kb of amelogenin 3’ noncoding sequence. This construct was assembled and used to 
generate enamelin transgenic mice. The expression level of Enam gene in different 
transgenic mice lines varies from very little to as high as around 5 times as the amount of 
endogenous gene expression. Using these transgenic mice to breed with Enam knockout 
mice, we found that appropriate transgene expression level can fully recover the defective 
phenotype of Enam knockout mice. In one transgenic mouse line, which as a moderate 
expression level, the transgene successfully rescued th  defective phenotype of Enam 
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knockout mice. The enamel thickness and microstructu e of enamel is the same as wild-
type mouse in this transgene expressed in knockout background mice. Other transgenic 
mouse lines have a normal enamel thickness and normal decussation pattern when the 
transgene is expressed in heterozygous background. The teeth appear yellowish and 
smooth, which is similar to that of the wild-type mouse. We also found in moderate to 
high expression level enamelin transgenic mouse lins, the enamel started to have 
defective phenotypes: with moderate expression level, th  teeth show protrusive structure 
on the surface of enamel; with high transgene expression, the enamel layer is almost lost. 
This is the first time in the literature that described the effect of over-expression of 
















    A tooth is comprised of three mineralized tissues: enamel, dentin, and cementum, 
and is connected to a fourth mineralized tissue, bone, by the periodontal ligament. 
Due to its high mineral content and organized structure, enamel has exceptional 
functional properties and is the hardest substance in the human body (Margolis et al., 
2006). Dental enamel formation (amelogenesis) is under genetic control and is the 
result of highly orchestrated extracellular processes that regulate the initiation, growth, 
and organization of forming mineral crystals (Margolis et al., 2006; Nanci, 2003).  
    Amelogenesis can be subdivided into several stage : presecretory, secretory, 
transition and maturation stages. During the secretory stage, ameloblasts elaborate and 
organize the entire enamel thickness, resulting in the formation of a highly ordered 
tissue. During the maturation stage, ameloblasts modulate between smooth and ruffle-
ended phases and transport the ions required for the mineral deposition (Nanci, 2003). 
The three major enamel matrix proteins secreted in the secretory stage are amelogenin, 
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ameloblastin and enamelin. Enamelin is the largest and least abundant enamel matrix 
protein. It makes up about 1-5% of total enamel matrix protein (Fukae et al., 1996; Hu 
et al., 2001b). It was originally characterized when it was isolated from unerupted pig 
teeth (Fukae and Tanabe, 1987a). Porcine enamelin is a glycoprotein with a molecular 
weight of 186 kDa (Hu et al., 1997b). Human enamelin gene (ENAM) is localized on 
chromosome 4 (4q13.3) near ameloblastin (AMBN), which is a region linked to 
inherited enamel defects known as melogenesis imperfecta (Hu et al., 2001b; 
Karrman et al., 1997). Enam is a tooth-specific gene and is expressed predominantly 
by the enamel organ, and at very low levels in odontoblasts (Hu et al., 1998; Hu et al., 
2001b; Nagano et al., 2003). Studies of enamelin null (Enam-/-) mice show a dose 
effect: both heterozygous and homozygous mice have def ctive enamel with the null 
mice showing a more severe phenotype. The incisors of enamelin null mice appear 
chalky-white and rough, while the teeth of wild-type mice are yellow and smooth. In 
heterozygous mice, only lower incisors are affected. This suggests that enamelin plays 
a role in the process of enamel matrix mineralization. Although it is clear that 
enamelin plays a critical role in amelogenesis, theexact mechanism of how it 
functions remains unclear. Enamel mineralization is a complex process. While 
ameloblasts retreat from dentin and secret enamel proteins into the enamel matrix, 
enamel crystals grow in length. The mineralization fr t is along the secretory surface 
of the ameloblast plasma membrane. The mineralization front is critical in 
amelogenesis and has never been reconstituted in vitro.  
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    The goal of this study is to establish an in vivo animal model to study the structural 
and functional characteristics of enamelin in enamel formation. The strategy is to 
generate an enamelin transgene that will be expressed by ameloblasts at the same time 
that wild-type enamelin is normally expressed. It is expected that ameloblasts in 
different transgenic mice will express the enamelin transgene at different levels 
depending upon the copy number and chromosomal insertion site of the transgene. It 
is hoped that a range of transgenic enamelin expression levels can be identified that 
recovers the normal enamel phenotype in the Enam null background. Then subsequent 
studies can express enamelin transgenes containing site-directed mutations within the 
range of wild-type Enam transgene expression that previously recovered the 
phenotype in Enam null mice. Deviations from the normal enamel phenotype can then 
be ascribed to the change introduced by the mutation, rather than being due to 
differences in the Enam expression level. Therefore, if a range of wild-type enamelin 
transgene expression that fully recovers the enamel phenotype can be determined, this 
system will be a valuable tool to study the function of specific regions of the enamelin 
protein in vivo. Such an in vivo model system could be used to define protein-protein 








To develop an in vivo assay to study the structural and functional characte istics of 
Enam in enamel formation by establishing a range of enamelin transgene expression 
that recovers the enamel phenotype of enamelin knockout mice. 
 
Hypothesis 
    Enamelin plays a crucial role in dental enamel formation. The enamelin null mice 
showed no mineralization at the mineralization front during the secretory stage. The 
specific function of enamelin and its correlation with enamel mineralization is unclear. 
We hypothesize that by establishing transgenic mice expressing full-length enamelin, 
and breeding these enamelin transgenic mice with enam lin null mice, we can 
discover a range of enamelin transgenic expression that recovers the enamel 
phenotype in null mice. By characterizing the enamel phenotypes of enamelin 
transgenic mice we will achieve a better understanding of enamelin function while 
establishing an in vivo animal system to study the structural and functional 
characteristics of enamelin in the process of enamel formation.  
 
Specific Aims 
    The central hypothesis will be tested by addressing the following specific aims: 
Specific Aim 1: Establish enamelin transgenic mice and determine enamelin 
expression levels in transgenic mice. The mouse enamelin cDNA sequence will be 
flanked by the 5’ amelogenin promoter and 3’ amelognin untranslated region. This 
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construct will be used to generate enamelin transgenic mice. In these transgenic mice, 
we expect that enamelin will be expressed specifically by the enamel organ 
epithelium (EOE) during the secretory stage of enamel formation. Founders of these 
transgenic mice will be mated with wild-type C57BL/6 mice. Subsequent generations 
of offspring will be sacrificed on day 5, molars and incisors will be collected and 
analyzed separately. Real-time PCR and Western blotting will be performed to 
determine the expression levels of the enamelin transgene in developing teeth. 
 
Specific Aim 2: Cross breed enamelin transgenic mice with enamelin null mice 
and characterize the phenotype of the offspring. Enamelin transgenic mice 
(Enamtg;+/+ ) from different transgenic founders will be crossed with enamelin 
knockout mice (Enam-/-). Wild-type mice and mice having the parental genotypes will 
be characterized along with offspring having the following genotypes: 1) Enamtg;+/-, 2) 
Enamtg;-/-, and 3) Enam+/-. Histological, radiographic and scanning electron 
microscopic (SEM) evaluations will be conducted to compare enamel formed in mice 
with these genetic backgrounds to see whether the transgene can rescue the 
phenotype of the null mice. Day 5 first molars of the F2 offspring will be collected to 
check enamelin expression, at the protein level by Western-blotting and at the mRNA 
level by real-time PCR. 
 
Specific Aim 3: Characterize the enamel phenotype of Enam+/+ mice expressing 
the Enam transgene (Enamtg;+/+ ). Founders of the transgenic mice will be mated 
with wild-type C57BL/6 mice. Transgene-positive offspring of enamelin transgenic 
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mice will be sacrificed at 7 weeks. Oral photographs and scanning electron 
microscopy (SEM) will be performed to characterize the enamel phenotype 
specifically with respect to enamel prism decussation and the total thickness of the 
enamel layer. 
 
Significance and Background 
    Unlike other mineralized tissues, mature enamel is composed of over 95% (by 
weight) apatite crystals and has a unique hierarchical structure. Due to its high 
mineral content and organized structure, enamel has exceptional functional properties 
and is the hardest substance in the human body (Margolis et al., 2006). Dental enamel 
is made up of mineral crystals which are ionic solids comprised mainly of calcium 
(Ca2+), phosphate (PO4
3-), and hydroxyl (OH-) ions. The observed configuration is 
primarily calcium hydroxyapatite, which has the chemical formula Ca10(PO4)6(OH)2. 
Ions such as carbonate (CO3
2-), hydrogen phosphate (HPO4
2-), and fluoride (F-) can 
substitute irons in hydroxyapatite (HAP) and locally change the crystal properties 
(Nanci, 2003). Dental enamel formation (amelogenesis) i  under genetic control and 
is the result of highly orchestrated extracellular processes that regulate the initiation, 
growth, and organization of forming mineral crystal (Margolis et al., 2006; Nanci, 
2003).  
Enamel matrix proteins and dental enamel formation. Amelogenesis can be 
subdivided into several stages: presecretory, secretory, transition and maturation 
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stages. Ameloblasts are the cells that secrete matrix proteins and are responsible for 
creating and maintaining an extracellular environmet favorable for mineral 
deposition. During the presecretory stage, differentiati g ameloblasts acquire their 
phenotype, change polarity (of their nuclei), develop an extensive protein synthesis 
apparatus, and prepare to secrete the organic matrix of enamel. During the secretory 
stage, ameloblasts elaborate and organize the entire enamel thickness, resulting in the 
formation of a highly ordered tissue. During a short transition stage, ameloblasts 
become shorter and wider and reorganize their intracellular structures. A new basal 
lamina is established and maintains a strong connection between the enamel layer and 
maturation stage ameloblasts. During the maturation stage, ameloblasts modulate and 
transport the ions required for the deposition of mineral (Nanci, 2003). The three 
major enamel matrix proteins secreted in the secretory stage are amelogenin, 
ameloblastin and enamelin. Amelogenin and its cleavage products make up over 90% 
of the enamel matrix (Fincham et al., 1999b; Termine et al., 1980). They are mostly 
20 to 25 kDa in size, and hydrophobic (Margolis et al., 2006). Amelogenin null mice 
show a phenotype similar to human melogenesis imperfecta, with a thin surface layer 
of mineral lacking a typical rod pattern (Gibson et al., 2001). Ameloblastin is another 
major protein in the secretory stage enamel matrix. Over-expression of ameloblastin 
in mice significantly changes enamel crystal habit nd enamel rod morphology, also 
in a fashion resembling amelogenesis imperfecta (Paine et al., 2003). In ameloblastin 
knockout mice, ameloblasts seem to de-differentiate soon after the onset of secretory 
enamel deposition, resulting in nearly no enamel formation (Fukumoto et al., 2004). 
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Neurotrophic factor neurotrophin 4 (NT-4) induces ameloblastin expression i  vitro 
and may regulate proliferation and differentiation f the dental epithelium and 
promote production of the enamel matrix (Yoshizaki et al., 2008). Enam null mice 
show a failure to mineralize enamel, suggesting a critical function of enamelin in 
mineralization (Hu et al., 2008). Secreted enamel matrix proteins are cleaved by two 
proteinases that are also secreted in the enamel matrix. MMP-20, or enamelysin, is 
expressed during secretory stage. Mmp20 null mice show a severely abnormal enamel 
phenotype with altered rod patterns and hypoplastic (th n) enamel. Amelogenin full-
length protein was not proteolytically cleaved in Mmp20 null mice. This suggests 
proper processing of enamel matrix proteins is important during enamel formation 
(Beniash et al., 2006; Caterina et al., 2002). Kallikrein 4 (Klk4) is the second enamel 
matrix proteinase. Klk4 is a serine proteinase and synthesized and secreted during the 
maturation stage (Hu et al., 2002; Simmer et al., 1998). It is believed to be responsible 
for the complete breakdown of enamel proteins (Simmer and Hu, 2002). The enamel 
layer in the Klk4 null mouse was normal in thickness and contained dcussating 
enamel rods, but was rapidly abraded following weaning, despite the mice being 
maintained on soft chow. In the Klk4 null mice, individual enamel crystallites of 
erupted teeth failed to grow together, interlock, and function as a unit. Instead, 
individual crystallites seemed to spill out of the enamel when fractured. These results 
demonstrated that Klk4 is essential for the removal of enamel proteins and the proper 
maturation of enamel crystals (Simmer et al., 2009). Enamel matrix proteins and their 
proteolytic cleavage fragments play an important role in the process of enamel 
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formation. Their structural and functional characteris ics are still far from being 
understood and need to be further studied.  
 
Enamelin and its function in enamel formation. Human enamelin (ENAM ) consists 
of 9 exons and 8 introns and encodes a protein of 1103 amino acids and a signal 
peptide of 39 amino acids. It is a tooth-specific gene and is expressed predominantly 
by enamel organ, and at a low level in odontoblasts (Hu et al., 1998; Hu et al., 2001b; 
Nagano et al., 2003). Studies of enamelin null (Enam-/-) mice show a dose effect: both 
heterozygous and homozygous mice have defective enamel with the null mice 
showing a more severe phenotype. Histological sections of unerupted developing 
enamel in Enam null mice show a failure to mineralize the enamel layer at the 
secretory surface of the ameloblast, leaving the enamel matrix unmineralized (Hu et 
al., 2008) (Fig 1.1). Histological sections of unerupted, un-decalcified molars after 
von Kossa staining show mineralization of alveolar bone, dentin, and enamel in the 
various genotypes, as indicated (Fig 1.1). Whereas well-developed and mineralized 
enamel (e) and dentin (d) are present in both wild-type (Enam+/+) (Fig 1.1 D) and 
heterozygous (Enam+/-) (Fig 1.1 E) mice, only small, punctate foci of mineralization 
are observed in the enamel layer of Enam null mice (Enam-/-) (Fig 1.1 F). These foci 
localize near the dentino-enamel junction (DEJ), despit  there being a thick 
accumulation of organic material in the enamel layer, presumably amelogenin and 
other enamel matrix constituents. This suggests that en melin plays a critical role in 





Fig 1.1: Phenotype of enamelin knockout mice. Oral photograph of enamelin wild-
type (Enam+/+) (A), enamelin heterozygous (Enam+/-) (B) and enamelin knockout 
(Enam-/-) (C) mice are shown. Von Kossa staining for 1 week old incisors sections for  
enamelin wild-type (Enam+/+) (D), enamelin heterozygous (Enam+/-) (E) and enamelin 
knockout (Enam-/-) (F) mice are also shown. Od, odontoblast; Am, ameloblast; e, 
enamel; d, dentin. (Hu JC et al. J Biol Chem. 2008) 
 
Enamelin and Amelogenesis Imperfecta. The importance of the enamelin in enamel 
formation was first demonstrated when defects in ENAM mutations were found to 
cause autosomal dominant amelogenesis imperfecta. Amelogenesis imperfecta (AI) is 
a group of inherited disorders that are clinically heterogeneous and exhibit tooth 
enamel defects without systemic manifestations (Stephanopoulos et al., 2005; Witkop, 
1988). Both the primary and permanent dentitions are affected (Aldred and Crawford, 
1995). The major clinical manifestations are enamel hypoplasia (enamel is thin but 
seemingly well mineralized), hypomineralization (subdivided into hypomaturation 
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and hypocalcification), or a combined phenotype, which is seen in most cases (Aldred 
and Crawford, 1995; Stephanopoulos et al., 2005). Amelogenesis imperfecta can be 
subdivided according to its pattern of inheritance: autosomal-dominant, autosomal-
recessive, or X-linked. AmelX mutations cause X-linked amelogenesis imperfecta 
(Aldred et al., 2003; Stephanopoulos et al., 2005). The first mutation in ENAM was 
reported in 2001. It was a single nucleotide change, g.6395G>A, at the splice donor 
site of intron 8, probably caused the skipping of exon 8, resulting in an in-frame 
deletion of the amino acid sequence encoded by this exon. The phenotype of the 
affected individual is thin and smooth hypoplastic enamel, with a diagnosis of 





    The second ENAM mutation causing ADAI was g.2382A>T. It was a single base 
substitution in exon 5, resulting in a change of lysine to a stop codon, which truncated 
the protein of only 55 amino acids (Mardh et al., 200 ). The third mutation was 
g.8344delG. It is also an ADAI and caused by a single G-deletion within a series of 7 
G residues at the exon9-intron boundary of ENAM. This mutation alters the reading 
frame and causes a premature stop codon in the 5’ rgion of exon 10 (Kida et al., 
2002). This same mutation was later found in several other families with generalized 
and severe thinning of the enamel (Hart et al., 2003a; Kim et al., 2005b; Pavlic et al., 
2007). The fourth ENAM was a 2-bp insertion mutation that resulted in a premature 
stop codon in exon 10 (g.13185_13186insAG) (Hart et al., 2003b). This mutation was 
also found in several other families (Kang et al., 2009; Ozdemir et al., 2005; Pavlic et 
al., 2007; Chan et al., 2010). A fifth ENAM mutation was found in 2005, it was 
g.4806A>G. This mutation altered the intron 6 splice acceptor site, which potentially 
results in two defective splicing outcomes. Inclusion of intron 6 would cause a 
premature stop codon, while the skipping of exon 7 would delete a portion of the 
protein (Kim et al., 2005b). Two more mutations were also found in 2005 in one study. 
One is g.12663C>A, a single substitution in exon 10 that leads to a truncated protein. 
This mutation causes ADAI. The second mutation results in an in-frame insertion of 7 
Fig 1.2: Mutation of enamelin gene cause Amelogenesis Imperfecta (AI). (A), 
Pedigree of one AI family; filled symbols denote affected individuals. (B), 
Sequencing of DNA from individual Ⅱ.1 reveals the presence of the mutation 
nt841+1 (G→A) (arrowed), which is not present in a control sample. (C and D), 
Photographs of individual Ⅱ.8 showing the small, smooth, yellow teeth that result 
from the enamel hypoplasia. (Rajpar et al. Hum Mol Gen. 2001) 
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amino acids in exon 10 (g.12946_12947insAGTCAGTACCAGT CTGTGTC), and 
was claimed to lead to an autosomal-recessive amelogenesis imperfecta (ARAI) 
(Ozdemir et al., 2005). One mutation was found in 2007 that causes ADAI. It was a 
c.G817T, generating a change of arginine to methionine in position 179 of the protein 
(Gutierrez et al., 2007). Two more mutations were found in 2009. One is a single T 
deletion in exon 10 (g.14917delT, c.2991delT), which is predicted to result in a frame 
shift with a premature termination codon (p.L998fsX1062) (Kang et al., 2009). The 
second mutation found in 2009 was a novel missense mutation (g.12573C>T) that 
substitutes leucine for a phosphorylated serine (p.S216L) (Chan et al., 2010). As 
summarized in Table 1.1, the phenotype of these ten ENAM mutations varies from 
localized pitting, smooth thin enamel, to generalized thin hypoplastic enamel. These 
mutations of ENAM and their correlation with amelogenesis imperfecta demonstrate 
strongly that enamelin plays an important role in amelogenesis in human.  
The inheritance pattern of enamel defects associated with ENAM mutations blurred 
after characterization of three kindreds with sever generalized enamel hypoplasia 
inherited in an autosomal recessive pattern (Hart et al., 2003b). All three probands 
were homozygous for p.P422fsX448. Most interestingly, all persons that were 
heterozygous for this mutation had localized hypoplastic enamel pitting. These defects 
were originally thought to be too minor to classify as AI, but in the light of these and 
later genetic analyses, they are clearly an enamel ph notype caused by a defective 
single allele of ENAM. In another AI kindred with severe generalized enamel 
hypoplasia the proband was a compound heterozygote, with the p.P422fsX448 defect 
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in one ENAM allele paired with a novel in-frame insertion of 7 amino acids 
(p.V340_M341insSQYQYCV) in the other (Ozdemir et al., 2005). In addition, simple 
heterozygotes with either of these defective ENAM alleles paired with a wild-type 
allele displayed mild localized hypoplasia mainly consisting of well-circumscribed 
enamel pits. Characterization of other simple heterozygotes with the p.P422fsX448 
defect showed the enamel phenotype could range from chalky white enamel with only 
mild local hypoplastic alterations to local hypoplastic AI (Pavlic et al., 2007). Simple 
heterozyotes for another ENAM frame shift mutation (p.L998fsX1062) showed 
similar differences in severity (Kang et al., 2009). One affected person had chalky 
white enamel with localized pitting while another had prominent horizontal bands of 
hypoplastic enamel affecting primarily the cervical third of the crowns. In another 
study, individuals with the mutation p.S216L in one ENAM allele paired with a wild-
type allele had chalky-white enamel with surface roughness or highly polished enamel 
with some localized surface pitting (Chan et al, 2010). Researchers in this field start to 
believe now that all inherited enamel defects, including minor pitting and surface 
roughness, be included under the designation amelogenesis imperfecta. Excluding 
minor phenotypes would sometimes require diagnosing iblings with the same ENAM 
mutation as having and not having AI when one enamel ph notype is only moderately 
more severe than the other. If we accept that minor inherited enamel defects are AI, 
ENAM defects can be said to have an autosomal dominant pattern of inheritance. 
Penetrance is variable, as some individuals heterozygous for the p.P422fsX448 
mutation showed no detectable enamel phenotype, not even pitting (Kang et al., 2009). 
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Expressivity is also variable as persons heterozygous f r the p.P422fsX448 mutation 
can exhibit chalky enamel with minor pitting or more severe horizontal grooves of 
enamel hypoplasia. 
 
Table 1.1: Enamelin mutation and Amelogenesis Imperfecta 
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    An interesting observation from the above mentioned reports as well as repots of 
AMELX mutations is that the clinical presentation of those cases share similar enamel 
defects.  For example, patients with amelogenisis imperfecta caused by ENAM and 
AMELX mutations generally have thin and hypoplastic enamel. A possible 
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explanation for this observation is that both of those genes produce proteins in 
secretory stage enamel formation that are important in proper enamel formation. The 
functions of those proteins may be similar in facilitating crystal elongation thus in 
their absence enamel doesn’t reach its full thickness. Another possibility is that those 
gene products may function differently, however, they interact together to regulate 
enamel crystal formation. Thus in the absence of either one of them, the defective 
enamel phenotypes are similar.  
 
Biochemistry and proteolytic cleavage of enamelin. Porcine enamelin cDNA was 
cloned in 1997, this was the first enamelin gene sequence reported (Hu et al., 1997b). 
Before this, studies of enamelin were all at the protein level. The porcine animal 
model is used to extract proteins from developing uer pted teeth because of its high 
quantity of protein and easy availability. Full-length enamelin protein has 1142 amino 
acids, with the first 38 being the signal peptide. The secreted intact protein is 186 kDa 
(residues 39-1142), and the large enamelin cleavage products (155-kDa, 142 kDa, 89 
kDa) were shown to accumulate only near the enamel surface, not in the matrix. All of 
these cleavage products contain the original N-terminus, since the enamelin protein is 
processed by successive cleavages from its C-terminus. Among these fragments, the 
89 kDa protein was studied in detail. It extends from Met39 to Trp665 (Hu et al., 
1997b; Hu and Yamakoshi, 2003; Hu et al., 2005). Using antibody raised from this 89 
kDa enamel cleavage protein, and as well as antibodies  against amelogenin, 
amelogenin C-terminus and ameloblastin 13-17 kDa protein, immunohistochemistry 
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showed these different enamel matrix protein cleavage products have different 








    Amelogenin cleavage products accumulate throught the whole thickness of the 
enamel matrix, while the intact protein (containing the C-terminus) is present only on 
Fig 1.3: Variation of enamel matrix protein localization. 
Immunohistochemistry of the porcine secretory-stage enamel showing 
immunolocalization of enamel proteins using light microscopy. The four 
antibodies used (from left to right) were a polyclonal antibody raised against intact 
(25 kDa) amelogenin, an anti-peptide antibody specific for the amelogenin C-
terminus, polyclonal antibodies raised against 13 to 17 kDa ameloblastin cleavage 
products, and polyclonal antibodies raised against the 89 kDa enamelin. The 
amelogenin C-terminal antibody, indicative of the intact protein, was restricted to 
the surface enamel. The ameloblastin antibody produce  a honeycomb pattern over 
the entire thickness of the immature enamel. The enamelin antibody generated a 
reverse honeycomb pattern. (Uchida et al. Histochemistry. 1991) 
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the surface. Ameloblastin cleavage products localize in the sheath of enamel rods 
producing a “honeycomb pattern”. The distribution pattern of enamelin 89 kDa has a 
“reverse-honeycomb pattern” and localizes among the enamel rods. This observation 
strongly suggests that the proteolytic cleavage products of enamel proteins are not 
simply degradation products. They are functional poly eptides, and their functions are 
possibly different from those of their intact proteins (Hu and Yamakoshi, 2003). Other 
smaller cleavage products of secreted enamelin include 25 kDa, 34 kDa and 32 kDa 
fragments. Among these, the 32 kDa (residue 174-279) fragment was intensively 
studied. It is a hydrophilic and acidic fragment with two phosphorylated serines 
(Ser191 and Ser216) and three glycosylated asparagines (Asn245, Asn252, and 
Asn264) (Yamakoshi, 1995). Immunohistochemistry using antibody against the 32 
kDa enamelin specifically stained the enamel rods (Uchida et al., 1991a). The 32 kDa 
enamelin and amelogenin proteins might cooperate to promote the nucleation of 
apatite crystals in vitro (Bouropoulos and Moradian-Oldak, 2004). This furthe  
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Enamelin (Enam) is essential for proper dental enamel formation. In Enam null mice 
the mineralization front associated with the secretory surface of the ameloblast 
membrane fails to initiate and elongate enamel mineral ribbons, so no true enamel 
forms. The mineralization front is a complex of enamel proteins that cannot be 
reconstituted in vitro, so an in vivo system is being developed. A mouse ameloblast-
specific expression vector was constructed using 4.6 kb of 5’ amelogenin gene up to 
the translation initiation codon, the 3.8 kb Enam cDNA, and 1.1 kb of amelogenin 3’ 
non-coding sequence. Rare (8 nucleotide) restriction enzyme recognition sequences 
were introduced at both ends of the Enam cDNA. This construct was assembled and 
used to generate enamelin transgenic mice. Offspring of the founders were genotyped 
using PCR to verify integration of the transgene. From thirteen original founders, 
eight were further derived as they showed stable int gration of the expression 




       The objectives of this study were to establish enamelin transgenic mice that 
express a wild-type enamelin transgene in ameloblasts using the amelogenin promoter 
(this chapter), to determine the transgene expression levels in each founding line 
(chapter 3), and to characterize the enamel phenotypes of Enam+/+ , Enam+/-, and 
Enam-/- mice (chapters 4 and 5) expressing the Enam transgenes from different 
founders.  
    Amelogenin is the most abundant protein in developing enamel (Fincham et al., 
1999b). The mouse amelogenin (AmelX) 5’ transcriptional regulatory region has been 
successfully used to drive transgenic expression specifically in ameloblasts (Snead et 
al., 1996; Snead et al., 1998b; Wen et al., 2008b). In this study, we introduced (by 
PCR amplification) four rare (8 bp) restriction site  at the edges of the mouse AmelX 
5’ and 3’ gene regulatory regions, and inserted the 3845 bp Enam cDNA sequence 
between them. The amplification products were cloned and used to construct an 
Enam transgene by serial subcloning. Enamelin transgenic mouse lines were 
established using this enamelin transgene construct. 
 
Materials and Methods 
Establishing the enamelin transgene construct. Genomic DNA from the tail tissue 
of C57BL/6 mice was isolated with the DNeasy Tissue kit (Qiagen, Valencia, CA) 
and used as template to amplify 5’ and 3’ AmelX sequences. The mouse enamelin 
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cDNA (NM_017468.2) was similarly amplified and cloned to add specific restriction 
enzyme sites. The three fragments of amplification products were ligated into the 
pCR2.1-TOPO cloning vector (Invitrogen) separately and ligated together as 
indicated (Fig 2.1) using the introduced restriction enzyme sites. Final enamelin 
transgene construct sequence is shown in Fig 2.2. 
 
Generation of Enam transgenic mice. The 9.6 kb Enam transgene was excised from 
the vector by restriction digestion with NotI-SrfI purified with a gel extraction kit 
(Qiagen, Germantown, Md., USA) and microinjected into fertilized C57BL/6 X SJL 
F2 oocytes and surgically transferred to recipients at the Transgenic Animal Model 
Core at the University of Michigan. A total of 13 independent lines were generated 
and mated with C57BL/6 mice. 
 
Genotyping enamelin transgenic mice. One primer set was designed to specifically 
detect the Enam transgene. The forward primer anneals to the amelogenin promoter 
and a reverse primer that anneals to the enamelin cDNA sequence. This primer set 
generates a 236 bp amplification product when the genomic DNA is isolated from 
mice carrying the enamelin transgenic mouse. Genomic DNA from wild-type mice 
does not amplify. A second primer set anneals to enamelin intron sequences and 
produces a 324 bp amplification product. This prime s t detects only the wild-type 
enamelin gene. A third primer set anneals to the lacZ sequence, which is found only 
in the enamelin knockout, and produces a 397 bp amplification product Sequence of 
these three primer sets were shown in Table 2.1. Basically PCR condition is to 
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maintain the DNA at 94°C for 5 minutes followed by 32 cycles of denaturation at 
94°C for 30 seconds, annealing at 58°C for 30 seconds, extension 72°C for 60 
seconds and then maintain the reaction at 72°C for 7 minutes to complete final 
reaction. 
 
Breeding the transgenic founders. The transgenic founders were bred to generate 
mice carrying the amelogenin-promoter-driven-enamelin-transgene in various genetic 
backgrounds. The first breeding strategy was to breed the transgenic mouse founders 
to C57BL/6 wild-type mice. Transgene in wild-type background (Enamtg,+/+) and 
wild-type mice (Enam+/+) will be generated from this strategy (Fig 2.3 left). 
Genotyping for this breeding strategy is shown in Fg 2.4 (A and B). The second 
breeding strategy is to breed the transgenic mice to Enam null mice for two 
generations to generate four genotypes: Enamtg,-/-, Enamtg,+/-, Enam-/- and Enam+/-. 
Original transgenic founders or offspring carrying the Enam transgene (Tg) were 
mated with Enam-/- mice. F1 offspring positive for the transgene and heterozygous for 
Enam (Enam+/-) were mated with Enam-/- mice, yielding four genotypes: enamelin 
transgene expressed in null background (Enamtg,-/-), enamelin transgene expressed in 
heterozygous background (Enamtg,+/-), enamelin null mice (Enam -/-) and enamelin 
heterozygous mice (Enam+/-) (Fig 2.3 right). Three primer sets were used to genotype 
the offspring: “Enam tg”, “Enam 4&5” and “lacZ”. Genotyping strategy for this 




Fabricating the enamelin transgene. The expression construct used to establish 
enamelin transgenic mice contained three fragments: the amelogenin (AmelX) 
promoter region (4.6 kb), the enamelin full-length cDNA coding region (3.8 kb) and 
the 3’ amelogenin region (1.1 kb). In order to make this gene construct, we performed 
a series of PCR amplification and subcloning steps. To introduce rare restriction 
enzyme sites, we designed PCR primers that had the esignated restriction sites at the 
5’ ends (Fig 2.1 B). The AmelX promoter (5’AmelX, 4655 bp), Enam coding region 
(Enam, 3845 bp) and AmelX downstream (3’AmelX, 1143 bp) sequences were 
amplified and then ligated into pCR2.1-TOPO (3931 bp) vector. We designated the 
clones “clone 1” (5’AmelX-pCR2.1-TOPO), “clone 2” (Enam- pCR2.1-TOPO), and 
“clone 3” (3’AmelX-pCR2.1-TOPO) (Fig 2.1 C).  
    Clones 1 and 2 were both restricted with NotI and AscI, and the 4.6 kb AmelX 
promoter from clone 1 was ligated to the 5’ side of the Enam coding sequence in 
Clone 2 to generate Clone 4 so that AmelX promoter sequence and Enam cDNA 
sequence were ligated together (Fig 2.1 D). Clones 3 and 4 were then restricted with 
NotI and SgfI, and the 8.5kb 5’AmelX-Enam fusion from clone 4 was ligated to Clone 
3 to generate Clone 5, with the AmelX promoter-Enam cDNA fusion and the AmelX 3’ 
sequence ligated together (Fig 2.1 E). Clone 5 is the final gene construct. Clone 5 was 
restricted with NotI and SrfI and the Enam transgene (9.6 kb) was separated from the 
cloning vector (3.9 kb) by agarose gel electrophoresis. The 5’AmelX-Enam-3’AmelX 
restriction fragment was used to generate transgenic mice. Transcription of the 
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transgene is predicted to initiate in the 5’AmelX region at the start of the amelogenin 
exon 1, which is non-coding. Intron 1 (1277 bp) of AmelX is removed by RNA 
splicing. Exon 2 contains 10 nucleotides from the amelogenin exon 2, the AscI site, 
followed by the Enam translation initiation codon and entire coding sequence (3845 
bp) (Fig 2.1 G). The DNA sequence of the transgene construct is shown in Fig 2.2.  
 
Generation of Enam transgenic mice. The 9.6 kb Enam transgene was excised from 
the vector by restriction digestion with NotI-SrfI, purified with a gel extraction kit, 
and microinjected into fertilized C57BL/6 X SJL F2 oocytes and then surgically 
transferred to recipients at the Transgenic Animal Model Core at the University of 
Michigan. A total of 13 independent lines were g nerated and mated with C57BL/6 
mice. The transgene fragment inserted randomly into genome, so the transgenic lines 
have different copy numbers and integration sites. The transgene expression levels are 
therefore expected to differ in the various transgeic lines. A summary of the 13 
transgenic mouse founders is shown in Table 2.2.  
 
Breeding the enamelin founders with C57/BL6 mice. These founders were used to 
breed with C57BL/6 wild-type mice to maintain the transgenic lines (Fig 2.3 left). 
Offspring of this breeding have two genotypes: enamelin transgenic mouse (Enamtg, 
+/+) and wild-type mouse (Enam +/+). “Enam tg” primer set is designed for genotyping 
transgenic mice. This primer set uses a forward primer that anneals to the amelogenin 
promoter and a reverse primer that anneals to the enam lin cDNA sequence. This 
primer set only amplifies genomic DNA isolated from ice carrying the enamelin 
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transgene and produces a 236 bp amplification product. Wild-type mice do not have a 
PCR product for this primer set. Enamelin transgenic mice also have a positive band 
for the “Enam 4&5” primer set, because the endogenous enamelin gne is still present 
in the genome of enamelin transgenic mouse; but have no positive bands for “LacZ” 
primer set, because there is no enamelin knockout cnstruct sequence present in the 
genome of mice with this genotype (Fig 2. B). Wild-type mice have a positive band 
for “Enam 4&5” primers, while the other two primer sets are both negative (Fig 2.4 
A). Founders 5, 8 and 13 were infertile. Founders 6 and 9 spawned offspring, but 
genotyping showed all of their pups were transgene negative, so breeding was 
terminated. All other founders were able to pass the transgene on to subsequent 
generations. It was expected that high enamelin trasgene expression levels might 
result in enamel malformations. Oral photographs of offspring from the 8 transgenic 
lines along with the wild-type are shown in Fig 2.5. 
 
Breeding the enamelin founders with Enam null mice. Enam transgenic mice were 
used to breed with Enam null mice to generate F1 offspring. Enam transgene positive 
F1 were used to breed with Enam null mice again to generate F2 offspring. Four 
genotype are generated in F2 offspring: Enamtg, -/-, Enamtg, +/-, Enam-/- and Enam+/-
(Fig 2.3 right). These genotypes were determined using three primer sets: “Enam tg”, 
“Enam 4&5” and “lacZ”. “ Enam tg” has a forward primer anneals to the AmelX 
promoter region and has a reverse primer anneals to 5’ of enamelin cDNA sequence; 
primer “Enam 4&5” recognize enamelin intron between exon 4 and 5; primer “lacZ” 
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recognize the Enam null construct sequence. Enamtg, -/- mice have positive bands for 
“Enam tg” and “lacZ” (Fig 2.4 C). Enamtg, +/- mice have positive bands for all three 
primer sets (Fig 2.4 D). Enam-/- mice have positive bands for only “lacZ” primer (Fig 
2.4 E). Enam+/- mice have positive bands for both “Enam 4&5” and “lacZ” primers 
(Fig 2.4 F). 
 
Discussion 
    We designed and fabricated a plasmid construct with rare restriction enzyme 
recognition sites positioned at key places so that desired coding sequences can be 
expressed specifically in ameloblasts. This construct allows for one-step directional 
cloning of any coding sequence between the 5’ and 3’ sequences from AmelX, 
provided that the coding region does not contain the 8-base recognition sequences for 
the restriction enzymes. 
    The thirteen Enam transgenic founders were bred with wild-type C57BL/6 mouse 
for the following reasons: 1) to obtain lines with stable transgene expression level 
(examine which lines can have the transgene stably passed onto the next generations); 
2) to maintain the different transgenic mouse lines; 3) to collect secretory stage 
molars from the offspring of all genotypes from this breeding strategy and examine 
the enamelin gene expression level of different transgenic mouse lines. Eight different 
transgenic mouse lines were maintained: lines 1, 2,3 4  7, 10, 11, and 12.  
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By gross evaluation of the oral-photograph of the incisors, it is evident that offspring 
of line 3 has obvious enamel defects: their teeth appe r chalky and white. Offspring 
of line 2 and 12 has some roughness on the surface o  incisors, with line 2 being more 


























Fig 2.1 Fabricating the enamelin transgene construct. Amplification and cloning 
of Enam transgene (Tg) components. A: Sequences of the six PCR primers used to 
amplify target sequences and to introduce rare (8 base cutter) restriction cut sites. B:
The AmelX promoter (5’AmelX, 4655 bp), the Enam cDNA (Enam, 3845 bp) and 
AmelX downstream (3’AmelX, 1143 bp) sequence were amplified from three pair of 
primers showed in A. C: the three amplification products were ligated into pCR2.1-
TOPO (3931 bp). Recombinant plasmids having the 5’ nds of the PCR products on 
the NotI side of the vector were used to construct the Enam transgene. D: Strategy to 
ligate AmelX promoter sequence and Enam cDNA sequence together. E: strategy to 
ligate the AmelX promoter-Enam cDNA fusion to AmelX 3’ sequence. F and G: Final 
gene construct to make enamelin transgenic mice. Sequence of AmelX5’-Enam 
connecting area is shown (Enam Tg). Sequence of wild-type AmelX gene in same area 
is also shown as compare (AmelX Wt). Transcription initiates in the 5’AmelX region at 
the start of the exon 1, which is non-coding. Intro 1 (1277 bp) of AmelX is removed 
by RNA splicing. The AscI site connects 5’AmelX, including 10 nucleotides in exon 2, 
to the Enam cDNA sequence (3845 bp). The splice junction at the start of exon 2 is 
indicated by hash marks in the expanded sequence surrounding the AscI site. The 
Enam cDNA sequence is immediately downstream of the AscI site and is in lower 


























    1 AAGGGCGAAT TCCAGCACAC TGGCGGCCGT TACTAGTGGA TCCGAGCTCG GTACCAAGCT 
   61 TGGCGTAATC ATGGTCATAG CTGTTTCCTG TGTGAAATTG TTATCCGCTC ACAATTCCAC 
  121 ACAACATACG AGCCGGAAGC ATAAAGTGTA AAGCCTGGGG TGCCTAATGA GTGAGCTAAC 
  181 TCACATTAAT TGCGTTGCGC TCACTGCCCG CTTTCCAGTC GGGAAACCTG TCGTGCCAGC 
  241 TGCATTAATG AATCGGCCAA CGCGCGGGGA GAGGCGGTTT GCGTATTGGG CGCTCTTCCG 
  301 CTTCCTCGCT CACTGACTCG CTGCGCTCGG TCGTTCGGCT GCGGCGAGCG GTATCAGCTC 
  361 ACTCAAAGGC GGTAATACGG TTATCCACAG AATCAGGGGA TAACGCAGGA AAGAACATGT 
  421 GAGCAAAAGG CCAGCAAAAG GCCAGGAACC GTAAAAAGGC CGCGTTGCTG GCGTTTTTCC 
  481 ATAGGCTCCG CCCCCCTGAC GAGCATCACA AAAATCGACG CTCAAGTCAG AGGTGGCGAA 
  541 ACCCGACAGG ACTATAAAGA TACCAGGCGT TTCCCCCTGG AAGCTCCCTC GTGCGCTCTC 
  601 CTGTTCCGAC CCTGCCGCTT ACCGGATACC TGTCCGCCTT TCTCCCTTCG GGAAGCGTGG 
  661 CGCTTTCTCA TAGCTCACGC TGTAGGTATC TCAGTTCGGT GTAGGTCGTT CGCTCCAAGC 
  721 TGGGCTGTGT GCACGAACCC CCCGTTCAGC CCGACCGCTG CGCCTTATCC GGTAACTATC 
  781 GTCTTGAGTC CAACCCGGTA AGACACGACT TATCGCCACT GGCAGCAGCC ACTGGTAACA 
  841 GGATTAGCAG AGCGAGGTAT GTAGGCGGTG CTACAGAGTT CTTGAAGTGG TGGCCTAACT 
  901 ACGGCTACAC TAGAAGAACA GTATTTGGTA TCTGCGCTCT GCTGAAGCCA GTTACCTTCG 
  961 GAAAAAGAGT TGGTAGCTCT TGATCCGGCA AACAAACCAC CGCTGGTAGC GGTGGTTTTT 
 1021 TTGTTTGCAA GCAGCAGATT ACGCGCAGAA AAAAAGGATC TCAAGAAGAT CCTTTGATCT 
 1081 TTTCTACGGG GTCTGACGCT CAGTGGAACG AAAACTCACG TTAAGGGATT TTGGTCATGA 
 1141 GATTATCAAA AAGGATCTTC ACCTAGATCC TTTTAAATTA AAAATGAAGT TTTAAATCAA 
 1201 TCTAAAGTAT ATATGAGTAA ACTTGGTCTG ACAGTTACCA ATGCTTAATC AGTGAGGCAC 
 1261 CTATCTCAGC GATCTGTCTA TTTCGTTCAT CCATAGTTGC CTGACTCCCC GTCGTGTAGA 
 1321 TAACTACGAT ACGGGAGGGC TTACCATCTG GCCCCAGTGC TGCAATGATA CCGCGAGACC 
 1381 CACGCTCACC GGCTCCAGAT TTATCAGCAA TAAACCAGCC AGCCGGAAGG GCCGAGCGCA 
 1441 GAAGTGGTCC TGCAACTTTA TCCGCCTCCA TCCAGTCTAT TAATTGTTGC CGGGAAGCTA 
 1501 GAGTAAGTAG TTCGCCAGTT AATAGTTTGC GCAACGTTGT TGCCATTGCT ACAGGCATCG 
 1561 TGGTGTCACG CTCGTCGTTT GGTATGGCTT CATTCAGCTC CGGTTCCCAA CGATCAAGGC 
 1621 GAGTTACATG ATCCCCCATG TTGTGCAAAA AAGCGGTTAG CTCCTTCGGT CCTCCGATCG 
 1681 TTGTCAGAAG TAAGTTGGCC GCAGTGTTAT CACTCATGGT TATGGCAGCA CTGCATAATT 
 1741 CTCTTACTGT CATGCCATCC GTAAGATGCT TTTCTGTGAC TGGTGAGTAC TCAACCAAGT 
 1801 CATTCTGAGA ATAGTGTATG CGGCGACCGA GTTGCTCTTG CCCGGCGTCA ATACGGGATA 
 1861 ATACCGCGCC ACATAGCAGA ACTTTAAAAG TGCTCATCAT TGGAAAACGT TCTTCGGGGC 
 1921 GAAAACTCTC AAGGATCTTA CCGCTGTTGA GATCCAGTTC GATGTAACCC ACTCGTGCAC 
 1981 CCAACTGATC TTCAGCATCT TTTACTTTCA CCAGCGTTTC TGGGTGAGCA AAAACAGGAA 
 2041 GGCAAAATGC CGCAAAAAAG GGAATAAGGG CGACACGGAA ATGTTGAATA CTCATACTCT 
 2101 TCCTTTTTCA ATTCAGAAGA ACTCGTCAAG AAGGCGATAG AAGGCGATGC GCTGCGAATC 
 2161 GGGAGCGGCG ATACCGTAAA GCACGAGGAA GCGGTCAGCC CATTCGCCGC CAAGCTCTTC 
 2221 AGCAATATCA CGGGTAGCCA ACGCTATGTC CTGATAGCGG TCCGCCACAC CCAGCCGGCC 
 2281 ACAGTCGATG AATCCAGAAA AGCGGCCATT TTCCACCATG ATATTCGGCA AGCAGGCATC 
 2341 GCCATGGGTC ACGACGAGAT CCTCGCCGTC GGGCATGCGC GCCTTGAGCC TGGCGAACAG 
 2401 TTCGGCTGGC GCGAGCCCCT GATGCTCTTC GTCCAGATCA TCCTGATCGA CAAGACCGGC 
 2461 TTCCATCCGA GTACGTGCTC GCTCGATGCG ATGTTTCGCT TGGTGGTCGA ATGGGCAGGT 
 2521 AGCCGGATCA AGCGTATGCA GCCGCCGCAT TGCATCAGCC ATGATGGATA CTTTCTCGGC 
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 2581 AGGAGCAAGG TGGGATGACA GGAGATCCTG CCCCGGCACT TCGCCCAATA GCAGCCAGTC 
 2641 CCTTCCCGCT TCAGTGACAA CGTCGAGCAC AGCTGCGCAA GGAACGCCCG TCGTGGCCAG 
 2701 CCACGATAGC CGCGCTGCCT CGTCCTGCAG TTCATTCAGG GCACCGGACA GGTCGGTCTT 
 2761 GACAAAAAGA ACCGGGCGCC CCTGCGCTGA CAGCCGGAAC ACGGCGGCAT CAGAGCAGCC 
 2821 GATTGTCTGT TGTGCCCAGT CATAGCCGAA TAGCCTCTCC ACCCAAGCGG CCGGAGAACC 
 2881 TGCGTGCAAT CCATCTTGTT CAATCATGCG AAACGATCCT CATCCTGTCT CTTGATCAGA 
 2941 TCTTGATCCC CTGCGCCATC AGATCCTTGG CGGCAAGAAA GCCATCCAGT TTACTTTGCA 
 3001 GGGCTTCCCA ACCTTACCAG AGGGCGCCCC AGCTGGCAAT TCCGGTTCGC TTGCTGTCCA 
 3061 TAAAACCGCC CAGTCTAGCT ATCGCCATGT AAGCCCACTG CAAGCTACCT GCTTTCTCTT 
 3121 TGCGCTTGCG TTTTCCCTTG TCCAGATAGC CCAGTAGCTG ACATTCATCC GGGGTCAGCA 
 3181 CCGTTTCTGC GGACTGGCTT TCTACGTGTT CCGCTTCCTT TAGCAGCCCT TGCGCCCTGA 
 3241 ATTTTGTTAA AATTCGCGTT AAATTTTTGT TAAATCAGCT CATTTTTTAA CCAATAGGCC 
 3301 GAAATCGGCA AAATCCCTTA TAAATCAAAA GAATAGACCG AGATAGGGTT GAGTGTTGTT 
 3361 CCAGTTTGGA ACAAGAGTCC ACTATTAAAG AACGTGGACT CCAACGTCAA AGGGCGAAAA 
 3421 ACCGTCTATC AGGGCGATGG CCCACTACGT GAACCATCAC CCTAATCAAG TTTTTTGGGG 
 3481 TCGAGGTGCC GTAAAGCACT AAATCGGAAC CCTAAAGGGA GCCCCCGATT TAGAGCTTGA 
 3541 CGGGGAAAGC CGGCGAACGT GGCGAGAAAG GAAGGGAAGA AAGCGAAAGG AGCGGGCGCT 
 3601 AGGGCGCTGG CAAGTGTAGC GGTCACGCTG CGCGTAACCA CCACACCCGC CGCGCTTAAT 
 3661 GCGCCGCTAC AGGGCGCGTC CATTCGCCAT TCAGGCTGCG CAACTGTTGG GAAGGGCGAT 
 3721 CGGTGCGGGC CTCTTCGCTA TTACGCCAGC TGGCGAAAGG GGGATGTGCT GCAAGGCGAT 
 3781 TAAGTTGGGT AACGCCAGGG TTTTCCCAGT CACGACGTTG TAAAACGACG GCCAGTGAAT 
 3841 TGTAATACGA CTCACTATAG GGCGAATTGG GCCCTCTAGA TGCATGCTCG AGCGGCCGCT 
 3901 GCACAAACAG ATATTTGGAA TGAATATATA ACCAAATAAA GACATATTTG GATTTCATAT 
 3961 CCTTACACTT GTCTCAGAGA TATCACAATA CAGAAAAATA AATTTATGCT TAAAATAGTG 
 4021 ACTTAAAAAG AACAAAGATA TACTCAACTT CAAAAGGCAA GAGTAAAAAG AATATTCTGG 
 4081 AAATGTTATT GATTCTGTAA CAAAATAAAT AATTTATTAA TTTATTAAAT AAATAATTTG 
 4141 TGTTTTCCAA AGCCAACTTA TAAAAATTAA ATAATTACTT GTTGATAAAA TATTAATTGA 
 4201 AATATTCTTT TTTCTAAAAC CCTTGGTAAT CTTTGTGTAT TGAGAGTAGA ATGAATCAGT 
 4261 ATGCATGTTA TTGGAATACA GTGTGGTATG AAGCACTACA TGACCAGCAT GCACTGATCA 
 4321 GTAATTAGCA TTTTCTTTTC CTAATAATTT CTTTATGGTT TAAGCCTTTG AGGTCCTCTC 
 4381 TCCAAGTACA TAAAACATAT ATAGGTGATG TGAACTATTA TTATCCTATT GTTCTGTGAA 
 4441 GCACCAAAAT TTTATTTCCT CTATCTAATT GTGTTTTGGT ATATGCTATC TAACATTCCC 
 4501 ATTCCTGCCT AGCTTCTAGG AATCAGTATT CGGCATTCAA ATTAATATTT ATAGCTTCTT 
 4561 CTATAGTTGA CTTATTTCAC TTAACAGGAT TTCGCTTTTT AAAACATTTT TATTAGATAT 
 4621 ATTCTTTATA TACATTTCAA ATGCTATCCC GAAAGTTACC TATACCCTCC CCCTGCCCTG 
 4681 CTCCCCTACC CACCCATTGC CACTTCTTGG CCCTGGCATT CCCTTGTACT GGGGCATATA 
 4741 AAGTTTGCAA TACCAAGGGG CCTCTCTTCC CAGTGATGGC CGACTAGCCC ATCTTCTGCA 
 4801 TATGTTGCAG ACCCTTTCAG CTCCTTGGGT ACTTTCTCTA GCTTCTCCAT TGTGGGCCCT 
 4861 TTGTTCCATC TTATAGATTA CTGTGAGCAT CAACTTCTGT ATTTGCCAGG CACTGGCATA 
 4921 GCCTCAAACG AGACAGCTAT ACCAGGGTCC CTTCAGCAAT ATCTTACTGG CATATGCAAT 
 4981 AGTGTCTGTG TTTGGTGGCT GATTATGGGA TGGATCCCCG GGTGACTGCC TTTTAGTTCC 
 5041 ATTCTCTTTT TCTGTTGTAA ATGGCATGAT TTCACTCTTC ATTATGATAC ATTGTGTACA 
 5101 TATACTTTAT TAATCCATTC ATCTGTTGAT AAACATCTAT GCTGCCTCTA TATCATGAGC 
 5161 ATTATAAATA GTGCCACAAA AACACCTGGA AGTGCAGTTG TATCTTTGAA TTAATGAAAT 
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 5221 TATTTTCTTT GGATATATGC ACAGGTGTGT AAATATGGAT CACAGAAAAG GTCCATTTTC 
 5281 AGTGTTCTTT CCACCCTTTA CAGACTTTGC TGCTTCTTAT CCCCTTTCAA CTTTACTTCT 
 5341 GATATATATG TTTCAGCAAT AAACATATTC ACAAATAAAT GCGAACCTTG GACACATTGA 
 5401 ATTTTTAGAG ACATATTCTG TGTTCACTTT CCTGTGTACA TTTGACTTAT TATGTCCTTT 
 5461 TACTACTACT CTCCCAAACT GAATGATGTA CCTTTCATAA TGACGTTCAG CTGTCCTTAC 
 5521 TAATGTATTC TCAAAGATAA TATTAGAACT TAGACCACAT TAGATCTTAC TATTAGCATC 
 5581 CTTTAAATAC TTGTCACTTT CAGGGGCATA GAGGTGTGGA ATGGTCAATG AAGAGCTTTC 
 5641 AATTCCCCTG CCTACATCTC TCACCTAATT TTTATACCCA TCTTCTTAGG TAGATTGTAT 
 5701 TATCATCCCT GTCCTACACA TAAGGAAATT GTGGTGAATC CGGAGTCAGA ATTAACATTG 
 5761 CCTAAGTTCG ATATTGTCAT GAAAATTATG CATTACACAA TTTAATAATG TTCCTGTATT 
 5821 ATCAATTTGA AGAATCTGTA GAAAGTATGT ATATATGTAG CTAAAGAAAA GTGTGCATAT 
 5881 TTATATAAAT GTATAAACTC AGTTTTTCAA AAGATCCAAC TCTATCACCA GTTACTGCAG 
 5941 TAATTCAGTA TTGACGCAAA ACCTAGTAGT TCCTGTCAAT AATTATAAAT TTATTTCTTA 
 6001 AATGATGAAA TTGCAGAATA AAGTAAAACC AACCCATGCT TTATTACAGT AAAGAGGTAA 
 6061 CAATACATGT AAACTGAGTA GCTAAATCAG AGGTCCCTGC AGGTGAACTG ACTTGGTCAA 
 6121 TGTTGCTTAA ACAAAGCAGA GCCTGCTGAA AACATGGGGC AATTCTTTGA AATGTGAAGG 
 6181 GAATTTCAGT TTGCAATATA AGAATCTGGC ATTGGTATGG TCTAGAAAAG ACTTGAGCAG 
 6241 TGGTTCTCCG TCTTTCTAAT GCTGAGACCC TCTAATATGT TTCCCCATGC TGTGGTAACC 
 6301 CCCAACCATA AAATTATTTT TGTTGTTATG TCATAACTGT AATTTTGCTG CTGATATGAA 
 6361 ATGTAATGTA AATATCTGTG TTTTCCAATG GTCTTAGGTG ACCTGTGTCA AAGGGTCATT 
 6421 TGACCTCCCC AACGGGTCAT GACCGACCAA CAGTTTGGGA ACGACTGGAT TAGAGAGAAG 
 6481 CCAAATAGCT CTGTAGTAAA ATCAGGGTGA TATTTCCTGT AGCACGCTTG TAAGTATTCA 
 6541 AGTAGATTTT CAAGCACATT GTATGGTATA TGACATTTGT TAACTTTGTC TTTTATGGCA 
 6601 TTAGAGTAAG TGTTGCTACT GTAATAGTCT TGAGGTCGTG GCTGTTTGCA TGACAGGTGG 
 6661 TTTTCTAGAC CAGAGTGGTA ATGGAGGACA GAAGGGACAG AGAAAATATC TGTGTCAGAA 
 6721 GCAGAGAAAG AACACCAGCG ATTGTGGAAT TTTGGGCGAA CTTTGGATTT TTACAAGAAT 
 6781 GGGGATTCAA TCCATGCAGC TTGATATGAA AAGTCTGGAG AACCTTAAGT GACTGTTTTG 
 6841 AGTACACTGG AGAAACTTGA CCATTCACTT AAAAAAAAAA AAAAGTAACG TTAATTGCTA 
 6901 GAACTGAGAC GTCGACAATG GCATAGCACT TTCTTAAAAA TGAATTCAAA TATATCAGCA 
 6961 TATGCAGTCA ACTAATTTGC TGACTTGAAG ACAGCTTCCC AAACCTATTA TTGCCTGTAA 
 7021 TGAACGACTA TATGCACTAA TCACAACATG CAGTCTTGAC AGTGCTCACG GCATCTAAAA 
 7081 AAATCATGAT ACAGGGATTT TTCTTTAGAC TCAACACATT TTTCATTCAG AAACCTGATT 
 7141 GGCTGTTCAA AGTGCCCTGC ATGATATAAA TTGGGGCACA GAGTTGGAAG AAACCATCGG 
 7201 ATCAAGCATC CCTGAGCTTC AGACAGAAAC TCACTGAGCA TACACTCAAA GGTATGTGGA 
 7261 TTTCATTCAT GATTTACCAT CTCCACTGTG GTCATTTCTT TCTCTGAATT TCATGTTTCA 
 7321 AATGTGTGAA TGAATTGCAC ATTTCTAATT CTTTGTGCCA TCTACACCAT ATGTACTTCT 
 7381 TTAGTTTTAC TATAATGAAA TTATAGACTT AAATCATTGA AAAGAAGTTT TAACTTTATA 
 7441 GTACAGTAAT GTATGTACTT CTGTAAATTT TAGGTCAAGC ATTCCAAAGC CTTTTGGGAG 
 7501 CCAGATTTGA TACAAAAATG TGTATTTGCT TTTTAGTTAA GATGCTGTTT TAACAGGCTG 
 7561 AGGGCTACTT CTTTACAAAA TCTTGTTAAA TCTTGTGAAT CCTTTTTCTT ATTACCTCAA 
 7621 CCTTTGGGGG GAAAAGGTTT AGATGTTAGA AATCCTCAAT GTATTTTTCA TAGGTAACAC 
 7681 CAATGCATTT TACATTCATG TCCTAAATTT ACTTTCAAGG TGTTGTCCAA AACCAATGGC 
 7741 ATATTTTAGG ATAGGTAGTT CTTGCTTCAT GTTTCAAAGG CCTTAATATG TAGAAGGAAT 
 7801 ACAGTATAGT TGACAAGCAA GAAGAGGGTG CTACTGGCTT AAGACAGAAC TCTTTACGTA 
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 7861 GAAACCATTC CACAACCCTT AAAGAAGCTT AGAATGGTAG CACTATTCTC TTTCTTTGGA 
 7921 TTAAGCATGC CTTCTGCTTC AAACCTGGAG TTTAAAGGCA TTATGAGAGA TTCTTGCCTA 
 7981 AAATTCTACA AGTGGACCTA AACCCACTCT GCCATTAATC CATTCTGTAA AATTATTCAA 
 8041 TATTTTCTCA AATAATTACT CTATGTATTT AACAGTAGCA ATGCTCAAGT GGGTTATGCC 
 8101 CCCCAAAAGA AAAACAACAT TTCTATCTTT TCTTGTTACC AAAGTATAAA ACCATGTTCA 
 8161 TTTGATTATC TCTCCAACTG TTATACTCAA CCCGATTCTT TTAATCAGTT TTATTGTTTC 
 8221 CATCTAGCTT CTAGGCATCC TTAGGCTGTA TAGCATAGAA AATGGTTTGC AGCATCATTC 
 8281 TTGTAGATCA CTTTTGGTCC TCTAACTCGT TAACCTTCAG CTTCAGCTTA GTTTTTAAAC 
 8341 AAATAAACAC ATTGCAATAT TAGTACTCCA GAAGCAATGA TAATTCCATA TGAATGTCAC 
 8401 TTTACAATAA GGGCCGCACC TTCTTTTTGA TTAGCAAGAC ATTAATGTGG ATTATATACA 
 8461 TGTATGAAGC ATAATTATAT TCATGCTTTT AAAAGTTTTT AAATGGTTGG TATTGATTTA 
 8521 CATTTCAGAA CCATCAAGGG CGCGCCGAAA ACATGTTGCT GCTTCAGTGC AGAAATCCGA 
 8581 CTTCTCCTCC AAAGCCATGT GGCCTGGTAC CAAATGTAAA GATGAGTCTC CTTGTTTTCC 
 8641 TGGGTCTGCT TGGTGTCTCT GCTGCCATGC CATTCCAGAT GCCAATGCCC CGAATGCCTG 
 8701 GATTTAGCAG TAAAAGTGAA GAGATGATGC GATATAATCA ATTCAACTTC ATGAATGCCC 
 8761 CACCAATGAT GCCTATGGGC CCATATGGAA ATGGTATGCC AATGCCGCCA CACATGCCTC 
 8821 CACAGTACCC TCCATACCAG ATGCCCATGT GGCCTCCACC AGTACCCAAT GGATGGCAGC 
 8881 AACCCCCAAT GCCCAATTTC CCAAGCAAGA CTGATCAAAC CCAGGAGACC GCCAAACCCA 
 8941 ACCAGACCAA TCCACAAGAG CCACAGCCAC AAAAGCAGCC TTTAAAGGAA CCACCAAATG 
 9001 AAGCAGCACG GGCCAAAGAT GACGCCCAGC CACCTCAGCC ATTCCCACCA TTTGGCAATG 
 9061 GACTTTACCC CTATCCACAA CCACCATGGC CAATTCCACA GAGGGGACCA CCAACAGCGT 
 9121 TTGGACGGCC AAAGTTCAGC AATGAAGAAG GAAATCCTTA CTATGCATTT TTTGGATATC 
 9181 ACGGCTTTGG GGGTCGTCCT TATTACTCAG AAGAGATGTT TGAAGATTAT GAAAAACCCA 
 9241 AAGAAAAAGA CCCTCCTAAA CCAGAGGACC CACCTCCAGA TGACCCACCC CCAGAGGCCT 
 9301 CTACAAACTC AACTGTGCCT GATGCTAATG CCACTCAATC AATTCCTGAA GGCGGAAATG 
 9361 ACACTAGCCC AATAGGAAAC ACAGGCCCTG GGCCGAACGC TGGGAACAAT CCTACAGTTC 
 9421 AAAACGGTGT CTTCCCTCCC CCTAAAGTTA ATGTTTCAGG CCAGGGAGTA CCAAAAAGCC 
 9481 AAATTCCGTG GAGACCAAGT CAGCCAAATA TTTATGAGAA TTATCCTTAC CCAAATTATC 
 9541 CTTCAGAAAG ACAATGGCAA ACCACTGGTA CCCAGGGGCC TAGACAGAAT GGACCTGGCT 
 9601 ACCGAAATCC ACAAGTTGAA AGGGGTCCTC AGTGGAATTC CTTTGCTTGG GAAGGCAAAC 
 9661 AAGCTACTCG TCCAGGAAAC CCAACTTACG GTAAACCTCC CTCTCCTACC TCCGGGGTTA 
 9721 ATTATGCAGG AAATCCAGTC CATTTCGGAA GAAACCTGCC AGGGCCAAAT AAACCCTTTG 
 9781 TGGGAGCCAA TCCGGCCTCA AATAAACCCT TTGTGGGAGC CAATCCGGCC TCAAACAAAC 
 9841 CCTTTGTGGG AGCTAATCCG GCCTCAAACA AACCCTTTGT GGGAGCCAAT CCGGCCTCAA 
 9901 ATAAACCCTT TGTGGGAGCC AATCCGGCCT CAAATAAACC CTATGTGGGA GCCAATCCGG 
 9961 CCTCAAACAA ACCCTTTATA GGAGCCAATC CGGCTGCAAA CAAACCATCT ATAGGAACCA 
10021 ATCCAGCCGC AAACAAACCA TCTATAGGAA CCAATCCAGC TGCAAATAAA CCCTTTGTGA 
10081 GAAACAATGT AGGTGCAAAT AAACCCTTTG TGGGAACCAA TCCCTCCTCA AACCAACCAT 
10141 TTCTGAGAAG CAATCAGGCC TCAAATAAAC CATTTATGAG AAGCAATCAG GCCTCAAATA 
10201 AACCATTTGT GGGCACCAAT GTGGCCTCAG TGGGTCCTAA ACAGGTCACT GTTAGCCACA 
10261 ATATGAAAAC TCAAAATCCA AAAGAAAAGT CACTAGGTCA AAAAGAAAGA ACAGTCACTC 
10321 CTACCAAAGA TGCAAGCAAC CCCTGGAGAA GTGCTAAACA ATATGGAATT AACAATCCAA 
10381 ACTATAATTT GCCTCGCTCT GAGGGCAGCA TGGTAGGCCC AAATTTTAAT TCCTTTGATC 
10441 AACAAGAAAA CTCCTACTTC TCAAAAGGAG CTTCCAAAAG AGTACCAAGT CCTAATATAC 
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10501 AAATCCAAAG CCAGAATTTG CCCAAAGGAA TTGCTTTAGA GCCAAGAAGA ACCCCATTTC 
10561 AATCAGAAAC TAAAAAACCT GAGTTAAAAC ATGGTACACA CCAGCCTGCA TACCCTAAGA 
10621 AAATCCCTTC TCCTACAAGA AAACATTTCC CTGCTGAAAG AAATACCTGG AATCGTCAAA 
10681 AAATCCTTCC ACCCTTAAAG GAAGACTATG GGAGGCAAGA CGAAAATTTA CGTCATCCGT 
10741 CCTATGGCTC TAGAGGAAAT ATTTTTTACC ATGAATATAC CAATCCTTAT CATAATGAAA 
10801 AATCACAGTA CATTAAAAGC AATCCATGGG ATAAGAGCTC TCCCAGTACT ATGATGCGGC 
10861 CAGAAAACCC ACAGTACACC ATGACTTCTC TAGACCAGAA GGAGACAGAG CAGTACAATG 
10921 AAGAGGATCC AATTGATCCA AATGAAGATG AATCTTTTCC AGGACAAAGT AGATGGGGGG 
10981 ATGAAGAGAT GAACTTCAAA GGAAACCCAA CAGTTAGGCA GTATGAAGGT GAGCACTACG 
11041 CCTCAACCCT AGCGAAGGAA TACCTTCCTT ATTCCTTAAG TAATCCACCA AAACCCAGTG 
11101 AAGATTTTCC TTACAGTGAA TTCTATCCCT GGAACCCACA GGAAACGTTT CCAATATATA 
11161 ACCCAGGTCC TACTATAGCA CCACCCGTGG ACCCCAGAAG TTATTATGTT AATAATGCCA 
11221 TAGGACAAGA AGAAAGCACT CTCTTTCCTT CATGGACCTC CTGGGACCAC AGGAATCAAG 
11281 CTGAGAGGCA GAAAGAGAGT GAGCCATATT TTAACAGAAA TGTCTGGGAT CAGTCAATAA 
11341 ATTTACACAA ATCTAATATA CCAAACCATC CTTATTCCAC TACATCCCCT GCTAGATTTC 
11401 CAAAAGATCC AACATGGTTT GAAGGTGAGA ATTTGAACTA TGATTTGCAA ATTACTAGTT 
11461 TAAGTCCACC AGAAAGAGAA CAGTTGGCTT TCCCAGACTT CCTGCCTCAA AGTTACCCAA 
11521 CAGGTCAAAA TGAAGCACAC TTATTTCACC AAAGTCAAAG AGGGTCTTGC TGTATTGGTG 
11581 GCTCCACAGG ACATAAAGAC AATGTGCTGG CTCTACAAGA CTACACTTCA TCCTATGGTC 
11641 TTCCACCAAG GAAGAACCAA GAAACCAGTC CAGTGCATAC AGAAAGCAGT TATATCAAGT 
11701 ATGCAAGACC TAACGTTTCC CCAGCAAGCA TCCTACCTAG TCAAAGAAAT ATCTCAGAGA 
11761 ACAAACTAAC TGCAGAAAGC CCAAACCCAA GTCCATTTGG AGATGGTGTG CCTACTGTGA 
11821 GGAAAAATAC TCCATATTCT GGAAAGAATC AACTAGAGAC AGGAATTGTG GCCTTTTCTG 
11881 AAGCCAGCTC TTCTCAGCCA AAAAACACGC CCTGTCTTAA AAGTGACCTT GGAGGAGATC 
11941 GGAGGGATGT TCTGAAACAA TTTTTTGAAG GCAGCCAGCT GAGTGAAAGA ACTGCTGGCC 
12001 TTACTCCTGA GCAGCTCGTC ATTGGTATTC CTGATAAAGG CTCTGGCCCA GATAGCATAC 
12061 AAAGTGAAGT CCAAGGAAAA GAGGGTGAGA TGCAGCAACA AAGGCCACCT ACCATCATGA 
12121 AGTTGCCATG CTTTGGCTCC AATTCAAAAT TTCACTCTTC TACCACTGGA CCTCCAATTA 
12181 ACAACAGAAG ACCAACCCTA CTTAATGGTG CTCTCTCCAC ACCCACTGAA AGTCCTAACA 
12241 CATTGGTTGG GTTAGCTACT AGGGAACAAC TTAAAAGTAT AAACGTAGAT AAACTTAATG 
12301 CAGATGAACA CACTACACTC GAATCTTTTC AAGGAACCAG TCCACAGGAC CAAGGCTGCT 
12361 TACTGCTTCA GGCTTAGGGA TCGCTTCAAC TGCGATCGCC GAAGTGGATA CTTTGGTTGT 
12421 TTTTAGGAAT AACTCAAGAA CACAATGATT TGTGCCTACA ATCACTTAGT AAATTCTGTA 
12481 ACTAAAAATA AGTATCATTA GCAGATAATA AAATGTTTGA AAAATCATTC ATGTCTTTGT 
12541 GTTGAATTAA ATTTAAATTT TCCTATCACT TGAGAGAAGA ACTTATAAGT GAATAATATA 
12601 GGGACTGGTC ATTTGCTCCT ACAAATTGAC CATTTAGCAG GCAAATCATG ACTATATCTT 
12661 CTTAGAGAAC TTTTATATTA TCTGTAATGT TTTCTTAAAA TAGAAATTTG TACATCATAA 
12721 ACAATAGCTG AGAAAGTTAA CAGAAATAGT TAAGCATGGA TAGTCACTGA ACCTGAACCA 
12781 AATGAAGGCA AGTTTAGAAG AAATATTCTT TACATTGAAA AAGATAAACT TTAAGGAATG 
12841 TTTATATTCT AAATCAAATT AAGACTTGGA ACTTTAGCTT TATTCTTCAC ACCACATCAG 
12901 TAACCAAAAT CTGGTCTTTT GATCTCATTC TATAGAAAAA TATTTTGAGT GAAATTATGT 
12961 GATATATATG GTAATTCACT GAAATTTAAA TTATTAAAAT AATTATTTTT CCTAAGAAAA 
13021 TTAATAACGG AGCCTCAAAC AGAGAATTGC AGTGATTTTA TACACAAGTC ATTTCTTTCA 
13081 CCTCATAATC TTTAAGCTGA TTAAGTCTAC CACATGGTCT TCAAAACGCT AACAGATGCG 
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13141 TAAAATGGAC TCAAAACAAG TTTTCTTTCC CACTCATATT TATATTTGAA TCATTTTTCC 
13201 TCTTACACCC ACACAAAATT GTAAACAGTC TTTGCAGGAT TTATGTTACA CAGCACCCAC 
13261 AGTAACTTTA TTCCAGTACC TTCATGATTA AGGTCTCTCT TAATCATTTT CTGGAATGAA 
13321 TAAACATAGC TTTCTCTGAG AAGATATCAA TATGCAAACA AATTAGTTGA TTTTAAAGAA 
13381 CTAAAATGCA GTAATAAAGG TAAAAATAAA GCATTTAATG AATTAGCATA GGCCACTTCT 
13441 AATCAACTGA GTAAATATTT CTCAAGCACT CACTAGACTG GGTATTACTG TATGTGATAG 
13501 TGAAAACAGT AATTCCTTAT CCTTAGGCCC GGGC 
 
Fig 2.2 DNA sequence of the Enam transgene construct. Enam transgene construct 
starting with pCR2.1-TOPO vector. Restriction sites used during construction are in 
bold and underlined. The Enam translation initiation and termination codons are in 
bold. 1-3899 is vector sequence ending at the NotI (GCGGCCGC) site; 3900-8538 is 
from the AmelX 5’ transcription regulatory (promoter) region (4639 bp) ending at the 
introduced AscI (GGCGCGCC) site; 8547-12391 is Enam cDNA sequence (3845 bp) 
ending at the introduced SgfI (GCGATCGC) site; 12400-13527 is from the AmelX 3’ 
region (1127 bp), which contains multiple transcription termination signals and ends 





Fig 2.3 Breeding strategy. Two breeding strategy is used for enamelin transgenic 
mice. Left: Enam transgenic mice were used to breed with C57/BL6 wild-type mice to 
generate transgenic mice (Enamtg,+/+) or wild-type mice (Enam+/+); Right: Enam 
transgenic mice were used to breed with Enam null mice to generate F1 offspring. 
Enam transgene positive F1 (Enamtg,+/-)  were used to breed with Enam null mice 
again to generate F2 offspring. Four genotypes were g nerated: Enamtg, -/-, Enamtg, +/-, 










Fig 2.4. Genotyping strategy. Genotyping result using the three primer sets (“Enam 
tg”, “Enam 4&5”, “LacZ). Genotypes includes wild-type (A), transgene exprssed in 
wild-type background (B), transgene expressed in null background (C), transgene 
expressed in heterozygous background (D), homozygous knockout mice (E) and 






Fig 2.5 Oral photograph of enamelin transgenic mice. Intraoral photographs 
enamelin transgenic mice are shown. Offspring of transgenic founder were cross bred 
with C57BL/6 wild-type mouse. Pictures shown are from founder 1, 2, 3, 4, 7, 8, 10, 
11 and 12 as noted on the upper left corner of eachpicture. Wild-type mouse intraoral 
picture is also shown (wt). Pictures shown of line 3, 4, 7, 8 are from F1 generation of 
transgenic mouse cross bred with C57BL6 wild-type mouse, while pictures of line 1, 




Table 2.1 Primer sequences for genotyping 
 






Enam tg F GCCGCACCTTCTTTTTGAT tg,+/+; tg,+/-; 
tg,-/- 






Enam4&5 F GCCCAAAGCACAGTCATTTT tg,+/+; tg,+/-; 








LacZ F AAGTTTTGGGATTTGGCTCA tg,+/-; tg,-/-; +/-
; -/- 




























ear tag # 
Gender DOB 
Positive Transgene Transmission? 
1 470 m 3/8-3/9/08 Yes 
2 473 f 3/8-3/9/08 Yes 
3 481 f 3/8-3/9/08 Yes 
4 488 m 3/8-3/9/08 Yes 
5 500 f 3/8-3/9/08 No, never give birth 
6 504 m 3/8-3/9/08 No, checked six litters, all pups were 
transgene negative. 
7 506 m 3/8-3/9/08 Yes 
8 508 f 3/8-3/9/08 Yes, but poor breeding 
9 513 f 3/8-3/9/08 No, produced one litter, all pups were 
transgene negative. Then founder dead. 
10 517 f 3/8-3/9/08 Yes 
11 526 f 3/8-3/9/08 Yes 
12 532 m 3/8-3/9/08 Yes 
13 547 f 3/8-3/9/08 Yes, but no adult offspring available. 
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ENAM TRANSGENE EXPRESSION 






    After generating Enam transgenic mice and breeding the founders, the first priority 
was to determine the expression levels of the Enam transgene in developing teeth. It 
was expected that the amelogenin promoter would dictate ameloblast-specific 
expression, but integration site and copy number would strongly influence expression 
levels. Our strategy was to first determine expression levels by real-time PCR. We 
designed three primer pairs with the following specificities: 1) detects total Enam 
expression (from the transgene and native Enam genes) 2) detects expression of the 
Enam transgene only, and 3) detects expression from the native (endogenous) Enam 





Materials and Methods 
Primer design. The first priority was to design primers that could specifically detect 
different mRNA. Historically, amplification products in the 100 to 150 bp range have 
proven suitable for semi-quantitative applications. The software application Primer3 
on the Web was used to help select primers that would not anneal to themselves or to 
each other to minimize primer-dimer artifacts. Specificity for the endogenous Enam 
mRNA was achieved by having one primer anneal to the Enam coding region and the 
second primer anneal to a region outside the Enam coding region that is only found on 
the native mRNA. Specificity for the Enam transgene was achieved by having one 
primer anneal to the 5’ amelogenin-specific sequence and the 3’ primer anneal to the 
Enam coding region. Specificity for both the Enam transgene and the native Enam 
genes used both primers from the Enam coding region. The idea of primer design is 
showed in Fig 3.1. The sequences of these three primer pairs along with a Gapdh 
primer pair used to normalize results to the amount of cDNA template, the PCR 
conditions, and the lengths of the amplification products are shown in Table 3.1. 
 
Isolation of day 5 first molars. Litters of mice were sacrificed at post-natal day 5. 
These mice were the product of an E am+/+ x Enamtg,+/+ cross, or an Enam-/- x 
Enamtg,+/- cross as described in Chapter 2. The pups were sacificed on day five and 
the four first molars surgically extracted. The ameloblasts of mouse first molars are all 
in the secretory stage. The two molars from one sidwere used to isolate RNA for 
reverse transcription-polymerase chain reaction (RT-PCR). The two molars from the 
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other side were stripped of soft tissue, and the hard tissue was used to extract proteins 
for Western blot analyses.  
 
Real-time PCR (rtPCR). Real-time PCR was performed on selected litters from 
Enam+/+ x Enamtg,+/+ or Enam-/- x Enamtg,+/- crosses (Table 3.2). Each mouse was 
genotyped as described in Chapter 2. Animals were terminated on post-natal day 5, 
one first upper and one first lower molar were used to isolate mRNA (RNeasy Mini 
kit, QIAGEN Sciences, USA Cat. No.74104). RNase-Free DNase (Qiagen Cat. No. 
79254) was used during RNA isolation to remove genomic DNA. RNA was reverse-
transcripted to cDNA using SuperScript® First-Strand Synthesis System for RT-PCR 
(Invitrogen, Cat. No. 11904-018). PCR reaction reagent used is iQTM SYBR GREEN 
SUPERMIX (Bio-Rad Laboratories, Hercules, CA, USA. Cat. No. 170-8882). The 
96-well plates and translucent tape that cover the plates were obtained from Bio-Rad 
(PCR plates, Low 96-well Clear, Cat. No. MLL9601; Optical tape, Cat No. 2239444, 
Bio-Rad Laboratories, Hercules, CA). Real-time PCR primer sequences are 
summarized in Table 3.1 (ordered from Invitrogen).  Gapdh, the housekeeping gene, 
was used as internal control. Basically the PCR condition is to maintain the DNA at 
95 °C for 3 minutes followed by 50 cycles of denatur ion at 95 °C for 15 seconds, 
annealing at 60 °C for 25 seconds, extension at 72 °C for 35 seconds and then 
maintain the reaction at 95 °C for 1 minutes, then at 55 °C for 1 minutes followed by 
68 cycles of graduate temperature increase reaction s arting at 68 °C with 0.5 °C 
increasing each time for 10 seconds each cycle to complete final reaction. The 
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mechanism of real-time PCR experiment used is based on SYBR green as a dye that 
binds to double stranded DNA, but not single-stranded DNA. Standard curves were 
generated by diluting the cDNA products of the RT-PCR reactions 10-fold and 100 
fold, then performing rtPCR using 1x, 0.1x, and 0.01x concentrations of cDNA as 
template. The point at which each PCR reaction reach d a threshold level was plotted.  
The correlation coefficient (r2) value of the standard curves was above 0.99 to be 
considered as a valid experiment. The rtPCR reactions were run in triplicate using the 
cDNA generated from each mouse in the litters. When multiple members of the litter 
had the same genotype, the rtPCR results were averaged. Statistical analyses were 
performed based upon the triplicate rtPCR runs, and the multiple runs performed 
when multiple littermates had the same genotype.  
 
Isolation of proteins. The hard tissues from a maxillary and a mandibular first molars 
were incubated in 800 uL 1 % formic acid (ACROS ORGANICS, New Jersey, Code 
147930010) at 4 °C for around 30 hours, centrifuged briefly to remove residual 
insoluble material, freeze at -80 °C for more than 4 hours, lyophilized overnight. 200 
uL of 1x sample buffer (diluted from NuPage LDS sample buffer 4x, Invitrogen, Cat 
No. NP0007) were added to each sample do dissolve the proteins. 2% 2-
mecaptoethanol (Bio-Rad Laboratories, Hercules, CA, at No. 161-0710) were added 
to each sample before load it on SDS-PAGE. 
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SDS-PAGE and Western blot Analysis. SDS-PAGE and Western blotting was 
performed on selected litters from Enam+/+ x Enamtg,+/+ or Enam-/- x Enamtg,+/- crosses 
(Table 3.3). Protein was isolated from the combined mineralized tissues of one 
maxillary and one mandibular first molar (PN5). When protein was obtained from 
multiple littermates with the same genotype, the tooth proteins were isolated 
separately but mixed prior to loading on gels. The amount loaded in each lane was the 
same fraction of tooth protein per tooth. 5uL sample were loaded to SDS-PAGE 
(NuPage 4-12% Bis-Tris Gel, Invitrogen, Carlsbad, CA. Cat No. NP0322BOX), 
transferred to a membrane, and Enam bands were visualized by Western blotting 
using rabbit anti-mouse antibody recognizing enamelin peptide starting from residue 
223. The mouse enamelin 223 antibody is used to incubate the membrane at dilution 
of 1:1000 in 5% milk overnight. Secondary antibody for enamelin antibody 
experiment is a horseradish peroxidase-linked antibody (from donkey) anti-rabbit IgG 
(GE Healthcare UK limited, Little Chalfont Bucking Hamshine HP7 9NA UK., Cat. 
NA934V). Secondary antibody is incubated at dilution f 1:5000 for 3 hours. 
Amersham ECL Plus Western Blotting Detection System (GE Healthcare UK limited, 
Little Chalfont Bucking Hamshine HP7 9NA UK., Cat. No. RPN2132) was use to 
incubate for 5 minutes to visualize the membrane and develop the film. From each 
transgenic mouse line, offspring of same litter were used to load on one gel to 
compare the protein expression level among various genotypes from the same 





Real-time PCR using the primer set that amplified both the Enam transgene and the 
native Enam genes were conducted on Enam+/+ and Enamtg,+/+ littermates, which 
permitted normalizing the results to wild-type levels of Enam expression (Fig 3.2). 
By subtracting the value of the wild-type Enam expression from the value of the 
Enam transgene plus wild-type levels, we were able to obtain the level of Enam 
transgene expression relative to the Enam wild-type expression levels. Transgene 
expression levels were: line 2 (47%), and line 3 (485%), line 4 (1%), line 10 (11%), 
line 11 (22%), line 12 (31%) (Fig 3.3). 
    Real-time PCR using the primer set that amplified only the Enam transgene was 
also conducted on Enam+/+ and Enamtg,+/+ littermates, but could not be normalized to 
wild-type expression (as the native Enam transcripts were not amplified). Therefore 
we normalized the results of the reactions with the transgene expression of line 12, 
which had been determined to express the Enam transgene at 31% of normal wild-
type Enam expression. The results are shown in Figure 3.4. For comparison to the 
real-time PCR results from the first primer set, the transgene expression levels 
normalized first to line 12 and then multiplied by 0.31 to adjust to the wild-type 
levels are: line 2 (40%), and line 3 (542%), line 4 (9%),  line 10 (5%), line 11 (7%) 
and line 12 (31%). (Table 3.4) As shown in Table 3.5, the real-time PCR result using 
these two primer sets (“Enam F/R” and “Enam tg F/R”) are consistent with each other. 
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The percentages of transgene expression level using these two primer sets are very 
close in each transgenic line. 
Real-time PCR using the primer set that amplified both the Enam transgene and the 
native Enam genes were conducted on Enam+/-, Enamtg,+/- , Enam-/-, and Enamtg,-/- 
littermates. As a wild-type mouse was not generated in the cross that produced these 
genotypes, data for wild-type mice were from the breding of founder 12 (the line for 
which data is available from all genotypes and real-time PCR primer sets). The real-
time PCR results for lines 1, 7, 10, and 12 were shown in Fig 3.5. When transgene 
expressed in null background (tg, -/-), the enamelin xpression from these four lines 
are 154% (line 1, Fig 3.5 A), 9% (line 10, Fig 3.5 B), 13% (line 7, Fig 3.5C) and 96% 
(line 12, Fig 3.5D).  
To compare the enamelin transgene expression level in different transgenic mice 
lines on three genetic backgrounds, i.e., on wild-type background, on heterozygous 
background and on null background, we summarized th real-time PCR results in 
Table 3.6. The averaged transgene expression level (as a percentage relative to gene 
expression level of the wild-type mice) in each transgenic lines are 140% (line 1), 
47% (line 2), 485% (line 3), 1% (line 4), 14% (line 7), 8% (line 10), 22% (line 11) 
and 59.3% (line 12). 
    Real-time PCR using the primer set that amplified only the endogenous Enam 
transgene was also conducted on Enam+/+ and Enamtg,+/+ littermates from the higher 
expressing transgenic founder lines (2, 3, and 12) (Fig 3.6). Expression of 
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endogenous Enam was slightly decreased when by Enam transgene expression level 
getting higher. 
    We used a rabbit anti-mouse antibody recognizing the enamelin peptide starting 
from residue 223 to check enamelin transgene expression level on protein level. As 
showed in Fig 3.7, transgenic mouse lines 7, 10 and 11 showed low transgene 
expression levels, that were almost undetectable when expressed in null background; 
while transgenic lines 1, 2 and 12 showed higher transgene expression levels. These 
results are basically consistent with the real-time PCR results, which measured 
transgene expression at the mRNA level. 
 
Discussion 
Transgene expression levels relative to wild-type Enam expression calculated from 
the total Enam and Enam transgene-specific primers in the wild-type background 
were: line 4 (1%; 9%), line 10 (11%; 5%), line 11 (22%; 7%), line 12 (31%), line 2 
(47%; 40%), and line 3 (485%; 542%). The results from the two primer sets are 
consistent and support the conclusion that Enam transgene expression levels relative 
to wild-type in lines 4, 10, and 11 are very low, lines 2 and 12 are moderate, and line 
3 is very high. 
 
Transgene expression levels in the six different geetic backgrounds using real-time 
PCR experiment showed some inconsistency. As showed in table 3.6, when transgene 
expressed in wild-type background, the transgene expression is lower than expressed 
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in null or heterozygous background. For example, for line 12, it showed 31% above 
wild-type enamelin expression on wild-type background, but when it expressed in null 
background, it showed 91% as the amount of wild-type enamelin expression. One 
possible explanation is that ameloblasts may have a feedback regulation system and 
try to maintain a certain level of enamelin expression for the proper enamel formation. 
When transgene and endogenous gene are both present, the ameloblasts try to express 
less enamelin than the transgene present alone. Another explanation is that if we use 


















Figures and Legends 
 
Fig 3.1 Real-time PCR primer design for checking Enam transgene expression 
level. A: Real-time PCR primer design. “Enam Tg F” and “Enam Tg R” primers 
amplify only the Enam transgene mRNA. “Enam F” and “Enam R” primers detect 
both endogenous enamelin and enamelin transgene mRNA. B: “Enam Endo F” and 
“Enam Endo R” anneals to the 5’ untranslated region of Enam cDNA. Gapdh primers 





Fig 3.2 Total Enam gene expression on wild-type background by Real-time PCR. 
Real-time PCR was used to check mRNA expression level among transgenic lines. 
Day 5 first molars were extracted from offspring of Enamelin transgenic mice 
breeding with C57BL/6 wild-type mice. From each transgenic line, littermates were 
divided into two groups: transgene positive (tg) group and transgene negative (wt) 
group. One upper and one lower first molar from each nimal were used to isolate 
mRNA. cDNA was obtained by reverse transcription from mRNA. Enam primer 
detects both endogenous enamelin and transgenic enameli . “Enam tg” primer detects 
only enamelin from transgene. Each transgenic line has 3-5 transgenic mice and 3-5 
wild-type mice. All wild-type animals from each line were averaged as the final “wt” 
group. Lines 2, 3, 10, 4, 11 are F3 generation of transgenic mouse bred with C57BL/6 
mice, while line 12 is F4 generation of the same breding strategy. Primer used is 
“Enam” primer (“primer 1” in table 3.2) which recognizes both endogenous and 




Fig 3.3 Derived Enam gene expression on wild-type background by real-time 
PCR. Material and methods are same as Fig 3.3, but expression level of every group 
were used to subtract wild-type group expression level to see how much more 






Fig 3.4 Relative Enam transgene gene expression level in different lines by real-
time PCR. Real-time PCR was used to check mRNA expression level among 
transgenic lines. Day 5 first molars were extracted from offspring of Enamelin 
transgenic mice breeding with C57BL/6 wild-type mice. From each transgenic line, 
littermates were divided into two groups: transgene positive (tg) group and transgene 
negative (wt) group. One upper and one lower first molar from each animal were used 
to isolate mRNA. cDNA was obtained by reverse transcription from mRNA. Enam 
primer detects both endogenous enamelin and transgenic enamelin. “Enam tg” primer 
detects only enamelin from transgene. Each transgenic line has 3-5 transgenic mice 
and 3-5 wild-type mice. All wild-type animals from each line were averaged as the 
final “wt” group. Lines 2, 3, 10, 4, 11 are F3 generation of transgenic mouse bred with 
C57BL/6 mice, while line 12 is F4 generation of thesame breeding strategy. Primer 
used is “Enam tg” primer (“primer 2” in table 3.2) which recognize only enamelin 
transgene, not endogenous enamelin gene. Expression level in each group were first 
subtract wild-type expression levels and then divided by the expression level of line 
12 to compare the result of primer 2 (“Enam tg” primer, this figure) with primer 1 








Fig. 3.5 Enam transgene expression levels at the mRNA level. Enam expression 
levels of F2 offspring were tested by real-time PCR. One upper and one lower day 5 
first molar from each mouse were combined and used to isolate mRNA. Day 5 wild-
type mouse samples from the same position were used a  control. Gapdh, a 
housekeeping gene, was used as control. Three animals from each genotype group 
were used for each transgenic line. Average expression level in each group were 
divided by the average wild-type expression level to estimate the relative transgene 
expression level expressed as percentage of wild-type counterparts in line 1 (A), line 
10 (B) , line 1(C) and line 12 (D). In each line, gnotypes were Enam wild-type (wt), 











Fig 3.6 Endogenous Enam expression levels in different transgenic lines. 
Real-time PCR was used to check mRNA expression level among transgenic lines. 
Day 5 first molars were extracted from offspring of Enamelin transgenic mice 
breeding with C57BL/6 wild-type mice. From each transgenic line, littermates were 
divided into two groups: transgene positive (tg) group and transgene negative (wt) 
group. One upper and one lower first molar from each nimal were used to isolate 
mRNA. cDNA was obtained by reverse transcription from mRNA. Enam primer 
detects both endogenous enamelin and transgenic enameli . “Enam tg” primer detects 
only enamelin from transgene. Each transgenic line has 3-5 transgenic mice and 3-5 
wild-type mice. All wild-type animals from each line were averaged as the final “wt” 
group. Lines 2, 3, 12 are check in this experiment. Primer used is “Enam Endo” 
primer (“primer 3” in table 3.2), which recognizes only endogenous enamelin, not 

















Fig 3.7 Enam transgene expression at the protein level. Western blots 
immunostained using an antibody raised against a mouse enamelin peptide starting at 
residue 223 and was used to examine protein expression level on F2 offspring of 
transgenic lines as noted. A, transgenic mouse line 1, 2, 7, 12 have all the six 
transgenic background from the two breeding strategy (as described in Chapter 2), 
including wild-type (lane +/+), transgene expressed in wild-type background (lane tg 
+/+), heterozygous (lane +/-), transgene expressed in heterozygous background (lane 
tg +/-), enamelin knockout (lane -/-), transgene expr ssed in knockout background 
(lane tg -/-). B, for line 10 and 11, four genotypes from breeding of enamelin 
transgenic mouse with knockout mice were compared with non-littermate wild-type 
animal sample. Equal fractions of enamel proteins extracted from day 5 one first 
upper and one first lower molar from Enam wild-type (lanes wt, or +/+), Enam 
knockout mice expressing an transgene (lanes tg,-/-), Enam heterozygotes expressing 
an Enam transgene (lane tg, +/-), Enam homozygous knockout mice (lanes -/-) and 








Table 3.1 Real-time PCR primer sequences 
 
Primers Sequences Product size (bp) 
Enam F 5’AACACATTGGTTGGGTTAGC3’ 
Enam R 5’GTCCTGTGGACTGGTTCCTT3’ 
114 
Enam tg F 5’ACTCAAAGAACCATCAAGGGC3’ 
Enam tg R 5’CATTTGGTACCAGGCCACAT3’ 
96 
Enam Endo F 5’TTTGGGTACTGAACATGACACC3’ 
Enam Endo R 5’CAAACTGCTGAAGCCAGAGA3’ 
99 
Gapdh F 5’TGACGTGCCGCCTGGAGAAA3’ 
Gapdh R 5’AGTGTAGCCCAAGATGCCCTTCAG3’ 
98 
 
Basically the PCR condition is to maintain the DNA at 95  °C for 3 minutes followed 
by 50 cycles of denaturation at 95  °C for 15 seconds, annealing at 60  °C for 25 
seconds, extension at 72 °C for 35 seconds and then maintain the reaction at 95  °C 
for 1 minutes, then at 55  °C for 1 minutes followed by 68 cycles of graduate 
temperature increase reaction starting at 68  °C with 0.5  °C increasing each time for 






Table 3.2 Real-time PCR done on different Enam transgenic lines of different gene background by three primer sets  
                    
primer set Genotype Line 1 Line 2 Line 3 line 4 Line 7 Line 10 Line 11 Line 12 
+/+  √ √ √  √ √ √ 
+/- √    √ √  √ 
-/- √    √ √  √ 
tg,+/+  √ √ √  √ √ √ 
tg,+/- √    √ √  √ 
primer 1 
(Enam F/R) 
tg,-/- √       √ √   √ 
+/+  √ √ √  √ √ √ primer 2 
(Enam tg 
F/R ) tg,+/+   √ √ √   √ √ √ 
+/+  √ √     √ primer 3 
(Enam Endo 
F/R) tg,+/+   √ √         √ 
          
Primer 1: This primer set amplifies the total Enam expression level, including the endogenous Enam and Enam transgene.  
 
Primer 2: This primer set amplifies only the Enam transgene.  
 
Primer 3: This primer set to amplifies only the endogenous Enam. It PCR the sequence between the 5' UTR and exon-- of endogenous Enam 
gene. 
+/+: Wide type mice.     
+/-: Heterozygous Enam knock out mice.     
-/-: Homozygous Enam Knock out mice.     
tg,+/+: Enam transgenic mice on wild-type background.     
tg,+/-: Enam transgenic mice on heterozygous Enam knock out mice.   





Table 3.3 Result of Western-Blot representing enamelin protein level of mice with different genotype from various transgenic lines 
background  
                    
Antibody Genotype Line 1 Line 2 Line 3 Line 4 Line 7 Line 10 Line 11 Line 12 
+/+ √ √   √   √ 
+/- √ √   √ √ √ √ 
-/- √ √   √ √ √ √ 
tg,+/+ √ √   √   √ 
tg,+/- √ √   √ √ √ √ 
Mouse 
Enam 223 
tg,-/- √ √     √ √ √ √ 





Table 3.4 Converted relative Enam transgene gene expression levels in different lines by real-time PCR. 
 
 wt     line 2     line 3     line 4       line 10      line 11       line 12 
average 0 1.32 17.47 0.29 0.15 0.24 1.00 
Converted 










           
            
          Table 3.5 Comparison of real-time PCR results from two primers. 
 
 wt     line 2     line 3     line 4       line 10      line 11       line 12 
Primer 1 
(Enam F/R) 0 47% 485% 1% 11% 22% 31% 
Primer 2 




  Table 3.6 Percentage of Enam transgene expression in different transgenic lines and different gene 
backgrounds  
                
  Line 1 Line 2 Line 3 Line 4 Line 7 Line 10 Line 11 Line 12 
 Percentage of transgene 
expression on wild-type 
background n/a 47% 485% 1%  n/a 11% 22% 31% 
Percentage of transgene 
expression on 
heterozygous background 127% n/a n/a n/a 20% 4% n/a 56% 
Percentage of transgene 
expression on null 
background 154 n/a  n/a  n/a  13% 9% n/a  91% 
Averaged transgene 












PHENOTYPIC RESCUE OF 
ENAMELIN KNOCKOUT MICE 








    In Enam null mice the mineralization front associated with the secretory surface of the 
ameloblast membrane fails to initiate and elongate enamel mineral ribbons, so no true 
enamel forms. The mineralization front is a complex of enamel proteins that cannot be 
reconstituted in vitro. This study is to establish an i  vivo system for assaying enamelin 
structure-function relationships by developing an enamelin transgene that can recover 
normal enamel formation in Enam null mice. A mouse expression vector was constructed 
using 4.6 kb of 5’ amelogenin gene up to the translation initiation codon, the enamelin 
3.8 kb cDNA, and 1.2 kb of amelogenin 3’ noncoding sequence. Transgenic mice 
established using this construct was bred with Enam null mice for two generations. 
Offspring of this breeding strategy have the following four genotypes: enamelin 
transgene expressed in the Enam null background (Enamtg,-/-), enamelin transgene 
expressed in the Enam heterozygous background (Enamtg,+/-), enamelin null mice (Enam -
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/-) and enamelin heterozygous mice (Enam+/-).  The enamel was characterized by 
scanning electron microscopy (SEM) and oral photographs to see whether the enamelin 
transgene rescued the enamel phenotype of Enam null mice. Offspring of founder 12, 
which were median expressers of the Enam transgene (transgene is similar as endogenous 
enamelin level), fully recovered the enamel phenotype in the Enam-/- background. SEM 
evaluation of Enamtg,-/- mice demonstrated that the enamel layer was the sam  thickness 
as wild-type mice and had well-defined, decussating e amel rods. Von Kossa staining of 
histological sections showed enamel mineralization fr m the DEJ to the enamel surface. 
Offspring of founders 10, which were low expressers of the Enam transgene (around 8% 
of the endogenous enamelin level), did not recover th  phenotype in the null background, 
but recovered the phenotype in the heterozygous background. Similar was the result from 
founder 1, which is a high expresser (transgene is around 140% of endogenous enamelin 
level): when transgene is expressed in null background, the enamel defect was not 
recovered; when transgene is expressed in heterozygous background, the phenotype is 
fully recovered. This study confirms the importance of enamelin in the enamel formation 
and that its role is dosage-dependent. This study also shows that appropriate expression 
of Enam transgene was can rescue the defective phenotype of enamelin knockout mice. 
This system is useful to study enamelin structure-fnction relationships in vivo. 
 
Introduction 
    Trying to rescue the defective phenotype of a mutant gene using another gene, mutated 
version of the same gene, fragment of the same gene, etc., is a useful approach to study 
the structure and function of a gene in many fields, including tooth development area. 
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This approach was used to study gene regulation in early stage tooth development. Tooth 
development is arrested at the bud stage in Msx1 deficient mice (Houzelstein et al., 1997; 
Satokata and Maas, 1994). Bmp4 is a downstream gene of Msx1 in early mouse tooth 
development. In one study, it was found that ectopi expression of a Bmp4 transgene 
driven by the mouse Msx1 promoter in the dental mesenchyme restored the expression of 
Lef-1 and Dlx2 but neither Fgf3 nor syndecan-1 in the Msx1 mutant molar tooth germ. 
The mutant phenotype of molar but not incisor could be partially rescued to progress to 
the cap stage (Zhao et al., 2000). By using the rescue approach, the authors in this study 
learned that Bmp4 can bypass Msx1 function to partially rescue molar tooth development 
in vivo, and to support alveolar process formation (Zhao et al., 2000). Another example of 
tooth development gene regulation study using a rescuing approach is that using the 
keratin 14 promoter to target expression of an activ ted form of TNF family receptor 
Edar in transgenic mice. Expression of this transgee is able to rescue the tooth 
phenotype in Tabby (Eda) and Sleek (Edar) mutant mice (Tucker et al., 2004), which has 
ectodermal dysplasia phenotype including missing teeth and smaller teeth with reduced 
cusps (Pispa et al., 1999). Rescuing approach can also be used to study the function of a 
gene in different developmental stages. This approach is used in one study on dentin 
development. Dentin matrix protein 1 (Dmp1) is expressed in both pulp and odontoblast 
cells and deletion of the Dmp1 gene leads to defects in odontogenesis and mineralization 
(Ye et al., 2004). Re-expression of Dmp1 in early and late odontoblasts under control of 
the Col1a1 promoter rescued the defects in mineralization as well as the defects in the 
dentinal tubules and third molar development. In cotrast, re-expression of Dmp1 in 
mature odontoblasts, using the Dspp promoter, produce  only a partial rescue of the 
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mineralization defects (Lu et al., 2007). In this study, the results suggest that Dmp1 is a 
key regulator of odontoblast differentiation and it is required in both early and late 
odontoblasts for normal odontogenesis to proceed (Lu et al., 2007). Rescuing approach is 
also used in the studies of enamel matrix proteins. Amelogenin is the most abundant 
protein in developing enamel (Fincham et al., 1999b). Amelogenin and its cleavage 
products make up over 90% of the enamel matrix (Fincham et al., 1999b; Termine et al., 
1980). There are several studies that use the rescuing approach to study the function of 
amelogenin by using fragments or modulated version of this gene to try to rescue the 
defective phenotype of the amelogenin knockout mice. Amelogenin null mice show a 
phenotype similar to human amelogenesis imperfecta, with a thin surface layer of mineral 
lacking a typical rod pattern (Gibson et al., 2001). Transgenic expression of bovine 
leucine-rich amelogenin protein (LRAP) in the enamel-secreting ameloblasts in 
amelogenin knockout mice, did not rescue the enamel ph notype (Chen et al., 2003). 
When they use transgenic mice that express LRAP (a 59 amino acid leucine-rich 
amelogenin peptide) under control of the AmelX regulatory regions to breed with 
amelogenin knockout mice, they found the organization of the enamel rod pattern was 
altered by the presence of the LRAP transgene (Gibson et al., 2009). In another study, 
amelogenin null (KO) mice were bred with two transgenic mouse lines, one expresses the 
most abundant amelogenin (TgM180), which has normal en mel; another expresses a 
mutated amelogenin (TgP70T), which leads to amelogenesis imperfecta in humans (Li et 
al., 2008a). The resultant TgM180KO offspring showed evidence of rescue in enamel 
thickness, mineral density, and volume in molar teeth. Rescue was not observed in the 
molars from the TgP70TKO mice (Li et al., 2008a). In the study of ameloblastin, another 
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major enamel matrix protein, transgenic mouse establi hed using full-length ameloblastin 
gene expressed driven by amelogenin promoter were bred with Ambn mutant mice. 
Appropriate expression level of transgene fully recovered the defective phenotype of 
Ambn mutant mice (Chun et al., 2010 in press).  
    The objective of this study was to establish an in vivo system for assaying enamelin 
structure-function relationships by developing an effective transgenic model that can 
recover normal enamel formation in Enam null mice. The mouse amelogenin (AmelX) 5’ 
transcriptional regulatory region has been successfully used to drive transgenic 
expression specifically in ameloblasts (Snead et al., 1996; Snead et al., 1998b; Wen et al., 
2008b). We established transgenic mouse lines that express Enam gene driven by 
amelogenin promoter, and used different transgenic mouse lines to breed with enamelin 
null mice to see whether the transgene can recover the defective phenotype of null mice, 
which show no true enamel layer and chalky-white teeth phenotype (Hu et al., 2008). 
 
Materials and Methods 
Von Kossa staining of secretory stage molars. Day 4 mandibles of F2 offspring from 
line 12 were fixed with 4% paraformaldehyde/0.1% glutaraldehyde, dehydrated in 
ethanol, embedded in paraffin and sectioned at 6mm. Von Kossa staining for mineral was 
performed by applying 1% silver nitrate to the sections and exposing them to ultraviolet 
light for 20 min. Unreacted silver was removed with 5% sodium thiosulfate. Sections 




Scanning electron microscopy (SEM) of mandibular incisors using fracture method. 
The soft tissue was removed from left and right half mandibles at 7 weeks. We used a 
rotating diamond disc (BRASSELER Dental Instruments, Savannah, GA, Cat. No. 
934.11.180) to cut a notch on mandibular incisor frm the dentin side (lingual side) at the 
level of the labial alveolar crest and fractured the incisor at the notch. SEM imaging of 
the broken surface highlights the decussating rods. A econd, parallel cut was made 
through the incisors 5-6 mm apical to the first cut. This cut surface was glued to an SEM 
stub so that the electron beam would be aimed directly perpendicular to the fracture 
surface. The surface was sputter coated with gold and analyzed by SEM to determine 
enamel thickness and structure.  
 
Scanning electron microscopy (SEM) of mandibular incisors using polish and etch 
method. The soft tissue was removed from left and right half mandibles at 7 weeks. We 
used a rotating diamond disc to cut through mandibular incisor at the level of the labial 
alveolar crest. The broken edge of the incisor was polished with two different Extra Thin 
Contouring and Polishing Disc (3M ESPE Dental Products, St. Paul, MN. REF 2381F, 
REF 2381SF) for about 1 minute each, using the orange colored disk (REF 2381F) first 
and the yellow colored disk (REF 2381SF) second. After polished the cutting surface, the 
sample was washed with 0.75 % Bleach for 10 seconds a  then lightly etched with 0.1% 
nitric acid (RICCA CHEMICAL co. Arlington, TX. Cat. No. 5320-16) for exactly 15 
seconds three times. Samples were washed with water in between etching. A second, 
parallel cut was made through the incisors 5-6 mm apical to the first cut. This cut surface 
was glued to an SEM stub so that the electron beam would be aimed directly 
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perpendicular to the first cut to accurately measure the thickness of the enamel layer. The 
surface was sputter coated with gold and analyzed by SEM to determine enamel thickness 
and structure. 
 
Oral photographs. Oral photographs of teeth were taken using Nikon DIGITAL 
CAMERA DXM1200 combined with microscope. For each sample, intraoral picture of 
upper and lower incisors in the head with skin (0.8x), labial view of lower incisor (2x), 
mesial view of lower mandible (1.3x) and mesial view of lower molars (3x) were taken. 
 
Results 
    We have characterized four lines of Enam transgenic mice bred with Enam null mice. 
 
Phenotype of F2 offspring from transgenic line 7. Based on the Western blotting and 
real-time PCR results, line 7 is a low expresser. Line 7 has a minimum transgene 
expression level that is hardly detectable at the protein level and is around 14% of wild-
type Enam based on real-time PCR result. Transgene expressing in null background 
showed no enamel recovery. The phenotype of this genotype, i.e. Enam tg, -/-, has severer 
defects than heterozygous mouse (Fig 4.1 E-H, compared with Q-T). However when 
transgene of this line expressed in heterozygous background, i.e. Enam(tg, +/-), the teeth 
look much better than Enam heterozygous mouse (Fig 4.1 I-L compared with Q-T) based 
on the oral photographs. On intraoral photograph, the incisors look yellowish in color, 
similar to wild-type animals (Fig 4.1 I). From the mesial view of the lower mandible, the 
enamel layer can be seen in the Enam(tg, +/-) mice from this line (Fig 4.1 K), similar as the 
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wild-type mice (Fig 4.1 C). On the Scanning Electron Microscopy (SEM) pictures, when 
the transgene from this line is expressed in null background, i.e., Enam(tg, -/-), no true 
enamel layer was found (Fig 4.2 and Fig 4.4 column 2). The molars of this genotype look 
rough on the surface and small in size (Fig 4.3 column 2, row 3 and 4). High 
magnification SEM (10,000x and 20,000x) pictures show no decussation pattern was 
found in the enamel microstructure in this phenotype (Fig 4.3 column 2, row 1 and 2). 
But when the transgene is expressed in heterozygous background, i.e., Enam(tg, +/-) , the 
enamel thickness is completely normal, and the decussation pattern of enamel rod-
interrod structure is evident (Fig 4.2, 4.3, 4.4 column 3). Molars of mice from this 
genotype look similar to the wild-type animals (Fig 4.3 column 3 row 3 and 4).  
 
Phenotype of F2 offspring from transgenic line 10. Based on the Western blotting and 
real-time PCR results, line 10 is also a low expresser. Line 10 has a minimum transgene 
expression level that is hardly detectable at the protein level and is around 8% of wild-
type Enam based on real-time PCR result. The phenotype of 7 weeks old mice from line 
10 is similar to those of line 7. When the transgene is expressed in Enam null background, 
no enamel thickness recovery is found (Fig 4.6 and 4.8, column 2). On high 
magnification SEM pictures, the enamel layer has some rod-interrod-like decussation 
structures coming back (Fig 4.7 column2, row 1 and 2). But when the transgene is 
expressed in Enam heterozygous background, the enamel thickness and decussation 
pattern is fully recovered (Fig 4.6, 4.7, 4.8 column3). The lower incisor for this genotype 
looks smooth on surface and yellowish in color (Fig 4.5 I), similar as those of wild-type 
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(Fig 4.5 A), much better than those of heterozygous mouse, which have chalky-white 
lower incisors (Fig 4.5 Q).  
 
Phenotype of F2 offspring from transgenic line 12. Line 12 has a transgene expression 
level similar as endogenous gene expression level. Transgene from line 12 successfully 
recovered the defects of the Enam null mice as shown by the oral photographs of adult F2 
offspring. When expressing an Enam transgene, both the null mice and heterozygous 
mice have their teeth appear normal (Fig 4.9, E-H and I-L individually). The teeth look 
smooth on the surface and yellowish in color for both genotypes (Fig 4.9 E and I 
individually). Scanning Electron Microscope (SEM) sections showed the Enam transgene 
in both null and heterozygous background recovered th  enamel thickness. Enamel of 
these mice has well-defined, decussating enamel rods (Fig. 4.10, 4.11, 4.12 column 2 and 
3). In secretory stage, enamel formation is recovered by the transgene from line 12 in the 
Enam null background, i.e. genotype Enam(tg, -/-), as shown by von Kossa staining on 
sections from day 4 F2 offspring (Fig 4.13A and B column1). The enamel layer has 
mineralization staining, while in the Enam null mice, no mineralization was found in 
enamel layer (Fig 4.13A and B column 4).  
 
Phenotype of F2 offspring from transgenic line 1. Based on the Western blotting and 
real-time PCR results, line 1 showed about 140% as much as those of wild-type Enam 
expression. In line 1, the transgene did not recover the phenotype in null background but 
recovered the phenotype well in the heterozygous background. Enam(tg, +/-) mouse in this 
line showed full enamel thickness and well defined d cussation pattern under SEM (Fig 
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4.15-4.17 column 3) and smooth surface and yellowish in color on oral photographs (Fig 
4.14 I-L), similar to those of wild-type mouse.  
 
Discussion 
    Based on our current results, phenotype of Enam(tg, +/-) mice from all four transgenic 
lines have their teeth look normal, fully recovered the phenotype of Enam(+/-) mouse. 
Each genotype from each line has more than 3 animals characterized and demonstrated 
similar results. In line 12, which has a transgene xpression level similar to wild-type 
Enam gene, F2 offspring in genotype of Enam(tg, -/-) showed full recovery of enamel 
phenotype. Secretory stage enamel formation is also recovered. Line 7 and line 10 have a 
transgene with a low expression level. For these two transgenic mouse lines, transgene 
recovered the phenotype in the heterozygous background but not in the null background. 
Line 1 has an expression level higher than normal, however, the Enam(tg, -/-) has a similar 
expression level as Enam(tg, +/-) yet with a different phenotype. Based on the current study, 
except the Enam(tg, -/-) mice from line 1, enamelin expression higher than 70% is adequate 
for facilitating enamel formation. When Enam expression level is lower than 50% (like 
around 10% in line 7 and 10) of the normal, the enamel defect cannot be recovered.  
    The recovery of the enamel phenotype in Enam null mice by transgenic expression of 
functional Enam confirms the previous observation that Enam is essential for proper 
dental enamel formation. Another finding of this study is that variation in transgene 
expression by ameloblasts among different transgenic li es dictated the degree of 
phenotypic rescue of Enam null mice. It further confirmed that there is a dose-dependent 
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effect of enamelin and that proper expression level of this gene is critical for proper 



















Figures and Legends 
 
 
Fig 4.1 Oral photograph of F2 offspring from transgenic mouse line 7. Intraoral 
photographs of 7 weeks old mice of wild-type mouse (A-D), F2 offspring from transgenic 
line 12 (E-T) are shown. Oral photograph of genotype Enam(tg, -/-) (E-H), Enam(tg, +/-) (I-L), 
Enam(-/-) (M-P) and Enam(+/-) (Q-T) are noted. These photographs includes direct intraoral 
photograph (A, E, I, M, Q), distal view of lower inc sor (B, F, J, N, R), mesial view of 
























Fig 4.2 SEM analysis of F2 offspring of line 7: low magnification. Mandibular incisors 
from 7-week-old F2 offspring were cut at the level of labial alveolar crest for SEM 
evaluation. SEM results of F2 offspring from transgenic mouse line 7 (column 2-5) and 
wild-type control were shown (column 1) with whole incisor (row 1), enamel layer (row 
2) and middle enamel (2000x in row 3 and 4,000x in row 4) are shown. Genotypes of 
groups are: wild-type (wt) (column 1), Enam(tg, -/-) (column 2), Enam(tg, +/-) (column 3), 


























Fig 4.3 SEM analysis of F2 offspring of line 7: high magnification and molars. 
Mandibular incisors from 7-week-old F2 offspring were cut at the level of labial alveolar 
crest for SEM evaluation. SEM results of F2 offspring from transgenic mouse line 7 
(column 2-5) and wild-type control (column 1) are shown. High magnification of enamel 
microstructure (10,000x in row 1, 20,000x in row 2) and the surface SEM of molars 
(mesial view in row 3, occlusal view in row 4) are shown. Genotypes of groups are: wild-
type (wt) (column 1), Enam(tg, -/-) (column 2), Enam(tg, +/-) (column 3), Enam(-/-) (column 4) 






















Fig 4.4 SEM analysis of F2 offspring of line 7 using polish and etch method. 
Mandibular incisors from 7-week-old F2 offspring were cut at the level of labial alveolar 
crest and processed for polish and etch for SEM evaluation to examine enamel thickness. 
SEM results of F2 offspring from transgenic mouse lin  7 (column 2-5) and wild-type 
control were shown (column 1) with cross section of incisor (row 1), enamel layer (row 2) 
and middle enamel (2000x in row 3 and 4,000x in row 4) are shown. Genotypes of 
groups are: wild-type (wt) (column 1), Enam(tg, -/-) (column 2), Enam(tg, +/-) (column 3), 
























Fig 4.5 Oral photograph of F2 offspring from transgenic mouse line 10. Intraoral 
photographs of 7 weeks old mice of wild-type mouse (A-D), F2 offspring from transgenic 
line 10 (E-T) are shown. Oral photograph of genotype Enam(tg, -/-) (E-H), Enam(tg, +/-) (I-L), 
Enam(-/-) (M-P) and Enam(+/-) (Q-T) are noted. These photographs include direct intraoral 
photograph (A, E, I, M, Q), distal view of lower inc sor (B, F, J, N, R), mesial view of 

























Fig 4.6 SEM analysis of F2 offspring of line 10: low magnification. Mandibular 
incisors from 7-week-old F2 offspring were cut at the level of labial alveolar crest for 
SEM evaluation. SEM results of F2 offspring from transgenic mouse line 10 (column 2-5) 
and wild-type control were shown (column 1) with cross section of incisor (row 1), 
enamel layer (row 2) and middle enamel (2000x in row 3 and 4,000x in row 4) are shown. 
Genotypes of groups are: wild-type (wt) (column 1), Enam(tg, -/-) (column 2), Enam(tg, +/-) 
























Fig 4.7 SEM analysis of F2 offspring of line 10: high magnification and molars. 
Mandibular incisors from 7-week-old F2 offspring were cut at the level of labial alveolar 
crest for SEM evaluation. SEM results of F2 offspring from transgenic mouse line 10 
(column 2-5) and wild-type control (column 1) are shown. High magnification of enamel 
microstructure (10,000x in row 1, 20,000x in row 2) and the surface SEM of molars 
(mesial view in row 3, occlusal view in row 4) are shown. Genotypes of groups are: wild-
type (wt) (column 1), Enam(tg, -/-) (column 2), Enam(tg, +/-) (column 3), Enam(-/-) (column 4) 























Fig 4.8 SEM analysis of F2 offspring of line 10 using polish and etch method. 
Mandibular incisors from 7-week-old F2 offspring were cut at the level of labial alveolar 
crest and processed for polish and etch for SEM evaluation to examine enamel thickness. 
SEM results of F2 offspring from transgenic mouse lin 10 (column 2-5) and wild-type 
control were shown (column 1) with whole incisor (row 1), enamel layer (row 2) and 
middle enamel (2000x in row 3 and 4,000x in row 4) are shown. Genotypes of groups are: 
wild-type (wt) (column 1), Enam(tg, -/-) (column 2), Enam(tg, +/-) (column 3), Enam(-/-) 
























Fig 4.9 Oral photograph of F2 offspring from transgenic mouse line 12. Intraoral 
photographs of 7 weeks old mice of wild-type mouse (A-D), F2 offspring from transgenic 
line 12 (E-T) are shown. Oral photograph of genotype Enam(tg, -/-) (E-H), Enam(tg, +/-) (I-L), 
Enam(-/-) (M-P) and Enam(+/-) (Q-T) are noted. These photographs include direct intraoral 
photograph (A, E, I, M, Q), distal view of lower inc sor (B, F, J, N, R), mesial view of 

























Fig 4.10 SEM analysis of F2 offspring of line 12: low magnification. Mandibular 
incisors from 7-week-old F2 offspring were cut at the level of labial alveolar crest for 
SEM evaluation. SEM results of F2 offspring from transgenic mouse line 12 (column 2-5) 
and wild-type control were shown (column 1) with whole incisor (row 1), enamel layer 
(row 2) and middle enamel (2000x in row 3 and 4,000x in row 4) are shown. Genotypes 
of groups are: wild-type (wt) (column 1), Enam(tg, -/-) (column 2), Enam(tg, +/-) (column 3), 
























Fig 4.11 SEM analysis of F2 offspring of line 12: high magnification and molars. 
Mandibular incisors from 7-week-old F2 offspring were cut at the level of labial alveolar 
crest for SEM evaluation. SEM results of F2 offspring from transgenic mouse line 12 
(column 2-5) and wild-type control (column 1) are shown. High magnification of enamel 
microstructure (10,000x in row 1, 20,000x in row 2) and the surface SEM of molars 
(mesial view in row 3, occlusal view in row 4) are shown. Genotypes of groups are: wild-
type (wt) (column 1), Enam(tg, -/-) (column 2), Enam(tg, +/-) (column 3), Enam(-/-) (column 4) 























Fig 4.12 SEM analysis of F2 offspring of line 12 using polish and etch method. 
Mandibular incisors from 7-week-old F2 offspring were cut at the level of labial alveolar 
crest and processed for polish and etch for SEM evaluation to examine enamel thickness. 
SEM results of F2 offspring from transgenic mouse lin 12 (column 2-5) and wild-type 
control were shown (column 1) with whole incisor (row 1), enamel layer (row 2) and 
middle enamel (2000x in row 3 and 4,000x in row 4) are shown. Genotypes of groups are: 
wild-type (wt) (column 1), Enam(tg, -/-) (column 2), Enam(tg, +/-) (column 3), Enam(-/-) 
























Fig 4.13 Secretory stage enamel formation of F2 offspring from transgenic mouse 
line 12. Von Kossa staining of day 4 molar sections from F2 offspring of line 12, upper 
molar (A) and lower molar (B). Upper row, 4x microsc pe; middle row, 10x microscope; 
lower row, 20x microscope. Genotype of these mice ar : Enam(tg,,-/-)(First column), 

















Fig 4.14 Oral photograph of F2 offspring from transgenic mouse line 1. Intraoral 
photographs of 7 weeks old mice of wild-type mouse (A-D), F2 offspring from transgenic 
line 1(E-T) are shown. Oral photograph of genotype Enam(tg, -/-) (E-H), Enam(tg, +/-) (I-L), 
Enam(-/-) (M-P) and Enam(+/-) (Q-T) are noted. These photographs include direct intraoral 
photograph (A, E, I, M, Q), distal view of lower inc sor (B, F, J, N, R), mesial view of 

























Fig 4.15 SEM analysis of F2 offspring of line 1: low magnification. Mandibular 
incisors from 7-week-old F2 offspring were cut at the level of labial alveolar crest for 
SEM evaluation. SEM results of F2 offspring from transgenic mouse line 1 (column 2-5) 
and wild-type control were shown (column 1) with whole incisor (row 1), enamel layer 
(row 2) and middle enamel (2000x in row 3 and 4,000x in row 4) are shown. Genotypes 
of groups are: wild-type (wt) (column 1), Enam(tg, -/-) (column 2), Enam(tg, +/-) (column 3), 
























Fig 4.16 SEM analysis of F2 offspring of line 1: high magnification and molars. 
Mandibular incisors from 7-week-old F2 offspring were cut at the level of labial alveolar 
crest for SEM evaluation. SEM results of F2 offspring from transgenic mouse line 1 
(column 2-5) and wild-type control (column 1) are shown. High magnification of enamel 
microstructure (10,000x in row 1, 20,000x in row 2) and the surface SEM of molars 
(mesial view in row 3, occlusal view in row 4) are shown. Genotypes of groups are: wild-
type (wt) (column 1), Enam(tg, -/-) (column 2), Enam(tg, +/-) (column 3), Enam(-/-) (column 4) 























Fig 4.17 SEM analysis of F2 offspring of line 1 using polish and etch method. 
Mandibular incisors from 7-week-old F2 offspring were cut at the level of labial alveolar 
crest and processed for polish and etch for SEM evaluation to examine enamel thickness. 
SEM results of F2 offspring from transgenic mouse lin  1 (column 2-5) and wild-type 
control were shown (column 1) with whole incisor (row 1), enamel layer (row 2) and 
middle enamel (2000x in row 3 and 4,000x in row 4) are shown. Genotypes of groups are: 
wild-type (wt) (column 1), Enam(tg, -/-) (column 2), Enam(tg, +/-) (column 3), Enam(-/-) 
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OVER-EXPRESSION OF ENAMELIN 







In Enam null mice the mineralization front associated with the secretory surface of the 
ameloblast membrane fails to initiate and elongate enamel mineral ribbons. True enamel 
was not formed in Enam null mice. While the phenotype of enamelin loss-of-function in 
vivo is clearly described in the enamelin null mouse study, no report has shown what 
happens when the enamelin is over-expressed in vivo yet. We established enamelin 
transgenic mouse lines using the amelogenin promoter. In these transgenic mouse lines, 
the enamel expression level varies. We show here when over-expression of enamelin is in 
median level (around one and half times as much as endogenous enamelin), enamel 
surface start to lose its smoothness, the enamel surface has some round protrusive 
structures. When the over-expression of enamelin is i  a high level (around five times as 
much as endogenous enamelin), the enamel layer is almost lost: the teeth look chalky and 
white on oral photographs. Scanning electron microscopy showed the enamel portion 
underneath the protrusive structure on the surface (roughness on enamel surface) start to 
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lose its rod-interrod decussation pattern. The higher t e level of enamelin over-expression, 
the more decussation pattern of the enamel is lost. On micro-CT analysis, mineral content 
of enamel layer decreased in the enamelin transgenic mouse compared to wild-type mice. 
We then concluded that enamelin expression level is critical for proper enamel formation. 
Over-expression of enamelin vivo caused defective enamel phenotype, the severity of 
defects is correlated with the level of enamelin over-expression.  
 
Introduction 
Mature enamel crystallites are about 70 nm wide and 30 nm thick, and organized into 
bundles called enamel rods (prisms), with about 10,000 parallel crystals in a rod (Daculsi 
and Kerebel, 1978; Nanci, 2003). Each rod is made by one ameloblast cell, the cell type 
which is responsible of secreting enamel matrix andorchestrating enamel formation 
(Nanci, 2003). Enamel crystals grow primarily in length in secretory stage. As the 
crystals extend, the enamel layer expands. Because enamel crystals grow longer at this 
mineralization front, the ameloblasts retreat away from the growing tooth. 
    Studies of enamelin null (Enam-/-) mice showed that the teeth of homozygous mouse 
look chalky and white and no enamel layer is present, while in heterozygous mice, the 
upper incisors look close to normal, and lower incisors look chalky and white. 
Histological sections of one week old developing enamel showed there is no 
mineralization in the enamel layer at the secretory surface of the ameloblast (Hu et al., 
2008). 
    While the phenotype of a tooth when lacking enamelin is clearly described in the 
enamelin null mice study, no report has shown what happens when the enamelin is 
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overexpressed in vivo. Over-expressing a gene in a tissue specific manner is an effective 
approach to investigate the role a protein in the context of a developing animal. We 
targeted enamelin over-expression to ameloblasts by generating transgenic animals in 
which enamelin expression was under the control of the ameloblast-specific amelogenin 
promoter. Amelogenin is the most abundant protein in developing enamel (Fincham et al., 
1999b). The mouse amelogenin (AmelX) 5’ transcriptional regulatory region has been 
successfully used to drive transgenic expression specifically in ameloblasts (Snead et al., 
1996; Snead et al., 1998b; Wen et al., 2008b). In this study, we characterized the dental 
enamel phenotype of these transgenic mice and found ver-expression of enamelin causes 
defects on enamel formation and this effect is dose dependent. 
 
Materials and Methods 
Oral photographs. Similar as previously described in Chapter 4, oral photographs of 
teeth were taken using Nikon DIGITAL CAMERA DXM1200 combined with 
microscope. As showed in Fig5.2 A, for each sample, intraoral picture of upper and 
lower incisors in the head with skin(0.8x), labial view of lower incisor (2x), mesial view 
of lower mandible (1.3x) and mesial view of lower molars (3x) were taken as noted 
magnification. Labial view of lower incisor with increased magnification (2x, 3x, 4x, 6x, 
8x individually) were also taken (Fig 5.2B).  
 
Assessing Enam transgene expression level by real-time PCR. The material and 
method for real-time PCR experiment was described in etail in Chapter 3. To further 
explain the data in this chapter, Table 5.1 and 5.2 was generated. For “Enam” primer, all 
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the wild-type animal relative expression levels were averaged (column 3 in Table 5.1). 
All the fold change numbers were divided by this aver ge number to make the wild-type 
animal enamelin expression levels in each transgenic li e close to 1, so it is easier to 
compare the transgenic animal enamelin expression levels with wild-type animal groups. 
In other words, for each comparison, fold change were assessed relative to the expression 
level of the wild-type animal which was set as 1. 
 
Assessing Enam transgene expression level by Western blotting. The material and 
method of Western-blotting was described in detail in chapter 3. From each transgenic 
mouse line, littermates of the offspring from enamelin transgenic mouse breed with 
C57BL/6 wild-type mouse were divided into two groups after genotyping: wild-type 
group and transgene positive group. Sample from all genotypes were loaded on SDS-
PAGE, wild-type animals (wt1-wt4) first followed by transgenic animals (tg1-tg5) 
(Fig5.1 D, E, F). 
 
Micro-computed tomography. Mouse hemimandibles were imaged using a cone-beam 
micro-computed tomography (µCT) system (eXplore Locus SP, Amersham Biosciences 
Pre-Clinical Imaging, London, Ontario, Canada) in the Orthopaedic Research Laboratory 
at the University of Michigan Department of Orthopaedic Surgery, as described 
previously (Park et al., 2007). In brief, hemimandibles were exposed to polychromatic x-
rays on a rotating stage. Measurements were taken at a operating voltage of 80 kV and 
80 mA of current, with an exposure time of 1600ms. The effective voxel size of the 





Gene expression levels in enamelin transgenic mice. The transgene expression levels 
vary in different transgenic lines. Here we show three transgenic mouse lines which have 
different enamelin expression level. Line 12 have th  lowest enamelin expression level 
among these three, with around 130% of enamelin expression in the transgenic mouse 
compared with wild-type littermates; line 2 have thmiddle expression level, with around 
150% of enamelin expressed in transgenic mouse; lin 3 have the highest expression, 
have as much as five times enamelin expressed in transgenic mouse as in wild-type 
littermates (Fig 5.1 A and Table 5.1 last column). When using the real-time PCR primer 
set which detects only enamelin transgene, the result correlates well to the result of 
enamelin primer in Fig 5.1 A. That is, the enamelin xpression level from low to high in 
line 12, 2 and 3 (Fig 5.1 B) was determined to be accurate. On protein level, it is 
consistent that the transgenic mice have higher enam lin expression than wild-type 
littermates in line 12 and 2 (Fig 5.1 C, D). This confirms that our strategy to establish 
enamelin over-expression transgenic mouse line is working and we have a range of 
enamelin over-expression i  vivo. 
 
Phenotype of enamelin transgenic mouse. Seven weeks old enamelin transgenic mouse 
and wild-type controls were oral-photographed. On the intraoral photograph for this three 
transgenic mouse lines, line 12 and 2 show some roughness (not smooth and shiny) on 
the surface of incisor (e and i in Fig 5.2A individually), while line 3 has incisor appear 
chalky and white (m in Fig 5.2A ), similar to the phenotype of enamelin null mice (Hu et 
 
 100 
al., 2008). The wild-type mouse incisors have yellowish and smooth surface (a in Fig 
5.2A). The roughness of the enamel surface on the incisors of transgenic mouse line 12 
and 2 can also be seen on the distal view of lower incisors (f and j in Fig 5.2A 
individually). For line 3, most enamel is lost, leaving the dentin exposed but sometimes, a 
little chalky rough materials left on top of dentin (n in Fig 5.2A). The surface roughness 
is associated with round, protrusive bumps which are hard and cannot be removed by 
hand instruments. From the mesial view of mandible, th  enamel layer can be seen in line 
12 (g in Fig 5.2A) and line 2 (k in Fig 5.2A) incisors, similar to the enamel layer in wild-
type controls (c in Fig 5.2A). Transgenic mice of line 2 have more protrusive bumps than 
line 12, it can be seen even on the mesial view of mandible (k in Fig 5.2A). But for line 3, 
no enamel layer is seen on the mesial view of lower incisor (o in Fig 3.2A). Molars of 
line 12 look similar to that of the wild-type mouse (h in Fig 5.2A); molar of line 2 seems 
to have some roughness on the surface (l in Fig 5.2A), not as smooth and shiny as wild-
type molars (d in Fig 5.2A); molars of line 3 are smaller and do not seem to have enamel 
layer or have a very thin enamel layer (p in Fig 5.2A)  Under higher magnification of the 
lower incisor surface, we can clearly see the round, protrusive structure on the enamel 
surface of transgenic mouse line 12 (f-j in Fig 5.2B) and line 2 (k-o in Fig 5.2B), with 
line 2 having a severer presentation. The protrusive tructure in line 2 is slightly larger 
than in line 12 and the texture seem to change a bit, because some bumps look whiter and 
chalkier than the others. While in line 3, covering most of the exposed dentin surface is 
sporadic chalky white material, which is similar but not identical to the protrusive bumps 
observed in line 2 and 12 (p-t in Fig 5.2B).  
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    On the surface SEM (scanning electron microscopy) analysis, we can clearly see the 
round protrusive structures of enamel on enamel surface of lower incisors in line 12 (e-h 
in Fig 5.3) and line 2 (i-l in Fig 5.3), compare with a smooth enamel surface for wild-type 
control animals (a-d in Fig 5.3). 
 
Enamel microstructure in enamelin transgenic mice. On the SEM photos of fractured 
surface, we can examine the micro-structures of enam l in the enamelin transgenic mice. 
Transgenic mice from line 12 and 2 still have an enamel layer as shown in SEM (Fig 
5.4B and C individually), while line 3 loses its enamel layer (Fig5.4 D). The rod-interrod 
decussation of enamel in wild-type mouse is shown (Fig 5.4 A, E, F, G). Most parts of 
enamel layer from enamelin transgenic mouse founder lin  12 have similar decussating 
pattern as wild-type (a, b, c in Fig 5.5 A), however, where there are protrusive bumps on 
the surface of enamel, the underneath enamel start to lose its decussating pattern (g, h, i in 
Fig 5.5 A). There are areas that the enamel has not completely lost its decussation pattern, 
the crystallite seems to have difficulty in forming bundle-like structures, but only in a 
longitudinal dimension. It seems only rod-like struc ures is there, but not much interrod-
like structures present (d, e, f in Fig 5.5 A). Transgenic mice from line 2 still have an 
enamel layer, but most part of the enamel has lost its decussating pattern (d, e, f in Fig 5.5 
B). Small portion of enamel has a decussating pattern (a, b, c in Fig 5.5 B), similar to the 
wild-type mouse. Enamel structure of the protrusive bumps has the long crystallite-like 
structures (g, h, i in Fig 5.5 B). Transgenic mouse from line 3 almost lost its enamel layer. 
The decussating pattern of enamel is gone. Some areas of the enamel layer where some 
protrusive bumps are located contain crystallite-lik  structure (a, b, c in Fig 5.5 C), some 
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other areas just have a thin layer of amorphous material on the dentin surface (d, e, f in 
Fig 5.5 C), similar to what we have seen on enamelin null mice (Hu et al., 2008). 
 
Micro-computed tomographic analysis of enamel in enamelin transgenic mice. Seven 
weeks old transgenic mice and wild-type control mice were also used for micro-CT 
analysis to evaluate mineral content of the dental en mel. Sagittal sections through the 
incisor (Fig.5.6 B, F, J) showed strong contrast betwe n enamel and dentin in both the 
wild-type enamelin transgenic mice. The three-dimensio al micro-computed tomography 
reconstructions of the hemimandibles using a low arbitr ry density demarcation displayed 
the entire mandible (Fig.5.6 A, E, I). Similar reconstructions were made using an 
arbitrary density demarcation that eliminated all of the dentin and bone of the wild-type 
hemimandibles but displayed the entire enamel layer of the molars and the maturation 
stage enamel of the incisors (Fig. 5.6 D, H, L). Onpictures of the two-dimensional 
sagittal section of incisors (Fig 5.6 B, F, J), and pictures of the three-dimensional outline 
of the hemimandibles (Fig 5.6 A, E, I), the protrusive structure on the incisor surface 
from line 2 can be seen (Fig 5.6 I, J), while line 12 (Fig 5.6 E, F) transgenic mouse has a 
similar profile as wild-type mice (Fig 5.6 A, B). On the three-dimensional image which 
shows only the enamel layer of molars and maturation stage enamel of the incisors, the 
mineral density of the maturation incisors from line 2 mice (Fig 5.6 K and L) is obviously 
decreased than that of the line 12 (Fig 5.6 G and H) and wild-type mice (Fig 5.6 C and D). 
The mineral density of the maturation incisor of line 12 (Fig 5.6 G and H) does not have 





    This is the first study that shows over-expression of enamelin resulting in the formation 
of round and hard protrusive structures on the enaml surface. Transgenic mouse line 2 
has more of these protrusive structures on the incisor surface than transgenic mouse line 
12. Since line 2 has a slightly higher enamelin expr ssion than line 12, we suspect that 
this defect of enamel may be dose-dependent. When enam lin expression level is too 
high, like in transgenic line 3 (more than five times as much as wild-type enamelin), the 
enamel formation is completely disrupted. The enamel layer is almost all lost in this 
transgenic line. The fact that wherever there are protrusive structures on the surface of 
enamel, the underlying enamel also lost its rod-interrod decussation pattern is quite 
interesting. The crystallites in these areas seem to have a longitudinal dimension 
extending from the dentino-enamel junction to the outer-enamel portion. It seems that the 
enamel crystals have the tendency to grow too long, instead of assuming the rod-interrod 
pattern. In transgenic mouse line 12, enamel in areas between the “good” and “bad” 
enamel, has crystallite attempted to form bundles of rods, but the interrod-like structure 
was lacking (Fig 5.5 A, d, e, f). We have learned from a previous study that ameloblastin 
over-expression caused interrod enamel to dominate the enamel structure, with the 
crystallites of interrod enamel growing longer in ameloblastin transgenic mice than in the 
wild-type (Paine et al., 2003). This is just opposite to the result of our study. Our data 
indicates that in enamelin null mice and enamelin heterozygous mice, where enamelin 
expression is decreased or obliterated, the ameloblastin expression level is also decreased. 
We also know that in the secretory stage pig tooth, immunostaining showed ameloblastin 
fragments was localized to a honeycomb pattern and enamelin was expressed in a reverse 
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honeycomb pattern (Uchida et al., 1991b). Enamelin is expressed in the enamel rod area 
and ameloblastin is expressed in the interrod area. Taking these pieces of evidence 
together, I hypothesized that during secretory stage enamel formation, enamelin and 
ameloblastin play a role in the rod and interrod structure formation separately. The 
expression level of these two proteins was maintained by ameloblasts in a specific 
manner. When enamelin expression level is low, the cells try to make less ameloblastin as 
well and try to maintain the proportional expression of these two proteins to sustain a rod-
interrod decussating pattern. When the proportional expression level of these two proteins 
was disrupted as in the enamelin transgenic mice and ameloblastin transgenic mice, the 
ameloblasts begin to fail to make enamel in a rod-interrod decussating pattern. In 
enamelin over-expression transgenic mouse, the median level of over-expression cause 
protrusive structures on the enamel surface, probably because the enamel rod structure to 
grow faster and longer than the interrods of enamel. When the enamelin over-expression 
is too high as in transgenic mouse line 3, the ameloblasts fail to make proper enamel. 
More detailed experimental design is needed to test thi  hypothesis. But this study is the 
first to provide information about the defective enamel phenotype of enamelin over-
expression in vivo supporting this hypothesis of enamel formation: the enamelin plays a 
role in enamel rod formation while ameloblastin plays  role in the interrod formation in 
the secretory stage amelogenisis; ameloblasts maintain the expression level of enamelin 
and ameloblastin in a specific manner to maintain the rod-interrod decussating pattern of 














Fig 5.1 Enamelin expression level in transgenic mouse. Enamelin expression level is 
tested in three transgenic mouse line on both mRNA (A and B) expression and protein 
level (C, D, E). Day 5 first molars were extracted from offspring of enamelin transgenic 
mice breeding with C57BL6 wild-type mice. From each transgenic line, littermates were 
divided into two groups: transgene positive (tg) group and transgene negative (wt) group. 
One upper and one lower first molar from each animal were used to isolate mRNA. The 
other upper and lower first molars were used to isolate protein. Enam primer detects both 
endogenous enamelin and transgenic enamelin. “E am tg” primer detects only enamelin 
from transgene. For real-time PCR analysis, animal numbers in each group are as follow: 
n(12-wt)=3, n(12-tg)=3, n(2-wt)=5, n(2-tg)=4, n(3-wt)=3, n(3-tg)=5. A:  Enamelin 
(detects both endogenous enamelin and enamelin from t ansgene) expression level in 
wild-type mouse and transgenic littermates from three transgenic lines. B: Enamelin 
transgene (only from transgene, not endogenous enamelin) expression level in transgenic 
mice and wild-type mice groups from six transgenic lines. C, D: Western-blots 
immunostained using an antibody raised against mouse enamelin peptide starting at 
residue 223. Equal fractions of enamel proteins extracted from day 5 upper and lower 
first molars from Enam wild-type mice (lanes wt1 to wt3) group and Enam transgenic 
mice group (lanes tg1 to tg5) from littermates were loaded on SDS-PAGE gel. Enamelin 








Fig 5.2 Oral photograph of enamelin transgenic mouse. A: Intraoral photographs of 7 
weeks old mice of wild-type mouse (a-d), offspring from transgenic line 12 (e-h), line 2 
(i-l) and line 3(m-p) are shown. These photographs includes direct intraoral photograph (a, 
e, i, m), distal view of lower incisor (b, f, j, n), mesial view of lower incisor and mandible 
(c, g, k, o) and mesial view of molars (d, h, l, p). B: Labial view of lower incisor from 
mice showed in A, i.e., wild-type mouse (a-e), offspring from transgenic line 12 (f-j), line 
2 (k-o) and line 3(p-t). In each row, the magnification is increased from left to right, 2x (a, 
















Fig 5.3 SEM analysis of incisor surface. Surface SEM is examined to show the 
roughness (protrusive structure) of enamel from transgenic mouse line 12(e-h) and line 2 
(i-l) compare to the smooth enamel in wild-type mouse (a-d). Enamel surface of the lower 
incisor (a, e, i), at apical third of lower incisor (b, f, j), middle third of lower incisor (c, g, 






























Fig 5.4 SEM analysis of the wild-type and enamelin transgenic mice. Seven weeks 
old mice were used for SEM (Scanning Electron Micros opy) analysis. Whole enamel 
from wild-type mouse (A), offspring from enamelin transgenic mouse line 12(B), line 2 
(C) and line 3 (D) is shown. Enamel decussation pattern for wild-type mouse is also 


























Fig 5.5 SEM analysis of enamelin transgenic mouse line 12, 2 and 3. Detailed 
structure of enamel is shown for offspring from enamelin transgenic mouse line 12 (A), 
line 2 (B) and line 3(C) by SEM. A: Most parts of enamel layer from enamelin transgenic 
mouse founder line 12 have similar decussation pattern as wild-type (600x in a, 2000x in 
b and 10,000x in c), while where there are protrusive bumps on the surface of enamel, the 
underneath middle enamel start to lose its decussation pattern (600x in g, 2000x in h and 
10,000x in i). There are areas that the enamel has not completely lost its decussation 
pattern (600x in d, 2000x in e and 10,000x in f). B: Transgenic mouse from line 2 still 
have an enamel layer, but most part of the enamel lost its decussation pattern (600x in d, 
2000x in e and 10,000x in f). Small portion of enamel has a decussation pattern (600x in 
a, 2000x in b and 10,000x in c) similar as wild-type mouse. Enamel structure of the 
protrusive area is also shown (600x in g, 2000x in h and 10,000x in i). C: Transgenic 
mouse from line 3 almost lost its enamel layer. Thedecussation pattern of enamel is gone. 
Some area of enamel layer where protrusive bumps are located has some crystallite-like 
structure (600x in a, 2000x in b and 10,000x in c), some other areas just have a thin layer 






Fig.5.6 uCT analysis of enamelin transgenic mice. Mandibles from 7-week old mouse 
were used for micro-CT analysis of wild-type group (A-D), transgenic mouse line 12 (E-
H) and line 2 (I-L). For every group of mice, 3-dimensional mandible (A, E, I), 2-
dimensional incisors (B, F, J), 2-dimensional incisors plus 3-dimensional enamel (C, G, 



































12-wt 1 1.9652421 1.118273814 
12-wt 2 1.862622 1.059880311 
12-wt 3 1.6741447 0.952631831 1.043595 0.084013 
12-tg 1 2.2988266 1.308092062 
12-tg 2 2.4089127 1.370733913 
12-tg 3 2.0338578 1.15731793 1.278715 0.109699 1.225297 
2-wt 1 1.6792271 0.955523848 
2-wt 2 1.8291224 1.040818168 
2-wt 3 1.7073953 0.971552286 
2-wt 4 2.2538085 1.282475593 
2-wt 5 1.7364913 0.988108666 1.047696 0.135105 
2-tg 1 3.3050502 1.880659433 
2-tg 2 2.6437149 1.504342465 
2-tg 3 2.7218759 1.548818105 
2-tg 4 2.149491 1.223116225 1.539234 0.269451 1.469161 
3-wt 1 1.9401212 1.103979369 
3-wt 2 1.3773149 0.783727962 
3-wt 3 1.3057891 0.743027924 0.876912 0.197696 
3-tg 1 7.274665 4.139473389 
3-tg 2 9.1700262 5.217983156 
3-tg 3 8.9793776 5.109499149 
3-tg 4 8.0136903 4.559997986 
3-tg 5 11.605036 
(12-wt1 + 12-
wt2 + 12-wt3 + 
2-wt1 + 2-wt2 
+ 2-wt3 + 2-











Table 5.2 Raw data from real-time PCR experiment plotted for Fig 5.1 B 
 
samples 




12-wt 1 3.21E-06 
12-wt 2 8.02E-07 
12-wt 3 6.04E-07 1.54E-06 1.45E-06 
12-tg 1 1.838011565 
12-tg 2 2.764589055 
12-tg 3 2.288000472 2.296867031 0.463352 
2-wt 1 1.59E-06 
2-wt 2 4.15E-06 
2-wt 3 1.48E-06 
2-wt 4 7.65E-06 
2-wt 5 4.78E-06 3.93E-06 2.55E-06 
2-tg 1 3.361381845 
2-tg 2 2.799421227 
2-tg 3 3.353104467 
2-tg 4 2.76306158 3.06924228 0.332903 
3-wt 1 3.48E-06 
3-wt 2 4.88E-06 
3-wt 3 0.000319356 1.09E-04 0.000182 
3-tg 1 38.00715029 
3-tg 2 34.16794541 
3-tg 3 39.7676823 
3-tg 4 37.62824166 
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Summary of Thesis Findings 
 
There are four portions of work that have been done in this dissertation: 1) The enamelin 
transgenic construct was fabricated and enamelin transgenic mice were established; 2) the 
enamelin transgenic mouse were bred with wild-type mouse as well as enamelin 
knockout mice, the transgene expression levels from different transgenic mouse lines 
were examined; 3) Phenotype of mouse with enamelin transgene expressed in knockout 
background and heterozygous background were describd to determined whether 
enamelin transgene can rescue the defective phenotype f knockout mice; 4) Phenotype 
of enamelin transgenic mouse were described and found to be defective when the 
transgene is expressed at high level. 
 
Enamelin is one of the major enamel matrix proteins that play an important role in tooth 
enamel formation. Enamelin knockout mice showed white and chalky teeth and the 
enamel layer is lost (Hu et al., 2008). Amelogenin is the most abundant enamel matrix 
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protein (Fincham et al., 1999b). Amelogenin promoter has been used to drive enamel 
protein expression successfully in previous studies (Snead et al., 1996; Snead et al., 
1998b; Wen et al., 2008b). Transgenic mice over-expessing enamelin that was driven by 
amelogenin promoter has never been made before. In chapter 2, I described the design 
and procedure of fabricating an enamelin transgene with an amelogenin promoter and the 
establishment of enamelin transgenic mouse made using th s transgene. This transgene 
construct have rare restriction enzyme recognition sites so that can be and already being 
used to make other enamel protein transgene constructs. 
 
In Chapter 3, I described the examination of enamelin transgene expression level in 
different transgenic mouse lines and when transgene is xpressed in different gene 
background. I used the real-time PCR and Western-blot methods to check transgene 
expression at both the mRNA and the protein level. We found that enamelin expression 
level varies, from very little to as high as around 5 times the amount of endogenous gene 
expression. 
 
In Chapter 4, I showed how enamelin transgene can rescue the defective phenotype of 
enamelin knockout mice. In one transgenic mouse line which has a moderate expression 
level, the transgene successfully rescued the defective phenotype of enamelin knockout 
mice. The enamel thickness and microstructure of enamel are same as the enamel of wild-
type mouse with this transgene expressed in knockout background mice. Other transgenic 
mouse lines all have a normal enamel thickness and normal decussation pattern when the 
transgene is expressed in heterozygous background, the teeth look yellowish and smooth, 
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which is similar to the wild-type mouse. These mice have better enamel than the 
heterozygous mice which do not have any enamelin transgene expression.  
 
In Chapter 5, I described the effects of enamelin over-expression on dental enamel 
formation. I found in moderate to high expression leve  enamelin transgenic mouse lines, 
the enamel starts to have defective phenotypes: with moderate expression level, the 
enamel surface is not smooth and has protrusive structure on the surface of enamel; with 
high transgene expression, the enamel layer is almost lost, similar as the phenotype of 
enamelin knockout mice. This is the first time in the literature that the effect of over-
expression of enamelin in developing enamel is described. The effect of transgene over-
expression is dosage dependent. 
 
Future Directions 
Enamelin is a gene that is specific to dental enamel formation. Defects in ENAM cause 
autosomal dominant amelogenesis imperfecta. In Enam null mice, the mineralization 
front fails and no enamel forms. We focus on the mineralization front, which is the center 
of enamel formation. We now know that enamelin transgene with full-length enamelin 
cDNA and proper expression level can rescue the defctive phenotype of enamelin 
knockout mice. We established an in vivo system to study the structural and functional 
relationship of enamelin gene in dental enamel formation. We can further make 
modification of enamelin gene to the area of interests to study the functional domains of 
this gene and their corresponding roles with other proteins and other genes. By 
discovering the molecular mechanisms of enamel formation we will gain important 
 
 119 
insights into the mechanism of biomineralization in general, and pathological conditions 
that cause enamel defects. We know the list of extracellular matrix proteins that are 
critical for dental enamel formation. By understanding how they work together and by 
properly reconstituting the enamel matrix in vitro, we may ultimately synthesize enamel 
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PORCINE DENTIN SIALOPHOSPHOPROTEIN: 
LENGTH POLYMORPHISMS, GLYCOSYLATION, 





Dentin sialophosphoprotein (DSPP) is critical for proper mineralization of tooth 
dentin, and mutations in DSPP cause inherited dentin defects. Dentin phosphoprotein 
(DPP) is the C-terminal cleavage product of DSPP that binds collagen and induces 
intrafibrillar mineralization. We isolated DPP from individual pigs and determined that 
its N-terminal and C-terminal domains are glycosylated, and that DPP averages 155 
phosphates per molecule. Porcine DPP is unstable at low pH and high temperatures, and 
complexing with collagen improves its stability. Surprisingly, we observed DPP size 
variations on SDS-PAGE for DPP isolated from indiviual pigs. These variations are not 
due to differences in proteolytic processing or degre s of phosphorylation or 
glycosylation, but rather to allelic variations in Dspp. Characterization of the DPP coding 
region identified 4 allelic variants. Among the 4 alleles, 27 sequence variations were 
identified, including 16 length polymorphisms rangi from 3 to 63 nucleotides. None of 
the length variations shifted the reading frame, and ll localized to the highly redundant 
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region of the DPP code. The four alleles encode DPPdomains having 551, 575, 589 or 
594 amino acids and completely explain the DPP size variations. DPP length variations 




About 85% of the organic material in tooth dentin is type I collagen. The non-
collagenous proteins in dentin are predominantly cleavage products of dentin 
sialophosphoprotein (DSPP). DSPP is processed by proteases into numerous parts. In pig, 
the three major cleavage products are dentin sialoprotein (DSP) (Yamakoshi et al., 
2005a), dentin glycoprotein (DGP) (Yamakoshi et al., 2005b), and dentin phosphoprotein 
(DPP). The linear order of the structural domains in porcine DSPP is DSP-DGP-DPP. In 
the rat, the designation DSP is used to include all of the non-DPP region of DSPP (DSP-
DPP). The initial proteolytic cleavage of DSPP is in a conserved context and releases 
DPP so that DPP proteins isolated from various mammls share the same N-terminal 
sequence: AspAspProAsn (DDPN) (Butler et al., 1983; Huq et al., 2000). The early work 
on rat DSP and DPP was performed without knowing that DSP and DPP are initially part 
of the same protein and must be secreted in equal amounts. Based upon the results of 
these early studies, it became generally accepted that DPP is ten times more abundant 
than DSP in dentin extracts (Butler et al., 1981; Butler, 1998; ibarPatel, 2001). As DPP 
and DSP are expressed in a 1:1 ratio (MacDougall et l., 1997), to get to a 10:1 ratio DSP 
must be rapidly degraded, and/or there must be altern tive forms of DSP that were not 
previously recognized that, when counted, bring the ratio back to 1:1. In fact, high 
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molecular weight forms of DSP have been discovered in rat dentin (Qin et al., 2003). 
Porcine DSP is a highly glycosylated proteoglycan that forms covalent dimers 
(Yamakoshi et al., 2005a). These glycosylations protect some parts of the protein from 
detection by DSP polyclonal antibodies, so it seems likely that DSP cleavage products 
may be more abundant than was originally thought. 
Defects in human DSPP cause various types of inherited dentin defects, including 
dentin dysplasia type II, and dentinogenesis imperfecta types II and III (Hart and Hart, 
2007; Kim and Simmer, 2007). Dspp knockout mice exhibit dentin defects reminiscent of 
those observed in human dentinogenesis imperfecta (Sreenath et al., 2003). The DSPP 
mutations reported so far are primarily along intro-exon borders near the 5’ end of the 
gene (Holappa et al., 2006; Kim et al., 2004; Kim et al., 2005a; Malmgren et al., 2004; 
Song et al., 2006; Xiao et al., 2001; Zhang et al., 2007). This region encodes DSP, the N-
terminal DSPP cleavage (Ritchie et al., 1994). The DPP coding region in the last exon of 
DSPP (exon 5) has a highly redundant region that is prone to artifacts during reverse 
transcription and polymerase chain reactions (Yamakoshi et al., 2003). Technical 
difficulties have so far thwarted mutational analyses of the DPP code in kindreds with 
inherited dentin defects. The only sequence variation reported to be disease-causing in the 
DPP region was a compound insertion (6 codons) and a deletion (12 codons) in the 
repetitive region (Dong et al., 2005). These insertions and deletions, however, are 
apparently normal sequence variations (polymorphisms) that do not cause the dental 
disease in that kindred. Alignment of four human DSPP sequences in GenBank identified 
10 length variations in the DPP redundant region, ranging in length from 3 to 153 
nucleotides, and all maintaining the reading frame (Kim and Simmer, 2007). An 
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independent analysis of the kindred with the compound insertion/deletion found similar 
(but not identical) deletions and insertions in the DPP redundant region in normal 
controls, and identified a missense mutation (p.P17S) in the DSP code that functional 
studies showed caused retention the DSPP protein in the endoplasmic reticulum (Hart and 
Hart, 2007). Separately, a p.P17S missense alteration was found in the affected members 
of another family with inherited dentin defects and was thought to be causing the disease 
(Zhang et al., 2007). These findings suggest that there may be extensive sequence length 
variations in the human DPP redundant region and that ese length variations are 
compatible with normal function. 
DPP protein has never been extensively characterized, and it is still not known if 
DPP is glycosylated (Qin et al., 2004). In this study we isolate porcine DPP, determine its 
abundance relative to DSP, characterize its post-translational modifications, and 
determine the molecular basis for variability in the size of DPP protein in dentin extracts. 
 
Material and Methods 
 
 
All experimental procedures involving the use of animals were reviewed and approved by 
the Institutional Animal Care and Use Program at the University of Michigan. 
 
Preparation of Dentin Powder. Tooth germs of permanent second molars were 
surgically and extracted with a hammer and chisel from the maxillae and mandibles of 
six-month-old pigs, within minutes of each animal's termination at the Michigan State 
University Meat Laboratory (East Lansing, MI). Typically two maxillary and two 
mandibular second molars were obtained from each animal. The developmental stage of 
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the molars was advanced in crown formation, but prior to the onset of root formation. The 
soft tissue was removed with forceps and secretory and maturation stage enamel was 
scraped off with a curette. The remaining hard tissue was reduced to powder using a jaw 
crusher (Retsch, Newtown, PA).  
 
Extraction of proteins from dentin powder. Dentin powder (1.7-4.4 gm each) obtained 
from 22 pigs individually, or combined from ~8 pigs (40 gm) for large-scale preparations, 
was suspended with 50 mM Tris-HCl/4M guanidine buffer (pH 7.4) containing Protease 
Inhibitor Cocktail Set III (1 mM AEBSF, 0.8 µM aprotinin, 50 µM bestatin, 15 µM E-64, 
20 µM leupeptin and 10 µM pepstatin) (Calbiochem, San Diego, CA) and 1 mM 1,10-
phenanthroline (Sigma, St. Louis, MO, USA). Each sample was intensively agitated with 
an orbital shaker for 24 h at 4 °C. Insoluble materi l was pelleted by centrifugation 
(15,900 x g) and the guanidine extraction repeated for two more days. The insoluble 
guanidine extracts were dialyzed against 16 L of 0.5 M acetic acid (HAc) containing 5 
mM benzamidine (Sigma, St. Louis, MO, USA), 1 mM PMSF (Sigma, St. Louis, MO, 
USA) and 1 mM 1,10-phenanthroline. Each day the calcium concentration in the 
reservoir was measured using the Calcium Reagent Set (Pointe Scientific, Canton, MI, 
USA) and the HAc/protease inhibitor solution was replaced. After five days, the calcium 
ion concentration of the HAc reservoir fell below 0.2 mM, indicating that the tooth 
mineral has fully dissolved. The dialysis bag contents were centrifuged and the pellet was 
extracted with 0.5 M acetic acid/ 2 M NaCl (AN), whic  dissolved dentin phosphoprotein 
(DPP) and DSP proteoglycan products. The AN supernatant was fractioned to purify DPP 




Purification of P\porcine DPP. AN extracts (~10-28 mg each) were dissolved in 0.05% 
trifluoroacetic acid (TFA) and fractionated by revers d phase-high performance liquid 
chromatography (RP-HPLC) using a Discovery C-18 column (1.0 cm x 25 cm, Sigma-
Aldrich / Supelco, Bellefonte, PA) run at a flow rate of 1.0 mL/min and monitored at 220 
nm (Buffer A: 0.05% TFA; Buffer B: 80% acetonitrile/buffer A). 
 
Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE). SDS-
PAGE was performed using Novex 4-20% Tris-Glycine or NuPage 3-8% Tris-Acetate 
Gels (Invitrogen, Carlsbad, CA, USA). Samples were dissolved in Laemmli sample 
buffer (Bio-Rad) and electrophoresis was carried out using a current of 20 mA for 65 min 
or 150V for 1 h, respectively. The gels were stained with Simply Blue Safe Stain 
(Invitrogen) or Stains-all (Sigma, St. Louis, MO, USA). The apparent molecular weights 
of protein bands were estimated by comparison with SeeBlue® Plus2 Pre-Stained 
Standard (Invitrogen). 
 
Release of N- and O-linked Glycan Chains by Glycopetidase A and O-glycanase 
Digestion. Acid phosphatase treated DPP (0.2 mg each) in 0.1M citrate-phosphate buffer 
(pH 5.0) or in 0.25 M sodium phosphate buffer (pH 5.0) was incubated with 1 mU of 
glycopeptidase A (Seikagaku America, East Falmouth, MA  USA) or a mixture of 2.5 
mU of O-glycosidase and 5 mU of sialidase Au (QA-Bio, LLC, Palm Desert, CA) 
containing the Protease Inhibitor Cocktail Set II (0.08 mM of AEBSF, 6.8 µM of Bestatin, 
0.8 µM of E-64, 0.35 mM of EDTA and 8 µM of Pepstatin A; Calbiochem, San Diego, 
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CA, USA) for 48 h or 2 h at 37 °C, respectively. At the end of the incubation period, 
aliquots were analyzed by SDS-PAGE. The six purified pronase digested DPP peptides 
were digested with glycopeptidase A, precipitated with three volumes of ice-cold ethanol 
and pelleted by centrifuged for 10 min at 10,000 x g. Glycans in the supernatant were 
evaporated and stored at -80°C. 
 
Quantitative Determination of Phosphoserine in DPP. DPP from individual 22 pigs 
(0.5-0.7 mg each) was partially hydrolyzed with 0.2ml of 6 N HCl for 3 h at 110 °C. 
After the reaction, the sample was evaporated and dissolved in 1 ml of deionized (DI) 
water, and 0.25 ml was fractionated on a TSK-gel SAX column (4.6 mm x 15 cm, 
TOSOH, Tokyo, JPN). The column was equilibrated with 40 mM potassium phosphate 
buffer (pH 4.0), and eluted with the same buffer at a flow rate of 1.5 ml/min at the room 
T. Phosphoserine was detected by monitoring absorbance t 210 nm and authentic 
phosphoserine, phosphothreonine and phosphotyrosine (Sigma, St. Louis, MO, USA) 
were used as references. The moles of phosphates released was divided by the starting 
weight times 100 g/mole (100-kDa molecular weight) to calculate phosphate per 
molecule. 
 
Quantitative Determination of DPP Phosphorylation by Acid Phosphatase Digestion. 
DPP (150 µg each) in 150 ml of 10 mM sodium acetate/ 50 mM EDTA buffer (pH 5.8), 
from individual pigs was incubated with 0.2 unit of acid phosphatase (White potato) 
(Sigma, St. Louis, MO, USA) containing the Protease Inhibitor Cocktail Set II (0.08 mM 
of AEBSF, 6.8 µM of Bestatin, 0.8 µM of E-64, 0.35 mM of EDTA and 8 µM of 
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Pepstatin A; Calbiochem, San Diego, CA, USA) for 48 h at 37 °C. Free phosphorus in 
aliquots (20 ml) of acid phosphatase digests was measur d by colorimetric assay using 
the Inorganic Phosphorus Reagent Set (Pointe Scientific, Canton, MI, USA). The number 
of phosphates per molecule was calculated assuming a molecular weight of 100-kDa. 
 
Extraction of DPP from gels. Three DPP protein bands from large-scale dentin 
preparations were excised from a polyacrylamide gel aft r Stains-all staining. Each gel 
slice was transferred to a D-Tube Dialyzer (midi size) (Novagen/EMD Chemicals, Inc., 
Gibbstown, NJ) and electroeluted with 25 mM Tris/ 250 mM Tricine/ 0.025% SDS buffer 
(pH 8.5) at 150 volts for 3 h. The eluate (DPP) was precipitated with 20% trichloroacetic 
acid. The pellet was incubated in acetone overnight at -20 ℃ and centrifuged at 4 ℃ for 
30 min at 14,000 x g. The supernatant was decanted, th  pellet dried under a hood, and 
characterized by Edman sequencing. 
 
Purification of DPP Glycopeptide by Pronase Digestion. DPP (25 mg) was digested 
with acid phosphatase, dialyzed against water for 2 days, and lyophilized. Acid 
phosphatase treated DPP (18 mg) was dissolved with 1 ml of 50 mM Tris-HCl buffer (pH 
8.0). This solution was incubated with 0.1 mg of pronase (Calbiochem) for 15 h at 37 °C. 
The digest was fractionated by size exclusion chromat graphy using a Sephadex G-15 
column (1.6 cm x 100 cm, GE Healthcare Life Sciences) equilibrated with 50 mM Tris-
HCl buffer (pH 8.0). DPP peptides were eluted with the same buffer at a flow rate of 0.2 
ml/min at 4  °C with absorbance monitored at 220 nm, and analyzed for glycosylations 
using a phenol-sulfuric acid assay at 490 nm. The fraction of peptides containing DPP 
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glycopeptide were eluted in the first peak and thisfraction was separated by hydrophilic 
interaction liquid chromatography (HILIC) using a PolyHYDROXYETHYL A column 
(4.6 mm ID x 20 cm, The Nest Group, Inc., Southborough, MA, USA) equilibrated with 
15 mM triethylamine-phosphate (TEAP) in 95% acetonitrile (pH 3.0). Peptides were 
eluted with a linear acetonitrile gradient containing 15 mM TEAP in 5% acetonitrile (pH 
3.0) at a flow rate of 0.5 ml/min at room T, while monitoring the absorbance at 220 nm. 
Six peaks were collected and evaporated. Aliquots were used for both amino acid 
sequence and glycosylation analyses. 
 
Preparation and Isolation of 2-AA-labeled Glycans. Glycans released by 
glycopeptidase A were labeled with 2-aminobenzoic ac d (2-AA) Labeling Kit (QA-Bio, 
Palm Desert, CA) and labeled glycans were purified by LudgerClean S cartridge (QA-
Bio). The 2-AA-glycans were fractionated by normal phase (NP) HPLC using a 
SUPELCOSIL LC-NH2 column (4.6 mm x 25 cm, Sigma-Aldrich/ Supelco, Bellefonte, 
PA). The column was equilibrated with 2% acetic acid and 1% tetrahydrofuran in 
acetonitrile. Glycans were eluted with a linear gradient using 5% acetic acid/ 1% 
tetrahydrofuran/ 3% triethylamine in water at a flow rate of 0.7 ml/min at room T. For the 
detection of 2-AA-glycans, an excitation wavelength of 230 nm and an emission 
wavelength of 420 nm were used. 
 
Effect of pH and Temperature for Stability of DPP Structure. DPP (1 mg) was 
dissolved with 0.2 ml of DI water. An 20 µl aliquot was mixed with 180 µl of 50 mM 
sodium acetate or 50 mM Tris-HCl or 50 mM carbonate buffers to achieve a final pH of 4, 
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5, 6, 7, 8, 9, 10 or 11 (50 mM sodium acetate for pH 4 and 5, 50 mM Tris-HCl for pH 6-8, 
or 50 mM carbonate buffer for pH 9-11), respectively. Each sample was divided into five 
tubes (40 µl each). One tube was immediately stored at -80 °C, another one tube was 
incubated for 5 min at 95 °C, and other three tubes w re incubated for 20 h at 4°, 20°, or 
37 °C, respectively. Aliquots (20 µl) of samples were separated by SDS-PAGE and 
visualized with Stains-all. 
 
Effect of Collagen on the Stability of DPP. DPP (0.2 mg) was dissolved with 0.2 ml of 
0.5 M acetic acid. An aliquot of sample (50 µl) was then mixed with 0.2 ml of 0.5 M 
acetic acid containing 0.2 mg of acid-soluble human placenta type I collagen (Abcam, 
Cambridge, MA). Another aliquot (50 µl) were mixed with 0.2 ml of 0.5 M acetic acid 
only. Two samples with and without the collagen were divided into five tubes (50 µl 
each). Each sample was incubated and analyzed by SDS-PAGE. 
 
Amino Acid Analysis. The purified peptide samples (0.02-0.03 mg) were hydrol zed 
with 6 N HCl at 115  °C for 16 h. The amino acid analyses were performed using a 
Beckman Model 7300 automatic amino acid analyzer. 
 
Automated Edman Degradation. Automated Edman degradation used the Applied 





Characterization of DPP Genomic Sequences. Genomic DNA was isolated from the 
ear auricles of the 22 pigs investigated using the DN asy Tissue Kit (QIAGEN, Valencia, 
CA). The DNA from eight pigs (B, J, H, M, N, P, R, V) was used as template to clone 
and characterize the DPP coding region. A segment from Dspp exon 5 containing the 
entire DPP coding region was amplified by polymeras chain reaction (PCR) using the 
primer pair 5’-TGGACCCAGCAAAAC ACATA and 5’-AATCGTAGCCAAGCTGG 
AGA). The reactions ran for 35 cycles, with denaturing at 94 ˚C for 30 s, annealing at 56 
˚C for 30 s, and extension at 72 ˚C for 3 min using the Expand High Fidelity plus PCR 
system (Roche, Indianapolis, IN). The amplification products for each pig were separated 
on 1% agarose gels containing ethidium bromide. The DNA bands were visualized with 
long wavelength UV light, excised with a razor blade, purified using a QIAquick gel 
extraction kit (QIAGEN), ligated into pCR2.1-topo vector (Invitrogen, Carlsbad, CA) and 
used to transform Top10 competent cells (Invitrogen). Individual colonies were grown in 
LB broth and DNA isolated using the SV Minipreps DNA Purification System (Promega, 
Madison, WI). Sequencing was carried out at the University of Michigan DNA 
Sequencing Core using four separate primers, the two used for the original amplification 
and two internal primers (5’ AGTGATGGCAATGGTGACAA and 5’-GATTG 
CTGTCACTGCCTTCA3’). Due to the cloning and characterization of some PCR 
artifacts, a second set of PCR/cloning reactions waconducted and only clones isolated 







Relative abundance of DSP and DPP in porcine dentin. Previously we developed a 
strategy for sequentially extracting proteins from porcine dentin and used DSP and DGP 
antibodies to identify where DSPP-derived cleavage products fractionated during the 
procedure (Yamakoshi et al., 2005a; Yamakoshi et al., 2005b; Yamakoshi et al., 2006). 
This extraction scheme is shown in Fig. A.1A. Dentin powder is first homogenized in 
guanidine. Dialysis of the guanidine extract causes some precipitation, separating it into 
guanidine soluble “GS” and guanidine pellet “GP” extracts. The original guanidine pellet 
is demineralized with acetic acid yielding an acid or “A” extract. The acid pellet is 
extracted with acetic acid/NaCl, generating the “AN” extract. The GS and GP extracts 
contain primarily enamel protein cleavage products and proteases (Yamakoshi et al., 
2005b; Yamakoshi et al., 2006). The A extract contains soluble collagen, 32-kDa 
enamelin (from enamel), osteocalcin, and relatively small cleavage products from the 
non-DPP portion of DSP (the N-terminal fragments of DSP, DGP and extended DGP). 
Very little protein in the AN extract stains with CBB, but this extract is rich in Stains-all 
positive DSPP-derived dentin proteins (Fig. A.1B). Lower molecular weight protein is 
removed from the AN extract by size exclusion chromatography and the high molecular 
weight DSPP-derived proteins are separated into DPP and DSP components by RP-HPLC. 
Five RP fractions are evident in the chromatogram (Fig. A.1C). R1 contains DPP 
fragments, R2 contains intact DPP and DPP fragments, R3 contains the central 
proteoglycan core of DSP, R4 contains DSP, and R5 contains DSP-DGP, or the entire 
non-DPP region of DSPP (Fig.A.1D) (Yamakoshi et al., 2006).  
To quantify the relative abundance of DPP and high molecular weight DSP, we 
isolated and weighed the AN extract from the second molars of 22 individual pigs and 
 
 133 
isolated the five RP-HPLC fractions containing DSPP-derived proteins. We normalized 
for variations in protein quantity among the pig extracts by dividing the quantity of 
protein in each RP fraction by the total amount of protein in the AN extract and 
calculated the total amount of DPP (R1+R2) relative to the total amount of high 
molecular weight DSP in fractions (R3+R4+R5). On a weight basis, porcine dentin in the 
second molars of six month old pigs contains between 1.2 and 2.0 times more DPP than 
high molecular weight DSP (Fig. A.1E). There are, however, low molecular weight DSP 
cleavage products outside of the AN extract (Lanes A, Fig. A.1B). These cannot be 
efficiently isolated and their quantity was not determined for individual pigs, but 
including the small DSP cleavage products in the A xtract would have brought the ratio 
of DSP to DPP (on a weight basis) very close to 1:1, which is consistent with the fact that 
DPP and DSP are synthesized from the same mRNA transcript in 1:1 molar ratios 
(MacDougall et al., 1997; Yamakoshi et al., 2003). 
 
DPP post-translational modifications. An estimate of the gross levels of post-
translational modifications in porcine dentin phospho rotein was made by examining 
DPP before and after dephosphorylation and deglycosylation (Fig. A.2). Porcine DPP in 
our large-scale preparations (that combine dentin powder from 8 pigs) typically appears 
as two prominent bands, often accompanied by a one or two distinct but weaker DPP 
bands. We originally assumed that the multiple DPP bands, all migrating near 100-kDa 
on SDS-PAGE, to be due to variations in the amount of DPP post-translational 
modifications. Dephosphorylation of DPP with acid phosphatase, however, causes these 
DPP bands to shift to a lower apparent molecular weight on SDS-PAGE (Fig. A.2A), but 
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does not alter the pattern of multiple bands. N-deglycosylation (Fig. A.2B) and O-
deglycosylation (Fig. A.2C) of the dephosphorylated DPP does not appreciably alter the 
mobility of DPP on SDS-PAGE and also does not alter th  pattern of multiple bands. 
Each DPP band was excised from the gel and characterized by N-terminal sequencing. 
All three DPP bands gave the same N-terminus: DDPNxxE. These results demonstrate 
that the various DPP bands extracted from porcine dentin do not differ from each other 
because of variations in the levels of phosphorylation, glycosylation, or through the use 
of multiple cleavage sites to release DPP from the parent DSPP protein. We then 
characterized the number of phosphates on DPP and ide tif ed DPP glycosylations sites.  
We isolated DPP from 22 individual pigs and determined the numbers of phosphate 
per molecule using two independent methods. One method measures the amount of 
phosphoserine released after acid hydrolysis, the or measures inorganic phosphate 
released by acid phosphatase. Using the apparent molecular weight of DPP (100-kDa) on 
SDS-PAGE to convert from grams to moles, the number of phosphates per molecule of 
DPP came to an average of 212 per molecule. This number of phosphates would 
contribute 17-kDa to the mass of the protein. 
To identify specific glycosylation sites, DPP was digested with pronase, a cocktail 
of proteolytic enzymes that digests glycoproteins down to short glycopeptides, which are 
protected from further degradation by their bulky carbohydrate chains. The pronase 
digestion products were fractionated by size exclusion chromatography and assayed for 
the presence of glycosylations (Fig. A.3A). The glycosylation-positive peak was 
separated into six fractions (labeled Pr-DPP-1 through Pr-DPP-6) by HILIC (Fig. A.3B). 
The protein in each fraction was deglycosylated and characterized by N-terminal 
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sequencing (Table A.2). The glycosylations were fluorescently labeled and analyzed by 
NP-HPLC (Fig. A.3C-3H). No labeled glycosylations were observed for Pr-DPP-1, Pr-
DPP-5, and Pr-DPP-6. Two N-linked glycosylation site  were identified in the other 
fractions: at Asn525 (Pr-DPP-2 and Pr-DPP-3) and Asn937 (numbered for the smallest 
DSPP allele; Pr-DPP-4). Based upon its retention time on the NP-HPLC column, the 
glycosylation at Asn525 can have either no sialic acid (Pr-DPP3) or two sialic acids (Pr-
DPP2). The glycosylation at Asn937 has two sialic acids (Pr-DPP4). These results 
demonstrate that porcine DPP is glycosylated at two positions, and that variations in 
glycosylation cannot account for the multiple bands of DPP observed on SDS-PAGE.  
 
Allelic polymorphisms as the source of DPP length variations. DPP protein was 
separately isolated from 22 pigs and analyzed by SDS-PAGE (Fig. A.4A). Each pig 
showed either one or two DPP bands of equal intensity, migrating near 100-kDa. DPP 
bands from six pigs representing the full range of DPP size variations were characterized 
by Edman sequencing and all displayed the same N-terminal sequence: DDPNxxE. 
Dephosphorylation caused the DPP bands to shift to a lower position on the gel, but did 
not alter the pattern of bands (Fig. A.4B). We amplified the DPP coding region (which is 
not interrupted by any introns) using genomic DNA isolated from the same 22 pigs used 
to obtain the DPP protein and found length variations in the DPP code that closely 
correlated with the length variations observed at the protein level (Fig. A.4C). 
The DPP PCR products from eight of the pigs were cloned and characterized. 
Some length variations in the DPP amplification products were identified as PCR 
artifacts (data not shown), as they could not be reproduced by repeating the experiment. 
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PCR products that represented singular events were consistently ignored in favor of only 
reproducible outcomes. We characterized four groups f DPP cDNAs that were generated 
from multiple independent PCR cloning experiments, and these clones can account for all 
of the DPP size variability observed at the protein l vel. The DPP clones correspond to 
four allelic variations of the DPP code in the Dspp genes of this group of pigs. The four 
clones varied in length due to the presence of multiple in-frame deletions or insertions. 
All of the length variations localized to the highly redundant region of the DPP code (Fig. 
A.5A). The DPP coding region has 27 sequence variations among the four alleles (Fig. 
A.5B). Of these, 11 are point mutations (changing 5 amino acids) and 16 are length 
variations ranging from 3 to 63 bp that maintain the open reading frame (Table 1, suppl).  
The DPP coding regions in the four alleles are 1656 (EU419998), 1728 
(EU419999), 1770 (EU420000), and 1785 bp (EU419997) in length (Fig. A.5C). Because 
the lengths of the DPP coding region closely correlate with the apparent sizes of the 
protein bands on SDS-PAGE (Figs. A.3A, A.3B), it was possible to deduce the 
distribution of the four DPP alleles in the 22 pigs nvestigated. In these pigs there are 44 
DPP alleles in total: 20 (1656 bp), 18 (1728 bp), 3 (1770 bp) and 3 (1785 bp). Thus, the 
two smallest DPP alleles (1656 bp and 1728 bp) predominate among the pigs in this 
group. These commercial pigs have no apparent dental phenotype and the observed DPP 
sequence variations are not associated with any loss of function. 
 
DPP stability. The effects of pH and temperature on the stability of DPP were examined 
(Fig. A.6). Dentin phosphoprotein is stable for at least 20 h at 4 ˚C and at 20 ˚C within 
the entire range of p 4 to pH 11). At 37 ˚C, DPP is sensitive to hydrogen ion 
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concentration and a significant reduction in the amount of DPP is observed after 20 h at 
pH 5 and below. The degradation of DPP at low pH 5 occurs more rapidly if the protein 
is heated at 95 ˚C for 5 min. The instability of DPP observed at low pH and high T is 




Relative abundance of DSP and DPP. Using the porcine animal model, which provides 
abundant dentin proteins, and having previously surveyed dentin extracts for the presence 
of DSPP-derived proteins, we were able to quantify levels of DSPP-derived proteins from 
developing pig molars and determine that there are approximately equal weights of DSPP 
cleavage products from the DSP-DGP and DPP regions in our dentin extracts. There are 
differences, however in the way these proteins are degraded. After the release of DPP, 
DSP-DGP is processed into numerous relatively small cleavage products (~17 to 35-kDa) 
that can be found in the A extract. Larger DSP-DGP pieces that contain the two long 
chondroitin sulfate attachments are in the AN extract. DPP degradation products do not 
form discrete bands, but rather show a continuum of all sizes that make a Stains-all 
positive smear on SDS-PAGE (Fig. A.1D, R1 and R2). This pattern might reflect an 
inherent chemical instability rather than processing by proteases (Ibaraki et al., 1991). 
 
DPP post-translational modifications. DPP is the most acidic protein known and has an 
isoelectric point of 1.1 (Jonsson and Fredriksson, 1978). The low electric point is due to 
its large number of acidic amino acids and phosphorylated serines. Porcine DPP migrates 
at about 100-kDa on SDS-PAGE. When DPP is isolated from individual pigs, either one 
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or two DPP bands are observed. We have demonstrated that the presence of multiple 
bands is due to allelic variation. Porcine DPP is relatively homogeneous with respect to 
its post-translational modifications. This contrasts with rat DPP where multiple forms 
have been proposed that vary according to their degee of phosphorylation (Butler et al., 
1983).  
We determined that the average number of phosphates per DPP molecule is 212 
when using DPPs apparent molecular weight (100-kDa) on SDS-PAGE to calculate 
moles of DPP in a weighed sample. The results of the cloning and post-translational 
modification studies, however, suggest that 73-kDa might be a better estimate for the 
molecular weight of porcine DPP. The predominant forms of DPP in our population of 
pigs contain 551 or 575 amino acids. Without post-translational modifications, the 
common DPP forms have calculated molecular weights of 54.6-kDa and 57.1-kDa. If 
DPP were 73-kDa, the average number of phosphates per molecule would be 155 (73-
kDa/mol x 212 P/100-kDa/mol = 155 P). This number of phosphates (155/molecule) has 
a mass of 12.4-kDa (155 P x 80 Da/P = 12.4-kDa). The breakdown for the 73-kDa native 
protein is: 56-kDa protein + 12.4-kDa P + 4.6 kDa N-glycos = 73 kDa. As there are 310 
serines per molecule, half of the serines in DPP are phosphorylated. 
The DPP deduced amino acid sequences of the four DPP alleles are aligned in Fig. 
8. There are eight potential N-linked glycosylation sites (NxS, where x≠P) in the N-
terminal region of DPP and five in the C-terminal region. Pronase digests of DPP 
generated short glycopeptides derived from one site in ach of these regions. It seems 
unlikely that additional sites are glycosylated as the mobility of DPP on SDS-PAGE does 




DPP length polymorphisms. The size of DPP varies among species. Rat, bovine, a d 
porcine DPPs have an apparent molecular mass just under 100-kDa (Butler et al., 1983; 
Termine et al., 1980), while human DPP migrates at about 140-kDa on SDS-PAGE 
(Chang et al., 1996). It is becoming increasingly apparent that the size of DPP also varies 
within species. These observations suggest that DPP function is not affected by length 
variations in its repeat region. The functional significance (or insignificance) of DPP 
length variations is important when considering whether a particular sequence variation is 
disease-causing or simply a polymorphism. It is also important when considering DPP 
function. 
Our studies of 22 commercial pigs demonstrate that DPP allelic variations at the 
DNA level translate into size variations at the protein level. The four Dspp alleles showed 
16 DPP length variations ranging from 1 to 21 amino acids and 5 single amino acid 
substitutions. There is no apparent loss of functio due to this variability. Previously we 
reported the cloning of two porcine DSPP (pDSPP) cDNA clones encoding a total of 600 
and 593 amino acids, respectively: pDSPP600/DPP128 (Acc# AY161863) and 
pDSPP593/pDPP121 (Acc# AY161862). The DPP part of these clones was short and 
apparently had most of the DPP region deleted during the cloning procedure, possibly 
during the reverse transcription reaction (Yamakoshi et al., 2003). Only the DPP region 
was affected by artifacts, and the early DSPP clones d monstrated that porcine DPP 
begins at Asp473 of DSPP. Therefore, the four DPP allelic variants identified in the 22 
pigs can be designated pDSPP1023/DPP551, pDSPP1047/DPP575, pDSPP1061/ DPP589, and 
pDSPP1066/DPP594. The pDSPP1023/ DPP551 and pDSPP1047/DPP575 alleles predominate 
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(38/44 alleles) in our group of pigs and express the two major DPP bands observed in 
protein preparations from the same animals. By comparison, rat DSPP protein has 970 
amino acids, 523 of which are in the DPP portion of the protein (rDSPP970/DPP523, Acc# 
AJ403971) (George et al., 1996), while human DSPP is larger and may also show allelic 
length variations (hDSPP1301/DPP839, Acc# NM_014208; hDSPP1253/DPP791 Acc# 
AAF42472) (Gu et al., 2000). 
 
DPP instability. The DPP domain is inherently unstable and degrades when heated in 
vitro (Ibaraki et al., 1991). Increasing concentrations f SDS helped protect against 
thermal degradation. We confirm these findings and d that DPP is unstable at low pH, 
and that type I collagen helps protect DPP from thermal degradation, presumably by 
forming Col I-DPP complexes. 
 
DPP is an intrinsically disordered protein. Proteins that do not appear to adopt a well-
defined conformation under native conditions are increasingly being categorized as 
intrinsically disordered proteins (IDP) (Hansen et al., 2006). The tendency for proteins to 
be intrinsically disordered can be predicted from their amino acid sequences. DPP is 29% 
aspartic acid and 54% serine, with half of the serines being phosphorylated. The PONDR 
computational software for predicting naturally disordered structures gives DPP its 
highest possible score (1.0) over a continuous region extending for more than 350 amino 
acids (Yamakoshi, in press). NMR analysis showed that bovine DPP is a molecule of 
uniformly high mobility, which is consistent with it being an intrinsically disordered 




In summary our results demonstrate that the amounts of protein in porcine dentin extracts 
that are derived from the DSP-DGP and DPP regions of DSPP are about equal. Porcine 
DPP is extensively phosphorylated, averaging 155 phos ates per molecule, and is 
glycosylated in its N-terminal and C-terminal domains. Although porcine DPP shows an 
apparent molecular weight of 100-kDa on SDS-PAGE, we estimate its actual size to be 
73-kDa, based upon the deduced weights of its amino acid chain and post-translational 
modifications. Allelic length variations in the DPP coding region translate into size 
variations at the protein level. Such length variations are exceedingly rare in proteins. 
They occur, however, within the highly redundant DPP region and represent normal 























Figures and Legends 
 
 
Fig A.1: Relative abundance of DSP and DPP in developing porcine molars. A. Strategy for 
isolating dentin proteins from dentin powder that generates four extracts: the guanidine 
supernatant (GS extract), guanidine pellet (GP extract), acid extract (A extract), and acid/NaCl 
(AN extract). B. SDS-PAGE (4-20% gradient gel) stained with CBB (left), Stains-all (center) and 
a Western blot immunostained with an anti-DSP Ab (right). High molecular weight DSPP-
derived proteins in the AN extract do not stain with CBB, but stain deeply with Stains-all. High 
molecular weight DSPP-derived proteins are in the AN extract are purified by size exclusion 
chromatography (not shown) followed by RP-HPLC. C. The RP-HPLC chromatogram exhibits 
five peaks, labeled R1 through R5. D SDS-PAGE (4-20% gradient gel) stained with Stains all 
shows DPP fragments (R1), intact DPP with DPP fragments (R2), DSP proteoglycan core (R3), 
DSP proteoglycan (R4), and DSP-DGP proteoglycan (R5). The weight of the AN extract and 
fractions R1 through R5 was measured for dentin obtained from each of 22 pigs (labeled A 
through V). E. Table showing the dry weights of fractions R1, R2and R3 through R5 divided by 
the total dry weight of the AN extract, and the dryweight of DPP (R1+R2) relative to DSP (R3-





Fig A.2. Multiple DPP bands are not due to variable levels of phosphorylation or 
glycosylation. A. DPP in large scale preparations (from 8 pigs) typically shows 2 
prominent bands and 1 or 2 additional feint bands (lane 1). Dephosphorylation with acid 
phosphatase shifts the multiple bands down the gel, but the pattern of multiple bands is 
preserved. B. N-deglycosylation of the dephosphorylated DPP with glycopeptidase A 
(lane 2) does not significantly alter the mobility of DPP or its pattern of multiple bands 
(lane 1). C. O-deglycosylation of dephosphorylated and N-deglycos lated DPP (lane 2) 
does not significantly alter the mobility of DPP or its pattern of multiple bands (lane 1). 
The three DPP bands from lane 1 in panel A were excis d from the gel and characterized 
by N-terminal sequencing. All gave the same result: DDPNS, which is the conserved 










Fig A.3. Identification of two N-glycosylation sites in DPP. A. Size exclusion 
chromatogram of pronase digestion products of DPP with absorbance monitored at 220 
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nm (blue line). Aliquots were analyzed for glycosylations by measuring the absorbance at 
490 nm (magenta) after performing the phenol-sulfuric acid assay. Fraction applied to 
next column is underlined. B. Chromatogram of glycosylation positive fraction (peak 1 in 
A) divided into 6 parts by hydrophilic interaction-HPLC. The six Pr-DPPs was digested 
with glycopeptidase A and the released N-glycosylations were fluorescently labeled. C-H. 
Chromatograms of labeled N-glycans on NP-HPLC and monitored with an excitation 
wavelength of 230 nm and an emission wavelength of 420 nm. No N-glycans were 
released from Pr-DPP fraction 1 (C), 5 (G), or 6 (H). N-glycans were eluted in order of 
the number of sialic acid (SA) indicated as Neutral, 1SA, 2SA and 3SA (Thomas et al., 
2004). The N-glycan for Pr-DPP-3 (E) has no SA, while those for Pr-DPP-2 (D) and Pr-





















Fig A.4 Length Polymorphisms of DPP protein and coding region. A. SDS-PAGE 
showing variations in the mobility of DPP protein isolated from 22 individual pigs. Nine 
of the 22 pigs showed only a single band of DPP (A,B,C D,G,H,L,O,Q). Thirteen pigs 
showed two DPP bands (E,F,I,J,K,M,N,P,R,S,T,U,V). Although no individual pig 
showed more than 2 DPP bands, six bands of non-identical size could be discerned 
among the 22 pigs. B. Dephosphorylation of DPP from the 22 pigs shifted he bands 
lower on the gel but did not alter the pattern of bands. C. DPP PCR products using 















Fig A.5. DPP allelic variations. A. Mapping of sequence variations in the porcine DPP 
coding region. Point mutations are indicated by numbered arrowheads; deletions are 
indicated by solid rectangles. On the left is the number of basepairs in each DPP allele. 
The first map (1863 bp, brown) is not an allele, but a merged reference sequence that 
contains all of the DPP code found on the four DPP alleles characterized. The 20 
divisions in the coding region correspond to rows of 93 nucleotides each in the DNA 
alignment of the DPP alleles (Table 1 suppl). The four DPP alleles had 1785 (black), 
1770 (blue), 1728 (green) and 1656 (red) basepairs. B. Key to the 27 sequence variations 
observed in the four DPP alleles characterized. C. Listing of the pigs analyzed for 
sequence variations, the number of coding basepairs (bp) in each allele, the number of 
amino acids (aa) in the DPP protein, and the pigs shown to host each allele. The 
predominant alleles in the 22 pigs were 1656 and 1728 bp. Based upon the mobility of the 
proteins (Fig. 4A), and the cloning results, these all les were likely present in 15 or 14 of 
the 22 pigs, respectively (1656: C2,D2,E,F,H2,J,K,M,N,O2,Q2,R,S,T,U; 1728: 
A2,B2,E,F,G2,I,J,L2,N,P,S,T,U,V). Only 6 of the 22 pigs hosted other alleles (I, 
K,M,P,R,V). The 1770 allele in pig P also appeared to be present in pigs I and V. The 
1785 allele in pigs M and R also appeared to be in pig K. The frequency of the four 
characterized alleles in the 22 pigs (44 alleles) were 1656: 20 alleles; 1728: 18 alleles; 











Fig A.6. Instability of DPP at low pH and high T. SDS-PAGE of DPP bands stained 
with Stains-all that have been incubated at the pH shown at the top and the temperature 





























Fig A.7. Collagen-DPP interactions increase the stability of DPP and induce collagen 
fibril assembly. A. SDS-PAGE stained with CBB or CBB plus Stains-all. DPP does not 
stain with CBB but can be visualized with Stains-all. DPP is not stable when incubated 
below pH 6 at higher T. B. SDS-PAGE showing type I collagen (Col I). Col I stains with 
CBB but does not stain with Stains-all (SA) only. C. SDS-PAGE of Col I and DPP after 
being mixed together and incubated at 4˚, 20˚, 37˚,or 95 ˚C. The presence of collagen 













Fig. A.8. Alignment of the DPP deduced amino acid sequences of f ur porcine DSPP 
alleles. pDSPP1066/DPP594 (black), pDSPP1061/DPP589 (blue), pDSPP1047/DPP575 (green) 
and pDSPP1023/DPP551, (red) were aligned together. Key: The five amino acid 
substitutions are in bold. Asparagines (N) in the appropriate context for glycosylation are 
underlined. Asparagines determined to be glycosylated following pronase digestions of 
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TRANGENIC RESCUE OF ENAMEL PHENOTYPE 






Ameloblastin null mice fail to make an enamel layer, but the defects could be due to an 
absence of functional ameloblastin or to the secretion of a potential toxic mutant 
ameloblastin. We hypothesized that the enamel phenotype could be rescued by the 
transgenic expression of normal ameloblastin in Ambn-/- mice. We established and 
analyzed five transgenic lines that expressed Ambn from the amelogenin (AmelX) 
promoter, and identified transgenic lines that exprss virtually no transgene, slightly less 
than normal (Tg+), somewhat higher than normal (Tg++), and much higher than normal 
(Tg+++) levels of ameloblastin. All lines expressing detectable levels of ameloblastin at 
least partially recovered the enamel phenotype. When ameloblastin expression was only 
somewhat higher than normal, the enamel covering the molars and incisors was of normal 
thickness, had clearly defined rod and interrod enamel, and held up well in function. We 










Amelogenin is a secreted enamel matrix protein that is expressed by ameloblasts starting 
just before the initial mineralization of dentin and terminating early in the maturation 
stage (Bronckers et al., 1993; Hu et al., 2001a; Ini et al., 1991; Wakida et al., 1999; 
Wurtz et al., 1996). Amelogenin is the most abundant protein in developing enamel 
(Fincham et al., 1999a), indicating that it is transcribed from a strong promoter. 
Amelogenin is predominantly expressed by ameloblasts, al hough trace expression has 
been reported in other tissues (Gruenbaum-Cohen et al., 2009). Mutations in AMELX 
cause X-linked amelogenesis imperfecta (AI), an inherited condition featuring “isolated” 
or “non-syndromic” enamel malformations, that is, having no defects outside of the 
dentition (Bailleul-Forestier et al., 2008; Hu et al., 2007). Vertebrates, such as birds, that 
have lost the ability to develop teeth during evoluti n, no longer encode a viable 
amelogenin gene (Sire et al., 2008). The strength and tissue-specificity of the amelogenin 
promoter make it an ideal choice to direct expression of transgenes in ameloblasts. 
The mouse amelogenin (AmelX) 5’ transcriptional regulatory region has been 
successfully used to drive transgenic expression specifically in ameloblasts (Paine and 
Snead, 2005; Snead et al., 1996; Snead et al., 1998a; Wen et al., 2008a). A 3.5 kb 
fragment of bovine AmelX 5’ regulatory region up to and including part of exon 1 
directed the expression of ß-galactosidase in ameloblasts, while a 5.5 kb segment of 
bovine AmelX expanded to include intron 1 and part of exon 2 directed expression of an 
amelogenin transgene in mouse ameloblasts (Gibson et al., 2007), which partially rescued 
the enamel phenotype in AmelX null mice (Li et al., 2008b). Transgenic expression of rat 
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ameloblastin by ameloblasts was successful using 2.3 kb of mouse AmelX promoter 
sequence (Paine et al., 2003) and human biglycan was expressed in ameloblasts after 
expanding the mouse AmelX promoter to include intron 1 (Wen et al., 2008a). These 
studies indicate that the AmelX promoter can direct the expression of transgenes by 
ameloblasts in a pattern that mimics the normal expression of enamel proteins during 
tooth development. 
Ameloblastin (Ambn) is an enamel matrix protein that is co-secreted with 
amelogenin by ameloblasts during enamel formation (Zalzal et al., 2008). AmelX and 
Ambn are members of the secretory calcium binding phospprotein (SCPP) family and 
evolved from a common ancestral gene (Delgado et al., 2001; Kawasaki and Weiss, 
2003). Ameloblastin expression is enamel-specific (Krebsbach et al., 1996; Lee et al., 
1996). Ambn is reduced to a pseudogene in whales that evolved alt rnatives to teeth 
(Demere et al., 2008). Ambn-/- mice exhibit a non-syndromic AI phenotype (Fukumoto e  
al., 2004). Currently, no AMBN mutations have been identified in persons with 
amelogenesis imperfecta, although AMBN mutational analyses have been performed on 
dozens of probands from AI kindreds. 
Mice normally secrete two ameloblastin isoforms, having 381 or 396 amino acids. 
The two isoforms differ by the alternative mRNA splicing of 15 codons at the beginning of 
exon 6 (Hu et al., 1997a). The best evidence that ameloblastin is essential for dental 
enamel formation comes from the absence of normal enam l in Ambn-/- mice (Fukumoto 
et al., 2004). However, the Ambn knockout construct deleted exons 5 and 6 and resulted in 
the expression of an ameloblastin protein having 279 amino acids (missing 102 or 117 
amino acids depending upon the isoform) (Wazen et al., 2009). The expression of 
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truncated amelogenins by ameloblasts, even in the presence of normal amelogenin 
expression, induced enamel malformations in transgenic mice (Paine et al., 2000). 
Therefore, the enamel phenotype in Ambn-/- mice might be due to the absence of functional 
ameloblastin and/or to a negative effect caused by secretion of the mutant ameloblastin 
protein (Smith et al., 2009; Wazen et al., 2009). If the phenotype is caused predominantly 
by the lack of functional ameloblastin, we hypothesiz  that the enamel phenotype in Ambn-
/- mice should be rescued by transgenic expression of normal ameloblastin by ameloblasts. 
We tested this hypothesis with a transgene that drives expression of the mouse 
ameloblastin 396 amino acid isoform from the mouse amelogenin promoter in Ambn-/- 
mice. 
 
Material and Methods 
Protocol Approval. Animal protocols were reviewed and approved by the University of 
Michigan Institutional Animal Care and Use Committee. 
 
Fabricating the Ambn Transgene. We sacrificed C57BL/6 mice on Post-Natal day 5 
(PN5) and removed the developing first molars by dissection under a stereoscopic 
microscope. Total RNA was extracted using Trizol (Invitrogen, Carlsbad, CA, USA) and 
chloroform, converted into cDNA with SuperScript II reverse transcriptase (Invitrogen), 
and used as template to amplify Ambn transcripts by polymerase chain reaction (PCR). We 
isolated genomic DNA from the tail tissues of C57BL/6 mice with the DNeasy Tissue kit 
(Qiagen, Valencia, CA) and used it as template to amplify 5’ and 3’ AmelX sequences. 
The amplification products were ligated into the pCR2.1-TOPO cloning vector 
(Invitrogen), transfected into bacteria, and selectd for by ampicillin resistance. The 
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orientation of the inserts were determined by restriction analyses of DNA mini-preps. 
Clones with their 5’ ends on the NotI side of the multiple cloning site were characterizd 
by DNA sequencing and used to fabricate the Ambn transgene (see on-line appendix for 
details). 
 
Generation of Ambn Transgenic Mice and Breeding with Ambn-/- Mice. The 7.5 kb 
Ambn transgene was excised from the vector by restriction digestion with NotI-SrfI 
purified with a Qiaquick gel extraction kit (Qiagen, Germantown, Md., USA) and 
microinjected into fertilized C57BL/6 X SJL F2 oocytes and surgically transferred to 
recipients at the Transgenic Animal Model Core at the University of Michigan. A total of 
17 independent lines were generated and mated with C57BL/6 mice. Germline 
transmission was determined by PCR analysis of genomic DNA obtained from tail 
biopsies. Offspring carrying the Ambn transgene (Tg) were mated with Ambn-/- mice 
(Fukumoto et al., 2004). F1 offspring positive for the transgene and heterozygous for 
ameloblastin (Ambn+/-) were mated, yielding four genotypes in the F2 generation (Suppl. 
Fig. B.1A). Tail biopsies were analyzed by PCR using primers specific for the Ambn Tg, 
wild-type Ambn, or the Ambn knockout gene. 
 
Assessing Ambn Tg Expression Levels By Western Blotting. To obtain an antibody 
that would specifically recognize the ameloblastin protein expressed from the wild-type 
gene and the ameloblastin transgene, but not the smaller mutant meloblastin expressed 
from the Ambn knockout gene, rabbit antibodies were raised against the KLH-conjugated 
peptide MRPREHETQQYEYS, which is encoded by the exon 5-6 region deleted in the 
ameloblastin knockout. Specific anti-peptide antibodies were purified from the final bleed 
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using an affinity column containing the immobilized, unconjugated ameloblastin peptide 
and designated Ambn-89 (YenZym, Burlingame, CA). 
 
Tg Expression Assessment by Western Blotting. Ambn+/+ mice and a litter from the F2 
generation were terminated on PN5. The first molars were surgically extracted under a 
dissecting microscope and the soft-tissue removed. Tails were collected for PCR 
genotyping. The hard tissues from a maxillary and a m ndibular first molars were 
incubated in 1 mL of 0.5% formic acid at 4 ˚C overnight, centrifuged briefly to remove 
residual insoluble material, and transferred to an Ultracel YM-3 filter (3 kDa cutoff, 
Millipore, Billerica, MA), centrifuged, and the enamel protein on the filter was raised in 
sample buffer, run on SDS-PAGE, transferred to a membrane, and ameloblastin bands 
were visualized by Western blotting. 
 
Scanning Electron Microscopy (SEM) of Mandibular Incisors. The soft tissue was 
removed from left and right half-mandibles at 7 weeks. We measured the distances from 
the incisor tip to the labial alveolar crest and then extracted the incisors. We used a 
rotating diamond disc to cut through just the dentin (at the measured distance from the 
incisor tip) and fractured the incisor at the notch. SEM imaging of the broken surface 
highlights the decussating rods. The broken edge of the incisor was polished with a 
diamond disc and lightly etched with 0.1% nitric acid. The surface was sputter coated 









We introduced rare (8 bp) restriction sites at the edges of mouse AmelX 5’ and 3’ 
genomic sequences and the Ambn cDNA by PCR amplification, cloned the products, and 
fabricated an ameloblastin transgene construct. Multiple independent transgenic lines 
were evaluated for their levels of ameloblastin transgene expression (Fig. B.1A.) We 
identified transgenic lines that express virtually no transgene, slightly less than normal 
(Tg+), somewhat higher than normal (Tg++), and much higher than normal (Tg+++) 
levels of ameloblastin and then compared their gross enamel phenotypes (Fig. 1B). 
Whenever detectable levels of ameloblastin protein was expressed in the Ambn-/- 
background, the enamel phenotype was at least partially recovered. In the case where the 
ameloblastin transgene expression was only somewhat higher than normal (Tg++), the 
enamel covering the molars and incisors appeared idntical to that of the wild-type. 
Transgenic mice with a high level of ameloblastin expr ssion (Tg+++) displayed chalky 
white mandibular incisors, suggesting that there is a range of ameloblastin expression that 
is optimal for dental enamel formation (Fig. B.1B). The mandibular incisors were 
extracted and examined under a dissecting microscope. The enamel layer of the extracted 
mandibular incisor from the Tg++ mouse was analogous t  the wild-type mouse along its 
entire length (Fig. B.2). 
Mandibular incisors at 7 weeks were cut or fractured at the level of the labial 
alveolar bone crest and analyzed by scanning electron microscopy. The enamel thickness 
and decussating pattern of enamel rods was significa tly recovered even with less than 
normal or much greater than normal expression of ameloblastin (Fig. B.3). Recovery was 
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most complete in the central region where the enamel forms earliest and reaches the 
greatest thickness. The area most sensitive to ameloblastin levels was the distal enamel 
surface, where low or high levels of ameloblastin expr ssion resulted in reduced enamel 
thickness and a rough surface. The enamel thickness and rod patterns looked normal in 
the mouse expressing somewhat higher than normal (Tg++) levels of ameloblastin, 
although there seemed to be a lack of definition, which might be attributable to increased 




We designed and fabricated a plasmid construct with rare restriction enzyme sites 
positioned at key places to direct high levels transgenic expression of target proteins 
specifically in ameloblasts. This construct allows for one-step directional cloning of a 
desired coding sequence between the 5’ and 3’ sequences from AmelX, and is a useful 
vector for specifically expressing transgenic proteins in ameloblasts. Transgenic mice 
were generated so that ameloblasts secreted the 396 amino acid isoform of mouse 
ameloblastin. We characterize five transgenic lines and assessed ameloblastin protein 
levels in developing first molars at PN5. Two lines did not secrete detectable levels of 
ameloblastin. Three lines expressed progressively increasing amounts of ameloblastin, 
ranging from less than normal amounts to levels well above normal. The thickness of the 
enamel layer and the decussating pattern of enamel rod were assessed by SEM. The 
enamel phenotype varied in each of the transgenic li es. When no ameloblastin was 
expressed, there was no recovery of the enamel phenotype in Ambn-/- mice. There was 
partial recovery when ameloblastin expression was below normal (Tg+) or much greater 
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than normal (Tg+++), with the best recovery being i the central portion of the incisor 
enamel. Ameloblastin transgene expression at somewhat higher than normal levels (Tg++) 
showed full recovery of enamel thickness and rod architecture. 
These results prove that the severe enamel phenotype in Ambn-/- mice is 
predominantly or entirely due to the absence of functio al ameloblastin, and not due to 
toxic effects caused by secretion of the shortened 279 amino acid ameloblastin protein, 
which appears to be relatively inert, but might contribute to higher levels of residual 
protein in the rescued enamel. The recovery of the enamel phenotype in Ambn-/- by 
transgenic expression of functional ameloblastin cofirms the previous conclusion that 
ameloblastin is essential for proper dental enamel formation and that Ambn-/- mice are a 
valid animal model to investigate the absence of functional ameloblastin on dental 
enamel formation.  
We were surprised to observe so much variation in ameloblastin expression in the 
various transgenic lines. Clearly integration site and copy number have a profound effect 
on transgene expression levels in ameloblasts, and expression levels are a major 
determinant of how transgenic expression affects enamel formation. Interpretations of the 
affects on enamel formation of transgenic protein expr ssion by ameloblasts are only 
meaningful in the context of transgenic protein expr ssion levels in the matrix. 
We used an anti-peptide antibody for this study that recognizes an epitope on the 
exon 5-exon 6 encoded portion of ameloblastin. This antibody specifically detected a 17-
kDa ameloblastin cleavage product in mouse tooth extracts. A homologous 17-kDa 
ameloblastin cleavage product having this epitope was previously isolated from porcine 
enamel and characterized (Fukae et al., 2006). It consists of the ameloblastin N-terminal 
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region (Val1 to Arg170) and is generated by Mmp-20 cleavage (Chun et al., submitted) of 
ameloblastin following its secretion. Despite its relatively small size, the 17-kDa 
ameloblastin cleavage product elutes in the first chromatographic peak on size exclusion 
columns, suggesting that the protein tends to aggregate (Fukae and Tanabe, 1987b). A 
ladder of immunopositive bands was observed on our Western blot of tooth proteins 
extracted from the transgenic line that over-expresses ameloblastin. These bands extend 
well above the apparent molecular weight of uncleaved ameloblastin (~65-kDa) and are 
likely to be aggregates of the 17-kDa ameloblastin cleavage product. Apparently Mmp-20 
is able to process ameloblastin completely, even thoug  significantly more ameloblastin 
than normal is being secreted by the ameloblastin tra sgene. When ameloblastin 
expression levels are highest, a smaller immunoreactiv  band appears below the 17-kDa 
band on the Western blot. The porcine 17-kDa ameloblastin is O-glycosylated 
(Kobayashi et al., 2007). We suspect that this smaller band is the unglycosylated form of 
the 17-kDa protein, and that excessive ameloblastin expression might allow some 
ameloblastin molecules to escape glycosylation. 
The ameloblastin transgene was able to recover the thickness of the enamel layer as 
a whole, the decussating pattern enamel rods, and the overall appearance of normal 
enamel. SEM analysis of the incisor enamel that was fr ctured to highlight the 
decussating prism pattern, however, seemed to be less w ll-defined than the wild-type. 
This suggests that the enamel in the transgenic rescue might contain more residual protein 
than normal. Increased protein retention may be due to the expression of the 279 amino 
acid non-functional form of ameloblastin or to over-expression of the ameloblastin 
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transgene. Expression of the ameloblastin transgene in a total knockout might help 






Figures and Legends 
 
Figure B.1. Ameloblastin Expression Levels and Associated Enamel Phenotypes. A: 
SDS-PAGE stained with Coomassie brilliant blue (CBB), and Western blots 
immunostained using an antibody raised against recombinant mouse amelogenin (Amel-
179), or against an ameloblastin peptide absent from the smaller ameloblastin expressed 
by the Ambn knockout (Ambn-89). The apparent molecular weights (in kDa) of protein 
bands in the samples are indicated on the left. Equal fractions of enamel proteins 
extracted from day 5 molars from Ambn wild-type (lanes ++), Ambn heterozygotes (lanes 
+-), Ambn heterozygotes expressing an ameloblastin transgene (la s +-T), Ambn 
homozygous knockout mice (lanes --), and Ambn knockout mice expressing an 
ameloblastin transgene (lanes --T) were applied to each lane. The yield of enamel 
proteins from the Ambn-/- mice was always much lower than other samples becaus  of the 
virtual absence of an enamel layer. Except for the wild-type (++) lanes, all samples on a 
single gel or blot are from littermates. The only ameloblastin band reacting against the 
Ambn-89 antibody migrates at 17-kDa. The ladder of immunopositive bands in Western 
for Line 14 is due to aggregation of the 17-kDa ameloblastin cleavage product when 
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loaded at the high concentrations expressed. B: Oral photographs at 7 weeks of the 
incisors in situ and a lingual view of molars following removal of soft tissue. The molars 
and incisors from the Ambn-/-Tg++ mice held up to occlusal forces, did not chip or abrade, 
and could not be distinguished from teeth from wild-type mice. Apparent differences in 




Figure B.2. Exposed Mandibular Incisors. These photos were taken through a 
dissecting microscope and show the labial surfaces of mandibular incisors at 7 weeks. 
The incisors from the transgenic line expressing somewhat higher than normal amounts 
of the ameloblastin transgene (Tg++) appeared similar to the wild-type when expressed in 









Figure B.3. Scanning Electron Micrographs of Mandibular Incisors at 9 Weeks. All 
images are of cross-sections obtained at the level of the buccal alveolar crest. Row1: Low 
magnification view of polished cross section showing the entire enamel layer. The 
Ambn+/+ and Ambn+/- mice show no enamel defects. The Ambn-/- mice have no true 
enamel, but a thin, rough crust of mineral covers the surface of dentin. The enamel 
phenotype is recovered in the central region when ameloblastin transgenes provide less 
than (Tg+) and more than (Tg+++) optimal amounts of ameloblastin, but the distal 
enamel is thinner than normal and has a rough surface. Row2: Higher magnification view 
of polished enamel showing the enamel thickness in the central region. The line spanning 
the enamel layer is where measurements of enamel thickness were made. The enamel 
layer in the Tg++ mice was the same thickness as in the wild-type. Row3: High 
magnification of polished, cut, lightly etched enamel showing the underlying rod 
architecture. Only the Ambn-/- mice show a complete absence of enamel rods. Rod and 
interrod enamel are clearly distinguished in the Tg++ mice. Row4: The enamel layer after 
being fractured reveals the decussating pattern of enamel rods. Although a normal pattern 
of decussating enamel rods is evident in the mice expressing different levels of the 
ameloblastin transgene, the fractured surface of the mice expressing the smaller Ambn 
from the knockout gene was not as well defined as the wild-type, possibly due to an 
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